View Filing Data

Print Document View Excel Document

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2013	Nov. 01, 2013
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3
Entity Registrant Name	Globalstar, Inc.
Entity Central Index Key	0001366868
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Voting Common Stock [Member]
Entity Common Stock, Shares Outstanding		466,486,563
Nonvoting Common Stock [Member]
Entity Common Stock, Shares Outstanding		283,047,118

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenue:
Service revenues	$ 17,056	$ 15,368	$ 47,854	$ 42,146
Subscriber equipment sales	5,493	5,169	13,863	15,110
Total revenue	22,549	20,537	61,717	57,256
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	8,181	7,413	22,913	22,218
Cost of subscriber equipment sales	4,148	4,040	10,675	10,465
Cost of subscriber equipment sales - reduction in the value of inventory		660		957
Marketing, general, and administrative	9,079	7,425	22,579	21,062
Reduction in the value of long-lived assets				7,218
Contract termination charge				22,048
Depreciation, amortization, and accretion	23,715	18,654	66,114	49,277
Total operating expenses	45,123	38,192	122,281	133,245
Loss from operations	(22,574)	(17,655)	(60,564)	(75,989)
Other income (expense):
Loss on extinguishment of debt	(63,569)		(110,809)
Loss on equity issuance	(2,733)		(16,701)
Interest income and expense, net of amounts capitalized	(16,901)	(6,565)	(39,869)	(13,396)
Derivative gain (loss)	(97,534)	(16,473)	(126,911)	(2,562)
Other	(1,540)	(439)	(1,125)	(938)
Total other income (expense)	(182,277)	(23,477)	(295,415)	(16,896)
Loss before income taxes	(204,851)	(41,132)	(355,979)	(92,885)
Income tax expense	118	56	341	361
Net loss	$ (204,969)	$ (41,188)	$ (356,320)	$ (93,246)
Loss per common share:
Basic	$ (0.30)	$ (0.10)	$ (0.64)	$ (0.25)
Diluted	$ (0.30)	$ (0.10)	$ (0.64)	$ (0.25)
Weighted-average shares outstanding:
Basic	673,546	392,344	559,515	376,518
Diluted	673,546	392,344	559,515	376,518
Comprehensive loss	$ (204,417)	$ (40,069)	$ (356,417)	$ (91,578)

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 6,643	$ 11,792
Restricted cash		46,777
Accounts receivable, net of allowance of $6,567 and $6,667, respectively	16,444	13,944
Inventory	37,482	42,181
Deferred financing costs		34,622
Prepaid expenses and other current assets	7,583	5,233
Total current assets	68,152	154,549
Property and equipment, net	1,187,288	1,215,156
Restricted cash	37,940
Deferred financing costs	79,861	16,883
Advances for inventory	9,158	9,158
Intangible and other assets, net	7,375	8,029
Total assets	1,389,774	1,403,775
Current liabilities:
Current portion of long-term debt		655,874
Accounts payable, including contractor payables of $17,801 and $27,747, respectively	26,444	35,685
Accrued contract termination charge	23,699	23,166
Accrued expenses	32,828	28,164
Payables to affiliates	303	230
Derivative liabilities	41,539
Deferred revenue	17,822	18,041
Total current liabilities	142,635	761,160
Long-term debt, less current portion	675,690	95,155
Employee benefit obligations	7,117	7,221
Derivative liabilities	254,207	25,175
Deferred revenue	7,317	4,640
Debt restructuring fees	20,795
Other non-current liabilities	15,411	15,880
Total non-current liabilities	980,537	148,071
Commitments and contingent liabilities (Notes 8 and 9)
Stockholders' equity:
Preferred Stock
Common Stock	71	49
Additional paid-in capital	976,386	864,175
Future equity issuance of common stock to related party	16,242
Accumulated other comprehensive loss	(1,855)	(1,758)
Retained deficit	(724,242)	(367,922)
Total stockholders' equity	266,602	494,544
Total liabilities and stockholders' equity	1,389,774	1,403,775
Preferred Stock [Member]
Stockholders' equity:
Preferred Stock
Series A Preferred Stock [Member]
Stockholders' equity:
Preferred Stock
Common Stock [Member]
Stockholders' equity:
Common Stock	45	35
Nonvoting Common Stock [Member]
Stockholders' equity:
Common Stock	$ 26	$ 14

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2013	Dec. 31, 2012
Accounts receivable, allowance	$ 6,567	$ 6,667
Accounts payable, including contractor payables	$ 17,801	$ 27,747
Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1	1
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common Stock [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,200,000,000	865,000,000
Common stock, shares issued	448,117,231	354,085,753
Common stock, shares outstanding	448,117,231	354,085,753
Nonvoting Common Stock [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	400,000,000	135,000,000
Common stock, shares issued	256,875,000	135,000,000
Common stock, shares outstanding	256,875,000	135,000,000

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows provided by (used in) operating activities:
Net loss	$ (356,320)	$ (93,246)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation, amortization, and accretion	66,114	49,277
Change in fair value of derivative assets and liabilities	126,067	2,562
Stock-based compensation expense	1,850	585
Amortization of deferred financing costs	6,256	2,498
Noncash interest and accretion expense	22,341	9,415
Reduction in the value of long-lived assets and inventory		8,176
Provision for bad debts	1,359	695
Contract termination charge		22,048
Loss on extinguishment of debt related to amendment and restatement of Thermo Loan Agreement	110,809
Loss on equity issuance	16,701
Unrealized foreign currency gain (loss)	635	(269)
Other, net	605	2,218
Changes in operating assets and liabilities:
Accounts receivable	(4,001)	(1,919)
Inventory	4,253	(240)
Prepaid expenses and other current assets	(1,353)	1,459
Other assets	874	6,253
Accounts payable and accrued expenses	4,617	360
Payables to affiliates	73	(147)
Other non-current liabilities	(996)	(1,093)
Deferred revenue	2,450	2,246
Net cash provided by operating activities	2,334	10,878
Cash flows used in investing activities:
Second-generation satellites, ground and related launch costs (including interest)	(37,732)	(43,305)
Property and equipment additions	(1,225)	(382)
Investment in businesses	(496)	(450)
Restricted cash	8,838	(3,650)
Net cash used in investing activities	(30,615)	(47,787)
Cash flows provided by financing activities:
Borrowings from Facility Agreement	672	5,008
Proceeds from contingent equity agreement	1,071	23,000
Payments to reduce principal amount of exchanged 5.75% Notes	(13,544)
Payments for 5.75% Notes not exchanged	(6,250)
Payments to lenders and other fees associated with exchange	(2,482)
Proceeds for equity issuance to related party	51,500
Proceeds from issuance of common stock and exercise of warrants	8,979	100
Payments of deferred financing costs	(16,904)	(250)
Net cash provided by financing activities	23,042	27,858
Effect of exchange rate changes on cash	90	319
Net decrease in cash and cash equivalents	(5,149)	(8,732)
Cash and cash equivalents, beginning of period	11,792	9,951
Cash and cash equivalents, end of period	6,643	1,219
Supplemental disclosure of cash flow information:
Cash paid for: Interest	11,445	18,958
Cash paid for: Income taxes	28	216
Supplemental disclosure of non-cash financing and investing activities:
Reduction in accrued second-generation satellites and ground costs	9,688	4,646
Increase in non-cash capitalized interest for second-generation satellites and ground costs	3,691	4,309
Capitalization of the accretion of debt discount and amortization of debt issuance costs	4,716	6,786
Interest and other payments made in convertible notes and common stock	4,240	4,629
Conversion of debt into common stock	23,570	2,000
Reduction in debt discount and issuance costs related to note conversions	13,164	1,812
Extinguishment of principal amount of 5.75% Notes	(71,804)
Issuance of principal amount of 8% Notes Issued in 2013	54,611
Issuance of common stock to exchanging note holders at fair value	12,127
Reduction in carrying amount of Thermo Loan Agreement due to amendment	(35,026)
Conversion of contingent equity account derivative liability to equity		5,853
Value of warrants issued in connection with the contingent equity account loan fee		$ 2,226

BASIS OF PRESENTATION	9 Months Ended
BASIS OF PRESENTATION	Sep. 30, 2013
BASIS OF PRESENTATION [Abstract]
BASIS OF PRESENTATION	1. BASIS OF PRESENTATION The Company has prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information. Certain information and footnote disclosures normally in financial statements have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission; however, management believes the disclosures made are adequate to make the information presented not misleading. These financial statements and notes should be read in conjunction with the consolidated financial statements and notes thereto included in Globalstar, Inc.'s Annual Report on Form 10-K for the year ended December 31, 2012 and Management's Discussion and Analysis of Financial Condition and Results of Operations herein. The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Certain reclassifications have been made to prior period condensed consolidated financial statements to conform to current year presentation. The Company evaluates estimates on an ongoing basis. Significant estimates include the value of derivative instruments, the allowance for doubtful accounts, the net realizable value of inventory, the useful life and value of property and equipment, the value of stock-based compensation, the reserve for product warranties, and income taxes. Actual results could differ from these estimates. All significant intercompany transactions and balances have been eliminated in the consolidation. In the opinion of management, the information included herein includes all adjustments, consisting of normal recurring adjustments, that are necessary for a fair presentation of the Company's condensed consolidated statements of operations, condensed consolidated balance sheets, and condensed consolidated statements of cash flows for the periods presented. These unaudited interim condensed consolidated financial statements include the accounts of Globalstar and its majority owned or otherwise controlled subsidiaries. The results of operations for the three and nine months ended September 30, 2013 are not necessarily indicative of the results that may be expected for the full year or any future period. Recently Issued Accounting Pronouncements In February 2013, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2013-02, Reporting Amounts Reclassified Out of Accumulated Other Comprehensive Income. This standard requires that companies present either in a single note or parenthetically on the face of the financial statements, the effect of significant amounts reclassified from each component of accumulated other comprehensive income based on its source and the income statement line items affected by the reclassification. ASU 2013-02 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2012. This adoption did not have an impact on the Company's condensed consolidated financial statements.

MANAGEMENT'S PLANS REGARDING FUTURE OPERATIONS

9 Months Ended

Sep. 30, 2013

MANAGEMENT'S PLANS REGARDING FUTURE OPERATIONS [Abstract]

MANAGEMENT'S PLANS REGARDING FUTURE OPERATIONS

2. MANAGEMENT'S PLANS REGARDING FUTURE OPERATIONS

Current sources of liquidity include cash on hand, cash flows from operations, cash received from the exercise of warrants and stock options, funds which Thermo Funding Company LLC (including its affiliates, "Thermo") has agreed to invest or arrange to be invested in the Company pursuant to the Equity Commitment, Restructuring Support and Consent Agreement dated as of May 20, 2013 among the Company, Thermo, BNP Paribas, as agent, and the lenders under the Facility Agreement (as defined below) (the "Consent Agreement") and the Global Deed of Amendment and Restatement (the "GARA") described below and funds available from the Company's equity line agreement with Terrapin Opportunity, L.P. ("Terrapin").

In order to continue as a going concern, the Company must execute its business plan, which assumes the modification of certain obligations and the funding of the financial arrangements with Thermo and Terrapin referred to above. Substantial uncertainties remain related to the impact and timing of these events. If the resolution of these uncertainties materially and negatively impacts cash and liquidity, the Company's ability to continue to execute its business plan will be adversely affected. The Company's financial statements have been prepared on a going concern basis, which contemplates continuity of operations, realization of assets and the satisfaction of liabilities in the normal course of business. The accompanying financial statements do not include any adjustments related to the recoverability and classification of recorded assets or the amounts and classification of liabilities that might result from the uncertainty associated with the items discussed below, except as otherwise disclosed.

The Company has taken the following steps towards improving operations; completing and maintaining its second-generation constellation and next-generation ground infrastructure; and obtaining additional financing:

•

Completed the relocation of its corporate headquarters to Covington, Louisiana, streamlined its supply chain and other operations, consolidated its world-wide operations, and simplified its product offerings. The Company has continued to maintain a low cost operating structure, while strategically investing in sales and marketing and new product development.

•

Increased revenues by transitioning legacy Duplex customers to more profitable plans, commensurate with the Company's improved service coverage, and adding new subscribers to the network at growing rates.

•

Successfully launched and placed into commercial service all of its second-generation satellites, excluding one on-ground spare.

•

Entered into financing arrangements with Thermo under which Thermo has provided or agreed to provide or arrange up to $85.0 million in equity or equity-linked financing.

•

Entered into a $30.0 million equity line agreement with Terrapin.

•

Drew $60.0 million from its contingent equity account.

•

Settled disputes with Thales Alenia Space ("Thales") regarding contractual issues.

•

Implemented sales and marketing programs targeted to the mass consumer market, as well as the traditional Mobile Satellite Services ("MSS") vertical markets, that are designed to take advantage of the introduction of new mobile satellite products and the continued expansion of the Company's Duplex coverage, including entering into new sales agreements and introducing new pricing plans commensurate with improved service levels.

•

Commenced a proceeding before the Federal Communications Commission ("FCC") seeking authority to utilize the Company's MSS spectrum to offer terrestrial wireless services, including mobile broadband, separate and apart from, but coordinated with, its satellite-based communications.

•

Introduced the SPOT Global Phone to the consumer mass market, which leverages the Company's retailer distribution channels and SPOT brand name.

•

Introduced the SPOT Gen3, the next generation of the SPOT Satellite GPS Messenger. SPOT Gen3 offers enhanced functionality with more tracking features, improved battery performance and more power options including rechargeable and USB direct line power.

•

Issued $54.6 million principal amount of new 8.00% Convertible Senior Notes (the "8.00% Notes Issued in 2013"), together with cash and shares of its common stock, in exchange for all of the Company's $71.8 million principal amount of 5.75% Convertible Senior Unsecured Notes (the "5.75% Notes"), which were in default.

•

Entered into the Global Deed of Amendment and Restatement (the "GARA"), which significantly adjusted the principal repayment schedule and covenant levels required under the Company's $586.3 million senior secured credit facility (the "Facility Agreement") and cured existing events of default under the Facility Agreement.

The Company believes that these actions, combined with additional actions included in its operating plan, will result in improved cash flows from operations, provided the significant uncertainties described in the first section of this footnote are successfully resolved. These additional actions include, among other things, the following:

•

Completing second-generation ground infrastructure upgrades that will permit the Company to offer a new suite of consumer and enterprise products that leverage the Company's new, inexpensive chip architecture and enhanced handset and gateway functionality.

•

Negotiating agreements with third parties to restart operations at certain existing Globalstar gateways to make coverage in additional areas commercially viable.

•

Continuing to pursue numerous opportunities in the field of aviation, including next-generation "space-based" air traffic management services, in association with the Company's technology partner, ADS-B Technologies, LLC.

•

Continuing to control operating expenses while redirecting available resources to the marketing and sale of product offerings.

•

Improving its key business processes and leveraging its information technology platform.

•

Introducing new and innovative Simplex, SPOT and Duplex products to the market that will further drive sales volume and revenue by continuing to target traditional MSS vertical markets as well as the consumer mass market.

•

Continuing the Company's ongoing petition before the FCC to utilize the Company's MSS spectrum for terrestrial wireless services, including broadband services. On November 1, 2013, the FCC released proposed rules for Globalstar terrestrial broadband services over 22 MHz of spectrum.

PROPERTY AND EQUIPMENT

9 Months Ended

Sep. 30, 2013

PROPERTY AND EQUIPMENT [Abstract]

PROPERTY AND EQUIPMENT

3. PROPERTY AND EQUIPMENT

Property and equipment consists of the following (in thousands):

	September 30,			December 31,
	2013			2012
Globalstar System:
Space component
Second-generation satellites in service	$	1,212,234		$	934,900
Prepaid long-lead items		17,040			17,040
Ground component		48,581			49,089
Construction in progress:
Space component		33,155			299,209
Ground component		109,384			84,423
Other		799			880
Total Globalstar System		1,421,193			1,385,541
Internally developed and purchased software		15,023			14,414
Equipment		12,996			12,800
Land and buildings		3,837			4,003
Leasehold improvements		1,507			1,512
		1,454,556			1,418,270
Accumulated depreciation and amortization		(267,268	)		(203,114	)
	$	1,187,288		$	1,215,156

Amounts in the above table consist primarily of costs incurred related to the construction of the Company's second-generation constellation and ground upgrades. Amounts included in the Company's construction in progress - space component balance as of September 30, 2013 consist primarily of costs related to a spare second-generation satellite that is capable of being included in a future launch of satellites. See Note 8 for further discussion of the Company's current contractual obligations.

Capitalized Interest and Depreciation Expense

The following tables summarize capitalized interest for the periods indicated below (in thousands):

	As of
	September 30,		December 31,
	2013		2012
Total interest capitalized	$	231,026	$	216,477

	Three Months Ended						Nine Months Ended
	September 30, 2013			September 30, 2012			September 30, 2013			September 30, 2012
Interest cost eligible to be capitalized	$	13,119		$	13,777		$	38,851		$	43,411
Interest cost recorded in interest expense, net		(10,151	)		(5,543	)		(24,302	)		(10,239	)
Net interest capitalized		2,968			8,234			14,549			33,172

The following table summarizes depreciation expense for the periods indicated below (in thousands):

	Three Months Ended				Nine Months Ended
	September 30, 2013		September 30, 2012		September 30, 2013		September 30, 2012
Depreciation expense	$	23,961	$	17,964	$	65,622	$	47,542

LONG-TERM DEBT

9 Months Ended

Sep. 30, 2013

LONG-TERM DEBT [Abstract]

LONG-TERM DEBT

4. LONG-TERM DEBT

Long-term debt consists of the following (in thousands):

	September 30, 2013				December 31, 2012
	Principal		Carrying		Principal		Carrying
	Amount		Value		Amount		Value
Facility Agreement	$	586,342	$	586,342	$	585,670	$	585,670
Thermo Loan Agreement		58,569		20,488		53,499		49,822
5.75% Convertible Senior Unsecured Notes		-		-		71,804		70,204
8.00% Convertible Senior Notes Issued in 2013		47,570		25,547		-		-
5.0% Convertible Senior Unsecured Notes		25,199		11,959		40,920		16,701
8.00% Convertible Senior Unsecured Notes Issued in 2009		49,665		31,354		48,228		28,632
Total Debt		767,345		675,690		800,121		751,029
Less: Current Portion		-		-		657,474		655,874
Long-Term Debt	$	767,345	$	675,690	$	142,647	$	95,155

The above table represents the principal amount and carrying value of long-term debt at September 30, 2013 and December 31, 2012. The principal amounts shown above include payment of in kind interest, if any. The carrying value is net of any discounts to the loan amounts at issuance, including accretion, as further described below.

Facility Agreement

The Company's Facility Agreement, as described below, was amended and restated in August 2013 and is scheduled to mature in December 2022. Semi-annual principal repayments are scheduled to begin in December 2014. The facility bears interest at a floating LIBOR rate plus a margin of 2.75% through June 2017, increasing by an additional 0.5% each year to a maximum rate of LIBOR plus 5.75%. Ninety-five percent of the Company's obligations under the Facility Agreement are guaranteed by COFACE, the French export credit agency. The Company's obligations under the Facility Agreement are guaranteed on a senior secured basis by all of its domestic subsidiaries and are secured by a first priority lien on substantially all of the assets of the Company and its domestic subsidiaries (other than their FCC licenses), including patents and trademarks, 100% of the equity of the Company's domestic subsidiaries and 65% of the equity of certain foreign subsidiaries. The Facility Agreement contains customary events of default and requires that the Company satisfy various financial and nonfinancial covenants. The Company was in compliance with all covenants as of September 30, 2013.

The Facility Agreement requires the Company to maintain a total of $37.9 million in a debt service reserve account. The use of the funds in this account is restricted to making principal and interest payments under the Facility Agreement. As of September 30, 2013, the balance in the debt service reserve account was $37.9 million and classified as restricted cash.

Former Terms of Facility Agreement

In 2009, the Company entered into the Facility Agreement with a syndicate of bank lenders, including BNP Paribas, Natixis, Société Générale, Caylon, Crédit Industriel et Commercial as arrangers and BNP Paribas as the security agent and agent for the Company's Facility Agreement. Prior to its amendment and restatement in 2013, the Facility Agreement had a maturity date of 84 months after the first principal repayment date, as amended. Semi-annual principal repayments were scheduled to begin on June 30, 2013, as amended. The Facility Agreement bore interest at a floating LIBOR rate, plus a margin of 2.25% through December 2017 increasing to 2.40% thereafter.

The Facility Agreement required the Company to maintain a total of $46.8 million in a debt service reserve account. The use of the funds in this account was restricted to making principal and interest payments under the Facility Agreement. The minimum required balance, not to exceed $46.8 million, fluctuated over time based on the timing of principal and interest payment dates. In December 2012, the amount required to be funded into the debt service reserve account was reduced by approximately $8.9 million due to the timing of the first principal repayment date scheduled for June 2013. In January 2013, the agent for the Facility Agreement permitted the Company to withdraw from the debt service reserve account $8.9 million that was in excess of the required balance to enable the Company to pay capital expenditure costs from the fourth launch of its second-generation satellites.

The Facility Agreement contained customary events of default and required that the Company satisfy various financial and nonfinancial covenants. As a result of the Thales arbitration ruling and the subsequent settlement agreements reached with Thales related to the arbitration ruling in 2012, the lenders concluded that events of default had occurred under the Facility Agreement. The Company was also in default of certain other financial and nonfinancial covenants, including, but not limited to, lack of payment of principal in June 2013 in accordance with the terms of the Facility Agreement, minimum required funding for the Company's debt service account, and in-orbit acceptance of all of its second-generation satellites by April 2013. As of June 30, 2013, the borrowings were shown as current on the Company's condensed consolidated balance sheet in accordance with applicable accounting rules. The Company also projected that it would not be in compliance with certain future financial and nonfinancial covenants specified under the Facility Agreement. These events of default were waived or cured by the amendment and restatement of the Facility Agreement.

Amended and Restated Facility Agreement

As previously disclosed, on July 31, 2013, the Company entered into the GARA with Thermo, the Company's domestic subsidiaries (the "Subsidiary Guarantors"), a syndicate of bank lenders, including BNP Paribas, Société Générale, Natixis, Credit Agricole Corporate and Investment Bank and Credit Industrial et Commercial as arrangers and BNP Paribas as the security agent and COFACE Agent, providing for the amendment and restatement of the Facility Agreement and certain related credit documents. The GARA became effective on August 22, 2013 and, among other things, waived all of the Company's defaults under the Facility Agreement and restructured the financial covenants.

Pursuant to the GARA,

In August 2013, Globalstar paid the lenders a restructuring fee plus an additional underwriting fee to COFACE in the aggregate amount of approximately $13.9 million, representing 40% of the total restructuring and underwriting fee, the balance of which is due no later than December 31, 2017. Globalstar also paid all outstanding incurred transaction expenses for the Lenders. The remaining $20.8 million due to the lenders no later than December 31, 2017 is included in noncurrent liabilities on the September 30, 2013 condensed consolidated balance sheet.

In August 2013, Globalstar drew the remaining approximately $0.7 million not previously borrowed under the Facility Agreement for certain milestone payments due to Thales for the construction of its second-generation satellites.

In August 2013, all amounts remaining under the Thermo Contingent Equity Account (approximately $1.1 million) and approximately $0.2 million in the Debt Service Reserve Account were paid to the Company's launch services provider for the account of Globalstar to pay certain costs for the launch of the Company's second-generation satellites.

Thermo confirmed its obligations under the Equity Commitment, Restructuring and Consent Agreement dated as of May 20, 2013 to make, or arrange for third parties to make, cash contributions to the Company in exchange for equity, subordinated convertible debt or other equity-linked securities, of $20.0 million on or prior to December 26, 2013, and an additional amount of up to $20 million on or prior to December 31, 2014. See further discussion below on the details of the Consent Agreement and subsequent cash contributions to Globalstar.

The Lenders waived all existing defaults or events of default under the Facility Agreement.

The GARA made the following changes to the terms of the Facility Agreement:

The initial principal payment date, formerly June 30, 2013, was postponed to December 31, 2014, and the final maturity date was extended from June 30, 2020 to December 31, 2022.

The remaining principal payments, with the final payment due December 31, 2022, were also restructured, resulting in an aggregate postponement of $235.3 million in principal payments through 2019.

The annual interest rate increased by 0.5% to LIBOR plus 2.75% through July 1, 2017, and increases by an additional 0.5% each year thereafter to a maximum rate of LIBOR plus 5.75%.

Mandatory prepayments were expanded in specified circumstances and amounts, including if the Company generates excess cash flow, monetizes its spectrum rights, receives the proceeds of certain asset dispositions or receives more than $145.0 million from the sale of additional debt or equity securities (excluding the Thermo commitments described above and up to $19.5 million under the Company's equity line with Terrapin.).

The financial covenants were modified, including changing the amount of permitted capital expenditures, reducing the required minimum liquidity amount from $5.0 million to $4.0 million, restructuring the other existing financial covenants to correspond to the Company's revised business plan reflecting the delays in delivery of the Company's second-generation satellites, and adding a new covenant with respect to the Company's interest coverage ratio.

The definition of Change of Control was amended to require a mandatory prepayment of the entire facility if Thermo and certain of its affiliates own less than 51% of the Company's common stock.

The required balance of the Debt Service Reserve Account was fixed at the current amount of approximately $37.9 million for the length of the Facility Agreement.

Any new subordinated indebtedness of the Company may not mature or pay cash interest prior to the final maturity date of the Facility Agreement.

The Company, while the Facility Agreement is outstanding, is prohibited from paying any cash dividends or repaying any principal or interest with respect to its indebtedness to Thermo under the Thermo Loan Agreement.

The Company is prohibited from amending its material agreements without the lenders' prior consent.

An event of default was added if any litigation against the Company results in a final judgment that imposes a material liability that was not anticipated by the Company's business plan.

The Company evaluated the GARA under applicable accounting guidance and determined that the amendment and restatement of the Company's Facility Agreement was a modification of the former indebtedness. As a result of the modification of the Facility Agreement, all financing costs paid to the Company's legal and other advisors, a total of $0.3 million, was recorded in other income and expense in the Company's condensed consolidated statements of operations for the three months ended September 30, 2013. Financing costs paid to the lenders were capitalized as a deferred asset on the Company's condensed consolidated balance sheet as of September 30, 2013 and will be amortized using the effective interest rate method to interest expense through the maturity of the Facility Agreement.

Contingent Equity Agreement

The Company has a Contingent Equity Agreement with Thermo whereby Thermo agreed to deposit $60.0 million into a contingent equity account to fulfill a condition precedent for borrowing under the Facility Agreement. Under the terms of the Facility Agreement, the Company had the right to make draws from this account if and to the extent it had an actual or projected deficiency in its ability to meet obligations due within a forward-looking 90-day period.

The Contingent Equity Agreement provided that the Company would pay Thermo an availability fee of 10% per year for maintaining funds in the contingent equity account. This annual fee was payable solely in warrants to purchase common stock at $0.01 per share with a five-year exercise period from issuance. The Company determined that the warrants issued in conjunction with the availability fee were derivatives and recorded the value of the derivatives as a component of other non-current liabilities, at issuance. The offset was recorded in other assets and was amortized over the one-year availability period. The warrants issued on June 19, 2012 were not subject to a reset provision subsequent to issuance and are therefore not considered a derivative instrument. The value of the warrants issued was recorded as equity and the offset was recorded in other assets and was amortized over the one-year availability period.

When the Company made draws on the contingent equity account, it issued Thermo shares of common stock calculated using a price per share equal to 80% of the average closing price of the common stock for the 15 trading days immediately preceding the draw. The 20% discount on the value of the shares issued to Thermo is treated as a deferred financing cost and is amortized over the remaining term of the Facility Agreement. The Company has drawn the entire $60.0 million from this account as well as interest earned from the funds previously held in this account of approximately $1.1 million.

Since the origination of the Contingent Equity Agreement, the Company has issued to Thermo warrants to purchase 41,467,980 shares of common stock for the annual availability fee and subsequent resets due to provisions in the Contingent Equity Agreement and 160,916,223 shares of common stock resulting from the Company's draws on the contingent equity account pursuant to the terms of the Contingent Equity Agreement. As of September 30, 2013, the Company had not yet issued 2,133,656 shares of nonvoting common stock to Thermo from the $1.1 million draw in August 2013 from the interest earned on the contingent equity account. The total fair value of these shares of $1.3 million was recorded as a future equity issuance in the stockholders' equity section on the Company's condensed consolidated balance sheet as of September 30, 2013, which represented the $1.1 million of interest and $0.2 million of deferred financing costs for the value of the 20% discount on the shares to be issued to Thermo. As of September 30, 2013, no warrants issued in connection with the Contingent Equity Agreement had been exercised.

No voting common stock is issuable to Thermo or any of its affiliates if it would cause Thermo and its affiliates to own more than 70% of the Company's outstanding voting stock. The Company may issue nonvoting common stock in lieu of common stock to the extent issuing common stock would cause Thermo and its affiliates to exceed this 70% ownership level.

Thermo Loan Agreement

The Company has an Amended and Restated Loan Agreement (the "Loan Agreement") with Thermo whereby Thermo agreed to lend the Company $25.0 million for the purpose of funding the debt service reserve account required under the Facility Agreement. In 2011, this loan was increased to $37.5 million. This loan is subordinated to, and the debt service reserve account is pledged to secure, all of the Company's obligations under the Facility Agreement. Amounts deposited in the debt service reserve account are restricted to payments due under the Facility Agreement, unless otherwise authorized by the lenders.

The loan accrues interest at 12% per annum, which is capitalized and added to the outstanding principal in lieu of cash payments. The Company will make payments to Thermo only when permitted under the Facility Agreement. The loan becomes due and payable six months after the obligations under the Facility Agreement have been paid in full, if the Company has a change in control or if any acceleration of the maturity of the loans under the Facility Agreement occurs.

As additional consideration for the loan, the Company issued to Thermo a warrant to purchase 4,205,608 shares of common stock at $0.01 per share with a five-year exercise period. No voting common stock is issuable upon such exercise if such issuance would cause Thermo and its affiliates to own more than 70% of the Company's outstanding voting stock. The Company may issue nonvoting common stock in lieu of common stock to the extent issuing voting common stock would cause Thermo and its affiliates to exceed this 70% ownership level. The Company determined that the warrant was an equity instrument and recorded it as a part of stockholders' equity with a corresponding debt discount which was netted against the principal amount of the loan. The Company accreted the debt discount associated with the warrant using an effective interest method to interest expense over the term of the loan agreement prior to the amendment and restatement as discussed below. As of September 30, 2013, $21.1 million of interest was outstanding; this amount is included in long-term debt on the Company's condensed consolidated balance sheet.

As previously disclosed, in connection with the amendment and restatement of the Company's Facility Agreement, the Company also amended and restated the Loan Agreement in July 2013. The Amended and Restated Loan Agreement made the following changes:

Provided that the indebtedness would be represented by a promissory note.

Provided that if a Fundamental Change (as defined in the Fourth Supplemental Indenture with respect to the 8% Notes issued in 2013) occurs prior to the repayment of the indebtedness, the Company would pay Thermo an amount equal to the Fundamental Make-Whole Amount (as defined in that indenture).

Provided that the indebtedness will be convertible into common stock of Globalstar on substantially the same terms as the 8.00% Notes Issued in 2013, excluding the conversion features on special conversion dates as defined in the Indenture.

The terms of the amendment and restatement were approved by a special committee of the Company's board of directors consisting solely of the Company's unaffiliated directors. The committee was represented by independent legal counsel.

Based on the Company's evaluation of the amended and restated Loan Agreement, this transaction was determined to be an extinguishment of the debt under the prior Loan Agreement. The Company recorded a loss on the extinguishment of this debt of $66.1 million in its condensed consolidated statement of operations during the third quarter of 2013. This loss represents the difference between the fair value of the Loan Agreement, as amended and restated, and its carrying value just prior to amendment and restatement. See Note 6 for further discussion on the fair value of this instrument.

The Company evaluated the various embedded derivatives within the Loan Agreement. The Company determined that the conversion option and the contingent put feature upon a fundamental change required bifurcation from the Loan Agreement. The conversion option and the contingent put feature were not deemed clearly and closely related to the Loan Agreement and were separately accounted for as a standalone derivative. The Company recorded this compound embedded derivative liability as a non-current liability on its condensed consolidated balance sheet with a corresponding debt discount which is netted against the face value of the Loan Agreement.

The Company is accreting the debt discount associated with the compound embedded derivative liability to interest expense through the maturity of the Loan Agreement using an effective interest rate method. The fair value of the compound embedded derivative liability will be marked-to-market at the end of each reporting period, with any changes in value reported in the condensed consolidated statements of operations. The Company determined the fair value of the compound embedded derivative using a Monte Carlo simulation model.

The Company netted the debt discount associated with the compound embedded derivative against the fair value of the Loan Agreement to determine the carrying amount of the Loan Agreement. The accretion of the debt discount will increase the carrying amount of the debt through the maturity of the Loan Agreement. The Company allocated the fair value at issuance as follows (in thousands):

Loan Agreement	$	18,958
Compound embedded derivative liability		101,114
Fair value of Loan Agreement	$	120,072

5.75% Convertible Senior Unsecured Notes

In 2008, the Company issued $150.0 million aggregate principal amount of 5.75% Notes, which were subject to repurchase by the Company for cash at the option of the holders in whole or part on April 1, 2013 at a purchase price equal to 100% of the principal amount ($71.8 million aggregate principal was outstanding at April 1, 2013) of the 5.75% Notes, plus accrued and unpaid interest, if any.

On March 29, 2013, U.S. Bank National Association, the Trustee under the Indenture and the First Supplemental Indenture governing the 5.75% Notes, each dated as of April 15, 2008, between the Company and the Trustee (collectively, as amended and supplemented or otherwise modified, the "Indenture"), notified the Company in writing that holders of approximately $70.7 million principal amount of 5.75% Notes had exercised their purchase rights pursuant to the Indenture. Under the Indenture, the Company was required to deposit with the Trustee on April 1, 2013, the purchase price of approximately $70.7 million in cash to effect the repurchase of the 5.75% Notes from the exercising holders. The Company did not have sufficient funds to pay the purchase price when due, which constituted an event of default under the Indenture.

In addition, the Indenture also required that, on April 1, 2013, the Company pay interest on the 5.75% Notes in the aggregate amount of approximately $2.1 million for the six months ended March 31, 2013. The Company did not make this payment. Under the Indenture, failure to pay this interest by April 30, 2013 also constituted an event of default.

As discussed below, these events of default were cured pursuant to the Exchange Agreement transactions consummated on May 20, 2013.

Exchange Agreement

On May 20, 2013, the Company entered into an Exchange Agreement with the beneficial owners and investment managers for beneficial owners (the "Exchanging Note Holders") of approximately 91.5% of its outstanding 5.75% Notes and completed the transactions contemplated by the Exchange Agreement.

Pursuant to the Exchange Agreement, the Exchanging Note Holders surrendered their 5.75% Notes (the "Exchanged Notes") to the Company for cancellation in exchange for:

	·	Approximately $13.5 million in cash, with respect to the principal amount of the Exchanged Notes, plus approximately $0.5 million in cash, equal to all accrued and unpaid interest on the Exchanged Notes from April 1, 2013 to the closing;
	·	Approximately 30.3 million shares of voting common stock of the Company; and
	·	Approximately $54.6 million principal amount of the Company's new 8.00% Convertible Senior Notes due April 1, 2028 (the "8.00% Notes Issued in 2013"), with an initial conversion price of $0.80 per share, subject to adjustment as described below.

In the Exchange Agreement, the Company also agreed that, if the Company grants certain liens to Thermo or its affiliates in connection with future financing transactions, the Exchanging Note Holders may participate in such transactions in an amount up to 50% of the participation of Thermo and its affiliates.

Pursuant to the Exchange Agreement, the Company also cured outstanding defaults under the 5.75% Notes by:

	·	Cancelling the Exchanged Notes as described above;
	·	Depositing with the Trustee approximately $2.1 million, an amount equal to the interest due on all of the 5.75% Notes on April 1, 2013 and accumulated interest thereon, for distribution to the holders of record of the 5.75% Notes as of March 15, 2013;

	·	Depositing with the Trustee approximately $6.3 million, an amount equal to the principal amount of the 5.75% Notes (other than the Exchanged Notes) and interest thereon from April 1, 2013 to June 26, 2013 and directing the Trustee to pay such amounts to the holders of the 5.75% Notes (other than the Exchanged Notes); and
	·	Redeeming the remaining 5.75% Notes.

On May 20, 2013, the Company agreed to redeem the remaining 5.75% Notes for cash equal to their principal amount.

Based on the Company's evaluation of the exchange transaction, the Exchange Agreement was determined to be an extinguishment of the 5.75% Notes. As a result of this exchange, the Company recorded a loss on the extinguishment of debt of $47.2 million in its condensed consolidated statement of operations during the second quarter of 2013. This loss represented the difference between the carrying value of the 5.75% Notes and the fair value of the consideration given in the exchange (including the new 8.00% Notes Issued in 2013, cash payments to both exchanging and non-exchanging holders, equity issued to the holders and other fees incurred in the exchange). See Note 6 for further discussion on the fair value of this instrument.

The Consent Agreement

To obtain the lenders' consent to the transactions contemplated by the Exchange Agreement, pursuant to the Consent Agreement, Thermo agreed that it would make, or arrange for third parties to make, cash contributions to the Company in exchange for equity, subordinated convertible debt or other equity-linked securities as follows:

	·	At the closing of the exchange transaction and thereafter each week until no later than July 31, 2013, an amount sufficient to enable the Company to maintain a consolidated unrestricted cash balance of at least $4.0 million;
	·	At the closing of the exchange transaction, $25.0 million to satisfy all cash requirements associated with the exchange transaction, including agreed principal and interest payments to the holders of the 5.75% Notes as contemplated by the Exchange Agreement, with any remaining portion being retained by the Company for working capital and general corporate purposes;
	·	Contemporaneously with, and as a condition to the closing of, any restructuring of the Facility Agreement, $20.0 million (less any amount contributed pursuant to the commitment described above with respect to the Company's minimum cash balance);
	·	Subject to the prior closing of the Facility Agreement restructuring, on or prior to December 26, 2013, $20.0 million; and
	·	Subject to the prior closing of the Facility Agreement restructuring, on or prior to December 31, 2014, $20.0 million, less the amount by which the aggregate amount of cash received by the Company under the first, third and fourth commitments described above exceeds $40 million.

In accordance with the terms of the Common Stock Purchase Agreement and Common Stock Purchase and Option Agreement discussed below, as of September 30, 2013, Thermo has contributed a total of $51.5 million to the Company in exchange for 145.9 million shares of the Company's nonvoting common stock. As of September 30, 2013, an additional $8.8 million had been contributed to the Company through warrant exercises and other equity issuances, reducing Thermo's remaining commitment to $24.7 million.

The Common Stock Purchase Agreement

On May 20, 2013, the Company and Thermo entered into a Common Stock Purchase Agreement pursuant to which Thermo purchased 78,125,000 shares of the Company's common stock for $25.0 million ($0.32 per share). Thermo also agreed to purchase additional shares of common stock at $0.32 per share as and when required to fulfill its equity commitment described above to maintain the Company's consolidated unrestricted cash balance at not less than $4.0 million until the earlier of July 31, 2013 and the closing of a restructuring of the Facility Agreement. In furtherance thereof, at the closing of the transactions contemplated by the Exchange Agreement, Thermo purchased an additional 15,625,000 shares of common stock for an aggregate purchase price of $5.0 million. In June 2013, Thermo purchased an additional 28,125,000 shares of common stock for an aggregate purchase price of $9.0 million pursuant to the Common Stock Purchase Agreement. Pursuant to its commitment, Thermo invested a further $6.0 million on July 29, 2013 and $6.5 million on August 19, 2013, on terms later determined by a special committee of the Company's board of directors consisting solely of the Company's unaffiliated directors as described below.

During the second quarter of 2013, Thermo purchased approximately 121.9 million shares of the Company's common stock pursuant to the Common Stock Purchase Agreement for an aggregate $39.0 million. For the three months ended June 30, 2013, the Company recognized a loss on the sale of these shares of approximately $14.0 million (included in other income/expense on the condensed consolidated statement of operations), representing the difference between the purchase price and the fair value of the Company's common stock (measured as the closing stock price on the date of each sale). Pursuant to the Common Stock Purchase Agreement, the shares of common stock are intended to be shares of non-voting common stock. As of May 20, 2013, the Company's certificate of incorporation did not provide for sufficient shares of authorized but unissued non-voting common stock. The Company recorded the fair value of these shares as a future equity issuance in the stockholders' equity section of the Company's condensed consolidated balance sheet as of June 30, 2013. On July 8, 2013, the Company filed an amendment to its certificate of incorporation increasing the number of authorized shares of non-voting common stock by 265.0 million shares to a total of 400.0 million shares and subsequently issued nonvoting shares to Thermo in exchange for the payments previously made under the Common Stock Purchase Agreement. These shares were subsequently recorded in common stock and additional paid-in capital in the third quarter of 2013.

The terms of the Common Stock Purchase Agreement were approved by a special committee of the Company's board of directors consisting solely of the Company's unaffiliated directors. The committee, which was represented by independent legal counsel, determined that the terms of the Common Stock Purchase Agreement were fair and in the best interests of the Company and its shareholders.

The Common Stock Purchase and Option Agreement

On October 14, 2013, the Company and Thermo entered into a Common Stock Purchase and Option Agreement pursuant to which Thermo agreed to purchase 11,538,461 shares of the Company's non-voting common stock at a purchase price of $0.52 per share in exchange for the $6.0 million invested in July and an additional $20 million, or 38,461,538 shares, in exchange for the $6.5 million funded in August and an incremental $13.5 million at a purchase price of $0.52 per share as and when requested to do so by the special committee through November 28, 2013. Thermo further agreed to purchase, upon the request of the special committee prior to December 26, 2013, up to $11.5 million of additional shares of non-voting common stock at a price equal to 85% of the average closing price of the voting common stock during the ten trading days immediately preceding the date of the special committee's request.

During the third quarter of 2013, Thermo purchased approximately 24.0 million shares of the Company's common stock pursuant to the terms of the Common Stock Purchase and Option Agreement for an aggregate purchase price of $12.5 million. For the three months ended September 30, 2013, the Company recognized a loss on the sale of these shares of approximately $2.4 million (included in other income/expense on the condensed consolidated statement of operations), representing the difference between the purchase price and the fair value of the Company's common stock (measured as the closing stock price on the date of each sale). As the terms for the stock purchased by Thermo had not been determined as of September 30, 2013, the Company recorded the fair value of these shares as a future equity issuance in the stockholders' equity section of the Company's condensed consolidated balance sheet as of September 30, 2013. On October 14, 2013, the Common Stock Purchase and Option Agreement was signed, and shares of nonvoting stock were issued to Thermo and subsequently recorded in common stock and additional paid-in capital in the fourth quarter of 2013.

The terms of the Common Stock Purchase and Option Agreement were approved by a special committee of the Company's board of directors consisting solely of the Company's unaffiliated directors. The committee, which was represented by independent legal counsel, determined that the terms of the Common Stock Purchase and Option Agreement were fair and in the best interests of the Company and its shareholders.

Share Lending Agreement

Concurrently with the 2008 offering of the 5.75% Notes, the Company entered into a share lending agreement (the "Share Lending Agreement") with Merrill Lynch International (the "Borrower"), pursuant to which the Company agreed to lend up to 36,144,570 shares of common stock (the "Borrowed Shares") to the Borrower, subject to certain adjustments, for a period ending on the earliest of (i) at the Company's option, at any time after the entire principal amount of the 5.75% Notes ceases to be outstanding, (ii) the written agreement of the Company and the Borrower to terminate, (iii) the occurrence of a Borrower default, at the option of Lender, and (iv) the occurrence of a Lender default, at the option of the Borrower. Pursuant to the Share Lending Agreement, upon the termination of the share loan, the Borrower was required to return the Borrowed Shares to the Company. Upon the conversion of 5.75% Notes (in whole or in part), a number of Borrowed Shares proportional to the conversion rate for such notes was required to be returned to the Company. At the Company's election, the Borrower was permitted to deliver cash equal to the market value of the corresponding Borrowed Shares instead of returning to the Company the Borrowed Shares otherwise required by conversions of 5.75% Notes.

Pursuant to and upon the terms of the Share Lending Agreement, the Company issued and loaned the Borrowed Shares to the Borrower as a share loan. The Borrowing Agent also acted as an underwriter with respect to the Borrowed Shares, which were offered to the public. The Borrowed Shares included approximately 32.0 million shares of common stock initially loaned by the Company to the Borrower on separate occasions, delivered pursuant to the Share Lending Agreement and the Underwriting Agreement, and an additional 4.1 million shares of common stock that, from time to time, could be borrowed from the Company by the Borrower pursuant to the Share Lending Agreement and the Underwriting Agreement and subsequently offered and sold at prevailing market prices at the time of sale or negotiated prices. The Borrowed Shares are free trading shares.

During July 2013, in connection with the exchange or redemption of all of the 5.75% Notes, the Company and the Borrower terminated the Share Lending Agreement. In connection with this termination, the Borrower returned 10.2 million Borrowed Shares to Globalstar and paid approximately $4.4 million in cash for the remaining 7.1 million Borrowed Shares. As of December 31, 2012, approximately 17.3 million Borrowed Shares are outstanding. At September 30, 2013, the Share Lending Arrangement had been terminated, and all Borrowed Shares had been either returned to the Company or purchased by the Borrower.

8.00% Convertible Senior Notes Issued in 2013

On May 20, 2013, pursuant to the Exchange Agreement, the Company issued $54.6 million aggregate principal amount of 8.00% Convertible Senior Notes (the "8.00% Notes Issued in 2013") to the Exchanging Note Holders. The 8.00% Notes Issued in 2013 are convertible into shares of common stock at an initial conversion price of $0.80 per share of common stock, or 1,250 shares of the Company's common stock per $1,000 principal amount of the 8.00% Notes Issued in 2013, subject to adjustment as provided in the Fourth Supplemental Indenture between the Company and U.S. Bank National Association, as Trustee, (the "New Indenture"). The conversion price of the 8.00% Notes Issued in 2013 will be adjusted in the event of certain stock splits or extraordinary share distributions, or as a reset of the base conversion and exercise price as described below.

The 8.00% Notes Issued in 2013 are senior unsecured debt obligations of the Company and rank pari passu with the Company's existing 5.0% Convertible Senior Unsecured Notes and 8.00% Convertible Senior Unsecured Notes Issued in 2009. There is no sinking fund for the 8.00% Notes Issued in 2013. The 8.00% Notes Issued in 2013 will mature on April 1, 2028, subject to various call and put features as described below, and bear interest at a rate of 8.00% per annum. Interest on the 8.00% Notes Issued in 2013 is payable semi-annually in arrears on April 1 and October 1 of each year, commencing on October 1, 2013. Interest is paid in cash at a rate of 5.75% per annum and additional 8.00% Notes Issued in 2013 at a rate of 2.25% per annum.

Subject to certain conditions set forth in the New Indenture, including prior approval of the Majority Lenders (as defined in the Facility Agreement), the Company may redeem the 8.00% Notes Issued in 2013, in whole or in part, on December 10, 2013, if the average of the volume-weighted prices of the Company's common stock for the 30-day period ending November 29, 2013, is less than $0.20, at a price equal to the principal amount of the 8.00% Notes Issued in 2013 to be redeemed plus an amount equal to 32% of such principal amount minus all interest which is paid on the 8.00% Notes Issued in 2013 prior to their redemption. The Company may also redeem the 8.00% Notes Issued in 2013, with the prior approval of the Majority Lenders, in whole or in part, at any time on or after April 1, 2018, at a price equal to the principal amount of the 8.00% Notes Issued in 2013 to be redeemed plus all accrued and unpaid interest thereon.

A holder of 8.00% Notes Issued in 2013 has the right, at the Holder's option, to require the Company to purchase some or all of the 8.00% Notes Issued in 2013 held by it on each of April 1, 2018 and April 1, 2023 at a price equal to the principal amount of the 8.00% Notes Issued in 2013 to be purchased plus accrued and unpaid interest.

A holder of the 8.00% Notes Issued in 2013 has the right, at the holder's option, to require the Company to purchase some or all of the 8.00% Notes Issued in 2013 held by it at any time if there is a Fundamental Change. A Fundamental Change occurs if the Company's common stock ceases to be traded on a stock exchange or an established over-the-counter market or there is a change of control of the Company. If there is a Fundamental Change, the price of any 8.00% Notes Issued in 2013 purchased by the Company will be equal to its principal amount plus accrued and unpaid interest and a Fundamental Change Make-Whole Amount calculated as provided in the New Indenture.

Subject to the procedures for conversion and other terms and conditions of the New Indenture, a holder may convert its 8.00% Notes Issued in 2013 at its option at any time prior to the close of business on the business day immediately preceding April 1, 2028, into shares of common stock (or, at the option of the Company, cash in lieu of all or a portion thereof, provided that, under the Facility Agreement, the Company may pay cash only with the consent of the Majority Lenders). Upon conversion, the holder will be entitled to receive shares of common stock, cash or a combination thereof (provided that, under the Facility Agreement, the Company may pay cash only with the consent of the Majority Lenders), in such amounts and subject to terms and conditions set forth in the New Indenture. The Company will pay cash in lieu of fractional shares otherwise issuable upon conversion of the 8.00% Notes Issued in 2013 as specified in the Indenture.

A holder may elect to convert up to 15% of its 8.00% Notes Issued in 2013 on each of July 19, 2013 and March 20, 2014. If a holder elects to convert on either of those dates, it will receive, at the Company's option, either cash equal to the par value of the 8.00% Notes Issued in 2013 plus accrued interest (provided that, under the Facility Agreement, the Company may pay cash only with the consent of the Majority Lenders) or shares of the Company's common stock equal to the principal amount of the 8.00% Notes Issued in 2013 to be converted plus accrued interest divided by the lower of the average price of the common stock in a specified period and $0.50. On July 19, 2013, $7.0 million of principal amount (approximately 12.9% of the outstanding principal amount) of 8.00% Notes Issued in 2013 were converted, resulting in the issuance of 14.3 million shares. There have been no other conversions as of September 30, 2013.

The base conversion rate may be adjusted on each of April 1, 2014 and April 1, 2015 based on the average price of the Company's common stock in the 30-day period ending on that date. If the base conversion rate is adjusted on April 1, 2014, the Company also will provide additional consideration to the holders of the 8.00% Notes Issued in 2013 in an amount equal to 25% of the principal amount of the outstanding 8.00% Notes Issued in 2013, payable in equity or cash at the Company's election (provided, under the Facility Agreement, that the Company may pay cash only with the consent of the Majority Lenders). That consideration will not reduce the principal amount of the 8.00% Notes Issued in 2013 or any interest otherwise payable on the 8.00% Notes Issued in 2013.

The New Indenture also provides for other customary adjustments of the base conversion rate, including upon the Company's sale of additional equity securities at a price below the then applicable conversion price. If a 8.00% Note Issued in 2013 is converted after May 20, 2014, the holder is entitled to receive additional shares of common stock as a make-whole premium equal to the first three years of interest on the Notes (i.e. 24% of the Notes less any interest already paid through the date of the conversion) as provided in the New Indenture. Due to common stock issuances by the Company since May 20, 2013, the base conversion rate was reduced to $0.75 per share of common stock as of September 30, 2013.

The New Indenture provides that the Company and its subsidiaries may not, with specified exceptions, including the liens securing the Facility and liens approved in writing by the Agent, create, incur, assume or suffer to exist any lien on any of their assets, provided that if the Company or any of its subsidiaries creates, incurs or assumes any lien which is junior to the most senior lien securing the Facility Agreement (other than a lien pursuant to a restructuring of the Facility Agreement in which Thermo and its affiliates do not participate as a secured lender), the Company must promptly issue to the holders of the 8.00% Notes Issued in 2013 $3,590,200 (representing 5.0% of the principal amount of the 5.75% Notes outstanding on the date of the Exchange Agreement, which was $71.8 million) of shares of the Company's common stock. At September 30, 2013, the Company did not believe that a lien will be created that does not meet at least one of the specified exceptions in the New Indenture, and therefore no amount is accrued for this feature at September 30, 2013.

The New Indenture requires that on or before December 31, 2013, but subject to the conditions described below, the Company must cause all of its subsidiaries that guaranty the obligations of the Company under the Facility Agreement or any notes of another series issued under the Indenture dated as of April 15, 2008 (the "Base Indenture") to execute and deliver to the Trustee a guaranty of the Company's obligations under the 8.00% Notes Issued in 2013 in the form attached to the New Indenture. The subsidiaries' obligations under the guaranty will be subordinated to their obligations under their guaranty of the Facility Agreement. The execution and delivery of the guaranty is conditioned on the prior completion of the restructuring of the Facility Agreement, the absence of any payment default under the Facility Agreement, and the absence of any breach by Thermo of its obligations to provide funds to the Company (the "Contribution Obligations") as required by the Consent Agreement (or, as applicable, the anticipated corresponding provision in the Facility Agreement. If the guaranty agreement is not executed and delivered on or before December 31, 2013, the Company must by January 2, 2014, issue to the holders of the 8.00% Notes Issued in 2013 approximately 11.2 million shares of the Company's common stock. The issuance of these shares will not reduce the principal of the 8.00% Notes Issued in 2013 or interest otherwise payable by the Company with respect to the 8.00% Notes Issued in 2013 and will not relieve its subsidiaries of the obligation to execute and deliver the guaranty at a later date if the conditions described above are then met. As of September 30, 2013, the Company expected its subsidiaries to issue the guarantee required by this provision on or before December 31, 2013, and therefore no amount has been accrued for this feature at September 30, 2013.

The New Indenture provides for customary events of default, including without limitation, failure to pay principal or premium on the 8.00% Notes Issued in 2013 when due or to distribute cash or shares of common stock when due as described above; failure by the Company to comply with its obligations and covenants in the New Indenture; default by the Company in the payment of principal or interest on any other indebtedness for borrowed money with a principal amount in excess of $10.0 million, if such indebtedness is accelerated and not rescinded with 30 days; rendering of certain final judgments; failure by Thermo to fulfill the contribution obligations described above; and certain events of insolvency or bankruptcy. If there is an event of default, the Trustee may, at the direction of the holders of 25% or more in aggregate principal amount of the 8.00% Notes Issued in 2013, accelerate the maturity of the 8.00% Notes Issued in 2013. The Company was not in default under the 8.00% Notes Issued in 2013 as of September 30, 2013.

The Company evaluated the various embedded derivatives within the New Indenture. The Company determined that the conversion option and the contingent put feature within the New Indenture required bifurcation from the 8.00% Notes Issued in 2013. The conversion option and the contingent put feature were not deemed clearly and closely related to the 8.00% Notes Issued in 2013 and were separately accounted for as a standalone derivative. The Company recorded this compound embedded derivative liability as a non-current liability on its condensed consolidated balance sheet with a corresponding debt discount which is netted against the face value of the 8.00% Notes Issued in 2013.

The Company is accreting the debt discount associated with the compound embedded derivative liability to interest expense through the first put date of the 8.00% Notes Issued in 2013 (April 1, 2018) using an effective interest rate method. The fair value of the compound embedded derivative liability is being marked-to-market at the end of each reporting period, with any changes in value reported in the condensed consolidated statements of operations. The Company determined the fair value of the compound embedded derivative using a Monte Carlo simulation model.

The Company netted the debt discount associated with compound embedded derivative against the fair value of the 8.00% Notes Issued in 2013 to determine the carrying amount of the 8.00% Notes Issued in 2013. The accretion of the debt discount will increase the carrying amount of the debt through April 1, 2018 (the first put date of the 8.00% Notes Issued in 2013). The Company allocated the fair value at issuance as follows (in thousands):

Senior notes	$	27,890
Compound embedded derivative liability		56,752
Fair value of 8.00% Notes Issued in 2013	$	84,642

5.00% Convertible Senior Notes

In 2011, the Company issued $38.0 million in aggregate principal amount of 5.0% Convertible Senior Unsecured Notes (the "5.0% Notes") and warrants (the "5.0% Warrants") to purchase 15,200,000 shares of voting common stock of the Company. The 5.0% Notes are convertible into shares of common stock at an initial conversion price of $1.25 per share of common stock, or 800 shares of the Company's common stock per $1,000 principal amount of the 5.0% Notes, subject to adjustment in the manner set forth in the Indenture. The 5.0% Notes are guaranteed on a subordinated basis by substantially all of the Company's domestic subsidiaries (the "Guarantors"), on an unconditional joint and several basis, pursuant to a Guaranty Agreement (the "Guaranty"). The 5.0% Warrants are exercisable until five years after their issuance. The 5.0% Notes and 5.0% Warrants have anti-dilution protection in the event of certain stock splits or extraordinary share distributions, and a reset of the conversion and exercise price on April 15, 2013 if the Company's common stock is below the initial conversion and exercise price at that time. On April 15, 2013, the base conversion rate for the 5.0% Notes and the exercise price of the 5.0% Warrants were reset to $0.50 and $0.32, respectively.

The 5.0% Notes are senior unsecured debt obligations of the Company and rank pari passu with the Company's existing 8.00% Notes Issued in 2009 and 8.00% Notes Issued in 2013 and are subordinated to the Company's obligations pursuant to its Facility Agreement. There is no sinking fund for the 5.0% Notes. The 5.0% Notes will mature at the earlier to occur of (i) December 14, 2021, or (ii) six months following the maturity date of the Facility Agreement and bear interest at a rate of 5.0% per annum. Interest on the 5.0% Notes is payable in-kind semi-annually in arrears on June 15 and December 15 of each year. Under certain circumstances, interest on the 5.0% Notes will be payable in cash at the election of the holder if such payments are permitted under the Facility Agreement. The indenture governing the 5.0% Notes contains customary events of default. No event of default existed as of September 30, 2013.

Pursuant to the terms of the 5% Notes Indenture, at any time on or after June 14, 2013 and on or prior to Stated Maturity, the closing price of the Globalstar's common stock has exceeded two hundred percent of the conversion price then in effect for at least thirty consecutive trading days, then, at the option of the Company, all Securities then outstanding shall automatically convert to shares of common stock. The conditions for the automatic conversion were met and the Company elected to convert all outstanding 5.0% Notes on November 7, 2013.

The Company evaluated the embedded derivative resulting from the contingent put feature within the Indenture for bifurcation from the 5.0% Notes. The contingent put feature was not deemed clearly and closely related to the 5.0% Notes and was bifurcated as a standalone derivative. The Company recorded this embedded derivative liability as a non-current liability on its condensed consolidated balance sheets with a corresponding debt discount, which is netted against the principal amount of the 5.0% Notes. The Company is accreting the debt discount associated with the 5.0% Notes and 5.0% Warrants to interest expense over the term of the agreement using the effective interest rate method.

As of September 30, 2013, approximately $16.5 million principal amount of 5.0% Notes had been converted resulting in the issuance of 39.0 million shares of Company common stock. As of September 30, 2013 5.0% Warrants had been exercised, which resulted in the Company issuing 5.1 million shares of common stock and receiving $1.5 million.

8.00% Convertible Senior Notes Issued 2009

In 2009, the Company issued $55.0 million in aggregate principal amount of 8.00% Convertible Senior Unsecured Notes (the "8.00% Notes Issued in 2009") and warrants (the "8.00% Warrants") to purchase shares of the Company's common stock. The 8.00% Notes Issued in 2009 will mature on June 19, 2019 and bear interest at a rate of 8.00% per annum. Interest on the 8.00% Notes Issued in 2009 is payable in the form of additional 8.00% Notes Issued in 2009 or, subject to certain restrictions, in common stock at the option of the holder. Interest is payable semi-annually in arrears on June 15 and December 15 of each year. The 8.00% Notes Issued in 2009 are subordinated to all of the Company's obligations under the Facility Agreement. The 8.00% Notes Issued in 2009 are the Company's senior unsecured debt obligations and rank pari passu with the Company's 5.0% Notes and 8.00% Notes Issued in 2013. The indenture governing the 8.00% Notes Issued in 2009 contains customary events of default. No event of default existed as of September 30, 2013.

The Company recorded the conversion rights and features and the contingent put feature embedded within the 8.00% Notes Issued in 2009 as a compound embedded derivative liability on its condensed consolidated balance sheets with a corresponding debt discount, which is netted against the principal amount of the 8.00% Notes Issued in 2009. Due to the cash settlement provisions and reset features in the 8.00% Warrants issued with the 8.00% Notes Issued in 2009, the Company recorded the 8.00% Warrants as an embedded derivative liability on its condensed consolidated balance sheets with a corresponding debt discount, which is netted against the principal amount of the 8.00% Notes Issued in 2009. The Company is accreting the debt discount associated with the 8.00% Notes Issued in 2009 and 8.00% Warrants to interest expense over the term of the Notes using an effective interest rate method.

As of September 30, 2013, the current exercise price of the 8.00% Warrants was $0.32 per share of common stock and the base conversion price of the 8.00% Notes Issued in 2009 is $1.19 per share of common stock.

As of September 30, 2013 approximately $17.6 million of the 8.00% Notes Issued in 2009 had been converted, resulting in the issuance of approximately 16.1 million shares of common stock and approximately 9.8 million 8.00% Warrants had been exercised, which resulted in the Company issuing 9.4 million shares of common stock and receiving $2.9 million. No 8.00% Notes Issued in 2009 were converted during the nine months ended September 30, 2013.

Terrapin Opportunity, L.P. Common Stock Purchase Agreement

On December 28, 2012 the Company entered into a Common Stock Purchase Agreement with Terrapin Opportunity, L.P. ("Terrapin") pursuant to which the Company may, subject to certain conditions, require Terrapin to purchase up to $30.0 million of shares of voting common stock over the 24-month term following the effectiveness of a resale registration statement. This type of arrangement is sometimes referred to as a committed equity line financing facility. From time to time over the 24-month term, and in the Company's sole discretion, the Company may present Terrapin with up to 36 draw down notices requiring Terrapin to purchase a specified dollar amount of shares of voting common stock, based on the price per share per day over 10 consecutive trading days (a "Draw Down Period"). The per share purchase price for these shares equals the daily volume weighted average price of common stock on each date during the Draw Down Period on which shares are purchased, less a discount ranging from 3.5% to 8.0% based on a minimum price that the Company solely specifies. In addition, in the Company's sole discretion, but subject to certain limitations, the Company may require Terrapin to purchase a percentage of the daily trading volume of its common stock for each trading day during the Draw Down Period. The Company has agreed not to sell to Terrapin a number of shares of voting common stock which, when aggregated with all other shares of voting common stock then beneficially owned by Terrapin and its affiliates, would result in the beneficial ownership by Terrapin or any of its affiliates of more than 9.9% of the then issued and outstanding shares of voting common stock.

When the Company makes a draw under the Terrapin equity line agreement, it will issue Terrapin shares of common stock calculated using a price per share as specified in the agreement. As of September 30, 2013 Terrapin had not purchased any shares of common stock. On October 3, 2013, Terrapin purchased 6.1 million shares of voting common stock at a purchase price of $6.0 million pursuant to the terms of the agreement.

Warrants Outstanding

As a result of the Company's borrowings described above, as of September 30, 2013 and December 31, 2012 there were warrants outstanding to purchase 107.0 million and 122.5 million shares, respectively, of the Company's common stock as shown in the table below:

	Outstanding Warrants				Strike Price
	September 30, 2013		December 31, 2012		September 30, 2013		December 31, 2012
Contingent Equity Agreement		41,467,980		41,467,980	$	0.01	$	0.01
Thermo Loan Agreement		4,205,608		4,205,608		0.01		0.01
5.0% Notes (1)		9,600,000		15,200,000		0.32		1.25
8.00% Notes Issued in 2009 (2)		51,769,358		61,606,706		0.32		0.32
		107,042,946		122,480,294

	(1)	On April 15, 2013, the exercise price of the 5.0% Warrants was reset to $0.32 due to the reset provision in the indenture.
	(2)	According to the terms of the indenture, additional 8.00% Warrants may be issued to holders if shares of common stock are issued below the then current warrant strike price.

DERIVATIVES

9 Months Ended

Sep. 30, 2013

DERIVATIVES [Abstract]

DERIVATIVES

5. DERIVATIVES

In connection with certain borrowings disclosed in Note 4, the Company was required to record derivative instruments on its condensed consolidated balance sheets. None of these derivative instruments are designated as a hedge. The following tables disclose the fair values and classification of the derivative instruments on the Company's condensed consolidated balance sheets (in thousands):

	September 30, 2013			December 31, 2012
Intangible and other assets:
Interest rate cap	$	170		$	84
Total intangible and other assets	$	170		$	84

Derivative liabilities, current:
Warrants issued with 8.00% Notes Issued in 2009		(41,539	)		-

Derivative liabilities, non-current:
Compound embedded derivative with 8.00% Notes Issued in 2009	$	(41,396	)	$	(4,163	)
Warrants issued with 8.00% Notes Issued in 2009		-			(18,034	)
Contingent put feature embedded in the 5.0% Notes		(845	)		(2,978	)
Compound embedded derivative with 8.00% Notes Issued in 2013		(74,399	)		-
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement		(137,567	)		-
Total derivative liabilities, non-current:		(254,207	)		(25,175	)

Total derivative liabilities, current and non-current	$	(295,746	)	$	(25,175	)

The following tables disclose the changes in value during the three and nine months ended September 30, 2013 and 2012 recorded as derivative gain (loss) on the Company's condensed consolidated statement of operations (in thousands):

	Three Months Ended
	September 30, 2013			September 30, 2012
Interest rate cap	$	(30	)	$	(39	)
Compound embedded derivative with 8.00% Notes Issued in 2009		(29,986	)		(2,417	)
Warrants issued with 8.00% Notes Issued in 2009		(6,323	)		(13,963	)
Contingent put feature embedded in the 5.0% Notes		848			(54	)
Compound embedded derivative with 8.00% Notes Issued in 2013		(25,590	)		-
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement		(36,453	)		-
Total derivative gain (loss)	$	(97,534	)	$	(16,473	)

	Nine Months Ended
	September 30, 2013			September 30, 2012
Interest rate cap	$	86		$	(161	)
Compound embedded derivative with 8.00% Notes Issued in 2009		(37,233	)		1,287
Warrants issued with 8.00% Notes Issued in 2009		(28,949	)		(4,031	)
Warrants issued in conjunction with contingent equity agreement		-			301
Contingent put feature embedded in the 5.0% Notes		2,133			42
Compound embedded derivative with 8.00% Notes Issued in 2013		(26,495	)		-
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement		(36,453	)		-
Total derivative gain (loss)	$	(126,911	)	$	(2,562	)

Intangible and Other Assets

Interest Rate Cap

In June 2009, in connection with entering into the Facility Agreement, which provides for interest at a variable rate, the Company entered into five ten-year interest rate cap agreements. The interest rate cap agreements reflect a variable notional amount ranging from $586.3 million to $14.8 million at interest rates that provide coverage to the Company for exposure resulting from escalating interest rates over the term of the Facility Agreement. The interest rate cap provides limits on the six-month Libor rate ("Base Rate") used to calculate the coupon interest on outstanding amounts on the Facility Agreement and is capped at 5.50% should the Base Rate not exceed 6.5%. Should the Base Rate exceed 6.5%, the Company's Base Rate will be 1% less than the then six-month Libor rate. The Company paid an approximately $12.4 million upfront fee for the interest rate cap agreements. The interest rate cap did not qualify for hedge accounting treatment, and changes in the fair value of the agreements are included in the condensed consolidated statements of operations.

Derivative Liabilities

The Company has identified various embedded derivatives resulting from certain features in the Company's debt instruments. These embedded derivatives required bifurcation from the debt host agreement. All embedded derivatives that required bifurcation, excluding the warrants issued in connection with the Company's contingent equity agreement (see below for further discussion), are recorded as a derivative liability on the Company's condensed consolidated balance sheet with a corresponding debt discount netted against the principal amount of the related debt instrument. The Company accretes the debt discount associated with each derivative liability to interest expense over the term of the related debt instrument using an effective interest rate method. The fair value of each embedded derivative liability is marked-to-market at the end of each reporting period with any changes in value reported in its condensed consolidated statements of operations. See below for further discussion for each liability and the features embedded in the debt instrument which required the Company to account for the instrument as a derivative.

Compound Embedded Derivative with 8.00% Notes Issued in 2009

As a result of the conversion rights and features and the contingent put feature embedded within the 8.00% Notes Issued in 2009, the Company recorded a compound embedded derivative liability on its condensed consolidated balance sheets with a corresponding debt discount which is netted against the principal amount of the 8.00% Notes Issued in 2009. The Company determined the fair value of the compound embedded derivative using a Monte Carlo simulation model.

Warrants Issued with 8.00% Notes Issued in 2009

Due to the cash settlement provisions and reset features in the 8.00% Warrants issued with the 8.00% Notes Issued in 2009, the Company recorded the 8.00% Warrants as an embedded derivative liability on its condensed consolidated balance sheets with a corresponding debt discount which is netted against the principal amount of the 8.00% Notes Issued in 2009. The Company determined the fair value of the warrant derivative using a Monte Carlo simulation model. As the exercise period for the 8.00% Warrants expires in June 2014, the Company has classified this derivative liability as current on its condensed consolidated balance sheet at September 30, 2013.

Warrants Issued in Conjunction with Contingent Equity Agreement

Prior to June 19, 2012, the Company determined that the warrants issued in conjunction with the availability fee for the Contingent Equity Agreement were a liability at issuance. The offset was recorded in other non-current assets and was amortized over the one-year availability period. The Company determined the principal amount of the warrant derivative using a Monte Carlo simulation model.

On June 19, 2012, the Company issued additional warrants in conjunction with the availability fee for the Contingent Equity Agreement. This tranche of warrants was not subject to a reset provision in the agreement and therefore is not marked-to-market at the end of each reporting period. The Company determined that the warrant was an equity instrument and recorded it as equity on its condensed consolidated balance sheets.

Contingent Put Feature Embedded in the 5.0% Notes

As a result of the contingent put feature within the 5.0% Notes, the Company recorded a derivative liability on its condensed consolidated balance sheets with a corresponding debt discount which is netted against the principal amount of the 5.0% Notes. The Company determined the fair value of the contingent put feature derivative using a Monte Carlo simulation model based.

Compound Embedded Derivative with 8.00% Notes Issued in 2013

As a result of the conversion option and the contingent put feature within the 8.00% Notes Issued in 2013, the Company recorded a compound embedded derivative liability on its condensed consolidated balance sheet with a corresponding debt discount which is netted against the face value of the 8.00% Notes Issued in 2013. The Company determined the fair value of the compound embedded derivative liability using a Monte Carlo simulation model.

Compound Embedded Derivative with the Amended and Restated Thermo Loan Agreement

As a result of the conversion option and the contingent put feature within the Loan Agreement with Thermo entered into in July 2013, the Company recorded a compound embedded derivative liability on its condensed consolidated balance sheet with a corresponding debt discount which is netted against the face value of the Amended and Restated Loan Agreement. The Company determined the fair value of the compound embedded derivative liability using a Monte Carlo simulation model.

- Definition

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7668309&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7668309&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41635-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5618551-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5580258-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624181-113959

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41638-113959

Reference 20: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

FAIR VALUE MEASUREMENTS

9 Months Ended

Sep. 30, 2013

FAIR VALUE MEASUREMENTS [Abstract]

FAIR VALUE MEASUREMENTS

6. FAIR VALUE MEASUREMENTS

The Company follows the authoritative guidance for fair value measurements relating to financial and non-financial assets and liabilities, including presentation of required disclosures herein. This guidance establishes a fair value framework requiring the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets and liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows:

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities.

Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability.

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

Recurring Fair Value Measurements

The following table provides a summary of the financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2013 and December 31, 2012 (in thousands):

	Fair Value Measurements at September 30, 2013:
	(Level 1)		(Level 2)		(Level 3)			Total Balance
Assets:
Interest rate cap	$	-	$	170	$	-		$	170
Total assets measured at fair value	$	-	$	170	$	-		$	170

Liabilities:
Derivative Liabilities:
Compound embedded derivative with 8.00% Notes Issued in 2009	$	-	$	-	$	(41,396	)	$	(41,396	)
Warrants issued with 8.00% Notes Issued in 2009		-		-		(41,539	)		(41,539	)
Contingent put feature embedded in 5.0% Notes		-		-		(845	)		(845	)
Compound embedded derivative with 8.00% Notes Issued in 2013		-		-		(74,399	)		(74,399	)
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement		-		-		(137,567	)		(137,567	)
Total Derivative Liabilities		-		-		(295,746	)		(295,746	)

Other Liabilities:
Liability for contingent consideration		-		-		(2,375	)		(2,375	)

Total liabilities measured at fair value	$	-	$	-	$	(298,121	)	$	(298,121	)

	Fair Value Measurements at December 31, 2012:
	(Level 1)		(Level 2)		(Level 3)			Total Balance
Assets:
Interest rate cap	$	-	$	84	$	-		$	84
Total assets measured at fair value	$	-	$	84	$	-		$	84

Liabilities:
Derivative Liabilities:
Compound embedded derivative with 8.00% Notes Issued in 2009	$	-	$	-	$	(4,163	)	$	(4,163	)
Warrants issued with 8.00% Notes Issued in 2009		-		-		(18,034	)		(18,034	)
Contingent put feature embedded in 5.0% Notes		-		-		(2,978	)		(2,978	)
Total Derivative Liabilities		-		-		(25,175	)		(25,175	)

Other Liabilities:
Liability for contingent consideration		-		-		(3,916	)		(3,916	)

Total liabilities measured at fair value	$	-	$	-	$	(29,091	)	$	(29,091	)

Assets

Interest Rate Cap

The fair value of the interest rate cap is determined using observable pricing inputs including benchmark yields, reported trades, and broker/dealer quotes at the reporting date. See Note 5 for further discussion.

Derivative Liabilities

The derivative liabilities in Level 3 include the compound embedded derivative in the 8.00% Notes Issued in 2009, the 8.00% Warrants issued with the 8.00% Notes Issued in 2009, the contingent put feature embedded in the 5.0% Notes, the compound embedded derivative in the 8.00% Notes Issued in 2013 and the compound embedded derivative in the Amended and Restated Loan Agreement with Thermo. The Company marks-to-market these liabilities at each reporting date with the changes in fair value recognized in the Company's condensed consolidated statements of operations. See Note 5 for further discussion.

The significant quantitative Level 3 inputs utilized in the valuation models as of September 30, 2013 and December 31, 2012 are shown in the tables below:

	Level 3 Inputs at September 30, 2013:
	Stock Price Volatility			Risk-Free Interest Rate			Note Conversion Price		Warrant Exercise Price		Market Price of Common Stock
Compound embedded derivative with 8.00% Notes Issued in 2009		65 - 100	%		1.3	%	$	1.19	$	N/A	$	1.09
Warrants issued with 8.00% Notes Issued in 2009		100	%		0.1	%	$	N/A	$	0.32	$	1.09
Contingent put feature embedded in 5.0% Notes		33 - 106	%		0.03 - 2.64	%	$	0.50	$	N/A	$	1.09
Compound embedded derivative with 8.00% Notes Issued in 2013		65 - 100	%		1.3	%	$	0.75	$	N/A	$	1.09
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement		65 - 100	%		2.6	%	$	0.75	$	N/A	$	1.09

	Level 3 Inputs at December 31, 2012:
	Stock Price Volatility		Risk-Free Interest Rate		Note Conversion Price		Warrant Exercise Price		Market Price of Common Stock
Compound embedded derivative with 8.00% Notes Issued in 2009	34 -107	%	0.02 - 1.78	%	$	1.59	$	N/A	$	0.31
Warrants issued with 8.00% Notes Issued in 2009	34 -107	%	0.02 - 1.78	%	$	N/A	$	0.32	$	0.31
Contingent put feature embedded in 5.0% Notes	34 -107	%	0.02 - 1.78	%	$	1.25	$	N/A	$	0.31

Stock price volatility is one of the significant unobservable inputs used in the fair value measurement of each of the Company's derivative instruments. The simulated fair value of these liabilities is sensitive to changes in the Company's expected volatility. Decreases in expected volatility would generally result in a lower fair value measurement.

Assumptions for future issuances of the Company's common stock are also used in the fair value measurement of the Company's derivative instruments. The Company is obligated to make certain equity issuances under various agreements, including the earnout agreement with Axonn, the equity line with Terrapin and the Consent Agreement with Thermo. Certain provisions in the Company's debt instruments may result in adjustments to the current base conversion rates or warrant exercise price if equity is issued at prices lower than the conversion or exercise price then in effect, with certain exclusions. As these prices decrease, the value of the note or warrant to the holder of the instrument increases, thereby increasing the fair value measurement of the derivative liability.

Probability of a change of control is another significant unobservable input used in the fair value measurement of the Company's derivative instruments, excluding the 8.00% Warrants issued with the 8.00% Notes Issued in 2009. Subject to certain restrictions in each indenture, the Company's debt instruments contain certain provisions whereby holders may require the Company to purchase all or any portion of the convertible debt instrument upon a change of control. A change of control will occur upon certain changes in the ownership of the Company or certain events relating to the trading of the Company's common stock. The simulated fair value of the derivative liabilities above is sensitive to changes in the assumed probabilities of a change of control. Decreases in the assumed probability of a change of control would generally result in a lower fair value measurement.

In addition to the Level 3 inputs described above, the indentures governing the related debt instrument for each of the derivative liabilities included in the Company's Level 3 fair value measurements have specific features that impact the valuation of each liability at reporting periods. These features are further described below for each of the Company's derivative liabilities.

Compound Embedded Derivative with 8.00% Notes Issued in 2009

In addition to the inputs described above, the valuation model used to calculate the fair value measurement of the compound embedded derivative with the 8.00% Notes Issued in 2009 includes payment in kind interest payments, make whole premiums and automatic conversions. Pursuant to the terms of the 8.00% Notes Issued in 2009, the base conversion rate cannot reset to lower than $1.00; therefore if the Company makes future equity issuances at prices below the then current conversion price, this conversion price may be adjusted downward to as low as $1.00.

Warrants Issued with 8.00% Notes Issued in 2009

In addition to the inputs described above, the valuation model used to calculate the fair value measurement of the 8.00% Warrants issued with the 8.00% Notes Issued in 2009 includes certain reset features. Pursuant to the terms of the 8.00% Warrants, there is no floor within the reset feature for the exercise price of the 8.00% Warrants; therefore if the Company makes future equity issuances at prices below the current exercise price, this exercise price may be adjusted downward. If the stock price on the issuance date is less than the then current exercise price of the outstanding 8.00% Warrants, additional warrants may be issued, which will increase the fair value of the warrant liability.

Contingent Put Feature Embedded in 5.0% Notes

In addition to the inputs described above, the valuation model used to calculate the fair value measurement of the contingent put feature embedded in the Company's 5.0% Notes includes payment in kind interest and other reset features in the indenture. Pursuant to the terms of the 5% Notes Indenture, if at any time on or after June 14, 2013 and on or prior to Stated Maturity, the closing price of the Globalstar's common stock has exceeded 200% of the conversion price then in effect for at least 30 consecutive trading days, then, at the option of the Company, all securities then outstanding shall automatically convert to common stock. As a result of the current base conversion price and the Company's recent stock prices ranges, the fair value measurement has considered this probability, which reduces the fair value measurement of the contingent put feature as conversion could occur prior to change of control of the Company.

Compound Embedded Derivative with 8.00% Notes Issued in 2013

In addition to the inputs described above, the valuation model used to calculate the fair value measurement of the compound embedded derivative within the Company's 8.00% Notes Issued in 2013 includes payment-in-kind interest payments, make whole premiums, and automatic conversions. Pursuant to the terms of the 8.00% Notes Issued in 2013 Indenture, there are also special distributions and certain put and call features within the notes which impact the valuation model. See Note 4 for further discussion on this feature.

Compound Embedded Derivative with Amended and Restated Thermo Loan Agreement

In addition to the inputs described above, the valuation model used to calculate the fair value measurement of the compound embedded derivative within the Amended and Restated Loan Agreement with Thermo includes payment in kind interest payments, make whole premiums, and automatic conversions.

Other Liabilities

Liability for Contingent Consideration

In connection with the acquisition of Axonn LLC ("Axonn") in December 2009, the Company is obligated to pay up to an additional $10.8 million in contingent consideration for earnouts based on sales of existing and new products over a five-year earnout period beginning January 1, 2010. The Company will make earnout payments in stock not to exceed 26,684,807 shares of common stock (10% of the Company's pre-transaction outstanding shares of common stock), but at its option may make payments in cash after 13 million shares have been issued. The Company's initial estimate of the total earnout expected to be paid was $10.8 million. Since the earnout period started, the Company has made revisions to this estimate, which was $9.4 million at September 30, 2013. Through September 30, 2013, the Company had made $6.6 million in earnout payments by issuing 17,531,459 shares of voting common stock. The liability of $2.4 million recorded at September 30, 2013 represents the present value of the remaining projected earnout payments to be made under the agreement.

The fair value of the accrued contingent consideration was determined using a probability-weighted discounted cash flow approach at the acquisition date and reporting date. The approach is based on significant inputs that are not observable in the market, which are referred to as Level 3 inputs. The fair value is based on the Company reaching specific performance metrics through the remaining earnout period. The change in fair value of the contingent consideration is recorded through accretion expense in the Company's condensed consolidated statements of operations.

The significant unobservable inputs used in the fair value measurement of the Company's liability for contingent consideration are projected future sales of existing and new products as well as earnout payments made each quarter determined by actual product sales. Decreases in forecasted sales would result in a lower fair value measurement.

The following tables present a roll-forward for all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three and nine months ended September 30, 2013 as follows (in thousands):

Balance at June 30, 2013	$	(113,749	)
Issuance of compound embedded derivative with the Amended and Restated Loan Agreement with Thermo		(101,114	)
Earnout payments made related to liability for contingent consideration		415
Change in fair value of contingent consideration		443
Derivative adjustment related to conversions and exercises		13,386
Unrealized loss, included in derivative gain (loss)		(97,502	)
Balance at September 30, 2013	$	(298,121	)

Balance at December 31, 2012	$	(29,091	)
Issuance of compound embedded derivative with 8.00% Notes Issued in 2013		(56,752	)
Issuance of compound embedded derivative with the Amended and Restated Loan Agreement with Thermo		(101,114	)
Third party issuance costs expensed to derivative gain (loss) in connection with Issuance of 8.00% Notes Issued in 2013		(905	)
Earnout payments made related to liability for contingent consideration		1,351
Change in fair value of contingent consideration		190
Derivative adjustment related to conversions and exercises		13,386
Unrealized loss, included in derivative gain (loss)		(125,186	)
Balance at September 30, 2013	$	(298,121	)

Nonrecurring Fair Value Measurements

The items measured on a nonrecurring basis include the 8.00% Notes Issued in 2013, the Amended and Restated Loan Agreement with Thermo and equity issued in connection with the Exchange Agreement and the Consent Agreement. As a result of certain transactions that have occurred with the Company's debt instruments, the Company was required to record these items at fair value as of the date of the respective agreements. See below for a further discussion of the fair value measurement for each item measured on a nonrecurring basis.

8.00% Notes Issued in 2013

The Company was required to record the 8.00% Notes Issued in 2013 initially at fair value as the issuance was considered to be an extinguishment of debt. Level 3 inputs were required to be used as there was not an active market for a substantial period of time between the issuance date and the balance sheet date. As of the issuance date, the fair value of the Notes was $27.9 million and the fair value of the compound embedded derivative liability was $56.7 million, for a total fair value of the 8.00% Notes Issued in 2013 of $84.6 million. As stated above, the value of the compound embedded derivative was bifurcated from the 8.00% Notes Issued in 2013 and is marked to market on a recurring basis. The Company recorded a loss on extinguishment of debt of $47.2 million in its condensed consolidated statement of operations during the second quarter of 2013. This loss was computed as the difference between the net carrying amount of the old 5.75% Notes of $71.8 million and the fair value of consideration given in the exchange of $119.0 million (including the new 8.00% Notes Issued in 2013, cash payments to both exchanging and non-exchanging holders, equity issued to the exchanging holders and other fees incurred for the exchange). See Notes 4 and 5 for further discussion.

The significant quantitative Level 3 inputs utilized in the valuation models as of the issuance date of the 8.00% Notes Issued in 2013 are shown in the table below:

	Level 3 Inputs at May 20, 2013:
	Stock Price Volatility			Risk-Free Interest Rate			Note Conversion Price		Discount Rate			Market Price of Common Stock
Compound embedded derivative with 8.00% Notes Issued in 2013		65 - 100	%		0.9	%	$	0.80		27	%	$	0.40

Other inputs used in the valuation model of the 8.00% Notes Issued in 2013 include the underlying features of the compound embedded derivative, including payment-in-kind interest payments, make whole premiums, automatic conversions, future equity issuances and probability of change of control of the Company. See further discussion above in "Derivative Liabilities" for the impact these inputs have on the fair value measurement.

Amended and Restated Loan Agreement with Thermo

The Company was required to record this Loan Agreement initially at fair value as the amendment and restatement of the Loan Agreement was considered to be an extinguishment of debt. Level 3 inputs were required to be used as there is not an active market for this debt instrument. As of the amendment and restatement date, the fair value of the Loan Agreement was $19.0 million and the fair value of the compound embedded derivative liability was $101.1 million, for a total fair value of the Loan Agreement of $120.1 million. As stated above, the value of the compound embedded derivative was bifurcated from the Loan Agreement and will be marked to market on a recurring basis. The Company recorded a loss on extinguishment of debt of $66.1 million in its condensed consolidated statement of operations for the third quarter of 2013. This loss was computed as the difference between the fair value of the debt, as amended and restated, and its carrying value just prior to amendment and restatement. See Notes 4 and 5 for further discussion.

The significant quantitative Level 3 inputs utilized in the valuation models as of the amendment and restatement date of the Loan Agreement are shown in the table below:

	Level 3 Inputs at July 31, 2013:
	Stock Price Volatility			Risk-Free Interest Rate			Note Conversion Price		Discount Rate			Market Price of Common Stock
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement		65 - 100	%		2.6	%	$	0.75		26	%	$	0.60

Other inputs used in the valuation model of the Amended and Restated Loan Agreement include the underlying features of the compound embedded derivative, including payment in kind interest payments, make whole premiums, automatic conversions, future equity issuances and probability of change of control of the Company. See further discussion above in "Derivative Liabilities" for the impact these inputs have on the fair value measurement.

Equity issued in connection with the Exchange Agreement

The stockholders' equity balances measured on a nonrecurring basis in Level 1 include the approximately 30.3 million shares of voting common stock of the Company issued to Exchanging Note Holders in partial payment for exchanged 5.75% Notes in connection with the Exchange Agreement executed on May 20, 2013. The Company was required to record this equity issuance at fair value initially as the Exchange Agreement was considered to be an extinguishment of debt. See Note 4 for further discussion. The Company calculated the aggregate fair value of the shares issued of approximately $12.1 million using the closing stock price on the issuance date (May 20, 2013) and included in its stockholders' equity in its condensed consolidated balance sheet.

Equity issued in connection with the Consent Agreement

On May 20, 2013, the Company and Thermo entered into the Consent Agreement and the Common Stock Purchase Agreement, and subsequently on October 4, 2013, the Common Stock Purchase and Option Agreement. The following table summarizes the amount invested in the Company pursuant to the Consent Agreement with Thermo as of September 30, 2013 and other relevant terms of these agreements (dollars in thousands, except amounts per share):

	Amount Invested		Issuance Price per Share		Closing Price per Share		Discount Value (5)		Total Fair Value		Shares Issued (6)
May 20, 2013 (1)	$	25,000	$	0.32	$	0.40	$	6,250	$	31,250		78,125,000
May 20, 2013 (1)		5,000		0.32		0.40		1,250		6,250		15,625,000
June 28, 2013 (1)		9,000		0.32		0.55		6,469		15,469		28,125,000
July 29, 2013 (2), (3)		6,000		0.52		0.62		1,154		7,154		11,538,462
August 19, 2013 (2), (3)		6,500		0.52		0.62		1,250		7,750		12,500,000
Total (4)	$	51,500					$	16,373	$	67,873		145,913,462

	(1)	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company's condensed consolidated balance sheet.
	(2)	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement.
	(3)	The terms of the issuance price per share were determined in October 2013; therefore the shares were not issued as of September 30, 2013. The total fair value of the shares of $14.9 million was recorded on the Company's condensed consolidated balance sheet as future equity issuance of common stock to related party.
	(4)	Pursuant to the terms of the Consent Agreement, certain equity transactions which result in cash invested into Globalstar may reduce the amounts committed by Thermo. As of September 30, 2013, the Company had received approximately $8.8 million due to cash received upon the termination of the share lending agreement and subsequent shares purchased by the borrower in that transaction and warrant exercises (see Note 4 for further discussion). These equity transactions reduced the remaining amounts available under the Consent Agreement to $24.7 million as of September 30, 2013.
	(5)	The discount on shares issued is recorded on the Company's condensed consolidated statement of operations in loss on equity issuance. This expense item represents the discount on shares issued to Thermo as well as certain other losses recorded on equity issued during 2013 related to cashless warrant exercises of the Company's 5% Notes.
	(6)	All shares issued to Thermo in connection with these agreements were shares of the Company's nonvoting common stock.

Under the terms of the Common Stock Purchase and Option Agreement, Thermo agreed to purchase an incremental $13.5 million of shares of non-voting common stock at a purchase price of $0.52 per share as and when requested to do so by the special committee through November 28, 2013. Thermo further agreed to purchase, upon the request of the special committee prior to December 26, 2013, up to $11.5 million of additional shares of non-voting common stock at a price equal to 85% of the average closing price of the common stock during the ten trading days immediately preceding the date of the special committee's request.

The stockholders' equity balances measured on a nonrecurring basis in Level 1 include the equity purchased by Thermo during the second and third quarters of 2013. As of September 30, 2013, Thermo had purchased approximately 145.9 million shares of the Company's common stock for an aggregate $51.5 million. The Company calculated the fair value of the Company's common stock issued to Thermo based on the closing stock price on the date of each sale. This aggregate fair value of approximately $67.9 million is included in stockholders' equity in the Company's condensed consolidated balance sheet as of September 30, 2013. Approximately $14.9 million of the total $67.9 million fair value is recorded as future equity issuance of common stock to related party as the shares were not issued as of September 30, 2013 and the remaining $53.0 million is recorded in additional paid-in capital as of September 30, 2013. See Note 4 for further discussion.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

ACCRUED EXPENSES AND NON-CURRENT LIABILITIES

9 Months Ended

Sep. 30, 2013

ACCRUED EXPENSES AND NON-CURRENT LIABILITIES [Abstract]

ACCRUED EXPENSES AND NON-CURRENT LIABILITIES

7. ACCRUED EXPENSES AND NON-CURRENT LIABILITIES

Accrued expenses consist of the following (in thousands):

	September 30, 2013		December 31, 2012
Accrued interest	$	10,712	$	5,620
Accrued compensation and benefits		3,737		4,076
Accrued property and other taxes		6,713		6,329
Accrued customer liabilities and deposits		2,666		2,961
Accrued professional and other service provider fees		966		1,006
Accrued liability for contingent consideration		2,021		2,585
Accrued commissions		1,079		685
Accrued telecommunications expenses		621		713
Accrued satellite and ground costs		486		373
Other accrued expenses		3,827		3,816
	$	32,828	$	28,164

Other accrued expenses primarily include outsourced logistics services, storage, inventory in transit, warranty reserve and maintenance.

Non-current liabilities consist of the following (in thousands):

	September 30, 2013		December 31, 2012
Long-term accrued interest	$	1,932	$	457
Asset retirement obligation		1,062		998
Deferred rent		447		579
Liabilities related to the Cooperative Endeavor Agreement with the State of Louisiana		1,536		1,949
Long-term portion of liability for contingent consideration		354		1,332
Uncertain income tax positions		5,399		5,571
Foreign tax contingencies		4,681		4,994
	$	15,411	$	15,880

COMMITMENTS	9 Months Ended
COMMITMENTS	Sep. 30, 2013
COMMITMENTS [Abstract]
COMMITMENTS	8. COMMITMENTS Contractual Obligations As of September 30, 2013, the Company had purchase commitments with Thales, Arianespace, Ericsson Inc. ("Ericsson"), Hughes Network Systems, LLC ("Hughes") and other vendors related to the procurement and deployment of the second-generation network. Second-Generation Satellites As of September 30, 2013, the Company had a contract with Thales for the construction of the Company's second-generation low-earth orbit satellites and related services. The Company has successfully launched all of these second-generation satellites, excluding one on-ground spare. Six satellites were launched in each of October 2010, July 2011, December 2011, and February 2013. The Company has also incurred additional costs for certain related services, of which a portion are still owed to Thales. As of September 30, 2013, the Company had a contract with Arianespace for the launch of the Company's second-generation satellites and certain pre and post-launch services under which Arianespace agreed to make four launches of satellites. The Company has successfully completed all of these launches. The Company has also incurred additional costs to Arianespace for launch delays. Next-Generation Gateways and Other Ground Facilities As of September 30, 2013, the Company had a contract with Hughes under which Hughes will design, supply and implement (a) the Radio Access Network (RAN) ground network equipment and software upgrades for installation at a number of the Company's satellite gateway ground stations and (b) satellite interface chips to be a part of the User Terminal Subsystem (UTS) in various next-generation Globalstar devices. In January 2013, the Company and Hughes amended the contract to extend the schedule of the RAN and UTS program and to revise the remaining payment milestones and program milestones to reflect the revised program timeline. This amendment extended certain payments previously due in 2013 to 2014 and beyond. As of September 30, 2013, the Company had recorded $10.0 million, excluding interest, in accounts payable related to this contract and had incurred and capitalized $72.6 million, excluding interest, of costs related to this contract. These costs are recorded as an asset in property and equipment. In August 2013, the Company entered into an agreement with Hughes which specified a payment schedule for the approximately $15.8 million deferred amount outstanding at the time of the agreement. The Company must make payments of $5.8 million in August 2013, $5.0 million in October 2013, and $5.0 million in December 2013. The Company has made both the August and October payments. Under the terms of the agreement, the Company will also be required to pay interest of approximately $4.9 million in January 2014 for amounts accrued at a rate of 10% on previously deferred balances. Hughes will also have the option to receive all or any portion of the deferred payments and accrued interest in Globalstar common stock. If Hughes chooses to receive any payment in stock, shares will be provided at a 7% discount based upon a trailing volume weighted average price calculation. Hughes will restart work under the contract upon the Company's payment of the amounts described above and an advance payment for the next milestone pursuant to the terms of the contract. If Globalstar does not make the payments described above by the specified payment dates in the agreement, these amounts will accrue interest at a rate of 15% per annum. If the Company terminates the contract for convenience, the Company must make a final payment of $20.0 million (less any amounts previously paid to reduce the $15.8 million total deferred amount) in cash to Hughes to satisfy its obligations under the contract. As of September 30, 2013, the Company had an agreement with Ericsson. Ericsson will work with the Company to develop, implement and maintain a ground interface, or core network system that will be installed at a number of the Company's satellite gateway ground stations. In September 2013, the Company entered into an agreement with Ericsson which deferred to November 2013 approximately $2.3 million in milestone payments scheduled under the core contract, provided the Company made one payment of $1.6 million, which offsets the total deferred amount, in September 2013. The Company made this payment. The remaining milestone payments previously due under the contract were deferred to later in 2013 and beyond. The deferred payments continue to incur interest at a rate of 6.5% per annum. As of September 30, 2013, the Company had recorded $0.7 million in accounts payable and accrued expenses, excluding interest, related to these required payments and has incurred and capitalized $6.8 million of costs related to this contract. The costs are recorded as an asset in property and equipment. If the Company and Ericsson are unable to agree on revised technical requirements and pricing for certain contract deliverables, the contract may be terminated without liability to either party upon the Company's payment of the outstanding $0.7 million deferred amount plus associated interest. The Company may, however, be required to record an impairment charge. If the contract is terminated for convenience, the Company must make a final payment of $10.0 million in either cash or shares of Company common stock at the Company's election. If the Company elects to make payment in common stock, Ericsson will have the option either to accept the shares of common stock or instruct the Company to complete a block sale of the common stock and deliver the proceeds to Ericsson. If Ericsson chooses to accept common stock, the number of shares it will receive will be calculated based on the final payment amount plus 5%. The Company issued separate purchase orders for additional phone equipment and accessories under the terms of executed commercial agreements with Qualcomm. As of September 30, 2013 and December 31, 2012, total advances to Qualcomm for inventory were $9.2 million. This contract was cancelled in March 2013, and the parties are seeking to resolve issues related to the contract termination.

CONTINGENCIES	9 Months Ended
CONTINGENCIES	Sep. 30, 2013
CONTINGENCIES [Abstract]
CONTINGENCIES	9. CONTINGENCIES Arbitration On June 3, 2011, Globalstar filed a demand for arbitration against Thales before the American Arbitration Association to enforce certain rights to order additional satellites under the Amended and Restated Contract for the construction of the Globalstar Satellite for the Second Generation Constellation dated and executed in June 2009 ("2009 Contract"). Globalstar did not include within its demand any claims that it had against Thales for work previously performed under the contract to design, manufacture and timely deliver the first 25 second-generation satellites. On May 10, 2012, the arbitration tribunal issued its award in which it determined that Globalstar materially breached the contract by failing to pay to Thales termination charges in the amount of €51,330,875.00 by October 9, 2011, and that absent further agreement between the parties, Thales has no further obligation to manufacture or deliver satellites under Phase 3 of the 2009 Contract. The award also required Globalstar to pay Thales approximately €53 million in termination charges and interest by June 9, 2012. On May 23, 2012, Thales commenced an action in the United States District Court for the Southern District of New York by filing a petition to confirm the arbitration award (the "New York Proceeding"). Thales and the Company entered into a Tolling Agreement as of June 13, 2013 under which Thales dismissed the New York Proceeding without prejudice. Thales may refile the petition at a later date and pursue the confirmation of the arbitration award, which Globalstar will oppose. Should Thales be successful in confirming the arbitration award, this would have a material adverse effect on the Company's financial condition and liquidity. On June 24, 2012, the Company and Thales agreed to settle their prior commercial disputes, including those disputes that were the subject of the arbitration award. In order to effectuate this settlement, the Company and Thales entered into a Release Agreement, a Settlement Agreement and a Submission Agreement. Under the terms of the Release Agreement, Thales agreed unconditionally and irrevocably to release and forever discharge the Company from any obligation to pay €35,623,770 of the termination charges awarded in the arbitration together with all interest on the award amount effective upon the earlier of December 31, 2012 and the effective date of the financing for the purchase of any additional second-generation satellites. Under the terms of the Release Agreement, Globalstar agreed unconditionally and irrevocably to release and forever discharge Thales from any and all claims related to Thales' work under the 2009 satellite construction contract, including any obligation to pay liquidated damages, effective upon the earlier of December 31, 2012 and the effective date of the financing for the purchase of any additional second-generation satellites. In connection with the Release Agreement, the Company recorded a contract termination charge of approximately €17.5 million which is recorded in the Company's condensed consolidated financial statements for the period ended September 30, 2013. The releases became effective on December 31, 2012. Under the terms of the Settlement Agreement, Globalstar agreed to pay €17,530,000 to Thales, representing one-third of the termination charges awarded to Thales in the arbitration, subject to certain conditions, on the later of the effective date of the new contract for the purchase of any additional second-generation satellites and the effective date of the financing for the purchase of these satellites. Because the effective date of the new contract for the purchase of additional second-generation satellites did not occur on or prior to February 28, 2013, any party may terminate the Settlement Agreement. If any party terminates the Settlement Agreement, all parties' rights and obligations under the Settlement Agreement shall terminate. However, the Release Agreement provides that it will survive a termination of the Settlement Agreement. As of September 30, 2013, no party had terminated the Settlement Agreement. Litigation Due to the nature of the Company's business, the Company is involved, from time to time, in various litigation matters or subject to disputes or routine claims regarding its business activities. Legal costs related to these matters are expensed as incurred. In management's opinion, there is no pending litigation, dispute or claim, other than the arbitration award discussed above, that may have a material adverse effect on the Company's financial condition, results of operations or liquidity.

RELATED PARTY TRANSACTIONS

9 Months Ended

Sep. 30, 2013

RELATED PARTY TRANSACTIONS

10. RELATED PARTY TRANSACTIONS

Payables to Thermo and other affiliates relating to normal purchase transactions were $0.3 million and $0.2 million at September 30, 2013 and December 31, 2012, respectively.

Transactions with Thermo

Thermo incurs certain expenses on behalf of the Company. The table below summarizes the total expense for the periods indicated below (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
General and administrative expense	$	74	$	30	$	229	$	230
Non-cash expenses		137		132		411		396
Loss on sale of equity issuance		2,404		-		16,373		-
Loss on extinguishment of debt related to amendment and restatement of Thermo Loan Agreement		66,088		-		66,088		-
Total	$	68,703	$	162	$	83,101	$	626

General and administrative expenses are related to expenses incurred by Thermo on the Company's behalf which are charged to the Company. Non-cash expenses are related to services provided by executive officers of Thermo (who are also directors of the Company) who receive no cash compensation from the Company which are accounted for as a contribution to capital. The Thermo expense charges are based on actual amounts (with no mark-up) incurred or upon allocated employee time.

Since June 2009, Thermo and its affiliates have also deposited $60.0 million into a contingent equity account to fulfill a condition precedent for borrowing under the Facility Agreement, purchased $20.0 million of the Company's 5.0% Notes, purchased $11.4 million of the Company's 8.00% Notes Issued in 2009, provided a $2.3 million short-term loan to the Company (which was subsequently converted into nonvoting common stock), and loaned $37.5 million to the Company to fund the debt service reserve account.

On May 20, 2013, the Company exchanged 8.00% Notes Issued in 2013 for 5.75% Notes. As a result of this exchange, the Company entered into the Consent Agreement and the Common Stock Purchase Agreement (see Note 4 for further discussion). During the second quarter of 2013, Thermo and its affiliates funded $39.0 million in accordance with the Consent Agreement and the Common Stock Purchase Agreement. During the third quarter of 2013, Thermo and its affiliates funded an additional $12.5 million in accordance with the Consent Agreement and the Common Stock Purchase and Option Agreement.

In August 2013, the Company drew the remaining $1.1 million from the interest earned on the contingent equity account and issued Thermo 2,133,656 shares of nonvoting common stock to Thermo in October 2013. The value of the 20% discount on the shares issued to Thermo was recorded as a deferred financing cost on the Company's condensed consolidated balance sheet as of September 30, 2013.

For the three and nine months ended September 30, 2013, the Company recognized a loss on the sale of these shares of approximately $2.4 million and $16.4 million (included in other income/expense on the condensed consolidated statement of operations), representing the difference between the purchase price and the fair value of the Company's common stock (measured as the closing stock price on the date of each sale).

In July 2013, the Company and Thermo entered into an Amended and Restated Loan Agreement. As a result of this transaction, the Company was required to record this Loan Agreement initially at fair value as the amendment and restatement of the Loan Agreement was considered to be an extinguishment of debt. As of the amendment and restatement date the fair value of the Loan Agreement was $120.1 million. The Company recorded a loss on extinguishment of debt of $66.1 million in its condensed consolidated statement of operations for the third quarter of 2013. The Company computed this loss as the difference between the fair value of the debt, as amended and restated, and its carrying value just prior to amendment and restatement. See Notes 4 for further discussion.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References + Details

INCOME TAXES	9 Months Ended
INCOME TAXES	Sep. 30, 2013
INCOME TAXES [Abstract]
INCOME TAXES	11. INCOME TAXES The Company follows authoritative guidance surrounding accounting for uncertainty in income taxes. It is the Company's policy to recognize interest and applicable penalties, if any, related to uncertain tax positions in income tax expense. For the periods ending September 30, 2013 and December 31, 2012, the net deferred tax assets were fully reserved. In January 2012, the Company's Canadian subsidiary was notified that its income tax returns for the years ended October 31, 2008 and 2009 had been selected for audit. The Canada Revenue Agency is in the process of reviewing the information provided by the Company. Except for the audit noted above, neither the Company nor any of its subsidiaries is currently under audit by the IRS or by any state jurisdiction in the United States. The Company's corporate U.S. tax returns for 2009 and subsequent years remain subject to examination by tax authorities. State income tax returns are generally subject to examination for a period of three to five years after filing of the respective return. The state impact of any federal changes remains subject to examination by various states for a period of up to one year after formal notification to the states. Through a prior foreign acquisition the Company acquired a tax liability for which the Company has been indemnified by the previous owners. As of September 30, 2013 and December 31, 2012, the Company had recorded a tax liability of $2.6 million and $2.8 million, respectively, to the foreign tax authorities with an offsetting tax receivable from the previous owners.

ACCUMULATED OTHER COMPREHENSIVE LOSS

9 Months Ended

Sep. 30, 2013

ACCUMULATED OTHER COMPREHENSIVE LOSS [Abstract]

ACCUMULATED OTHER COMPREHENSIVE LOSS

12. ACCUMULATED OTHER COMPREHENSIVE LOSS

Accumulated other comprehensive loss includes all changes in equity during a period from non-owner sources. The change in accumulated other comprehensive loss for all periods presented resulted from foreign currency translation adjustments.

The components of accumulated other comprehensive loss were as follows (in thousands):

	Three months ended						Nine months ended
	September 30,						September 30,
	2013			2012			2013			2012
Accumulated other comprehensive loss, June 30, 2013 and 2012 and December 31, 2012 and 2011, respectively	$	(2,408	)	$	(2,551	)	$	(1,758	)	$	(3,100	)
Other comprehensive income (loss):
Foreign currency translation adjustments		553			1,119			(97	)		1,668
Accumulated other comprehensive loss, September 30, 2013 and 2012, respectively	$	(1,855	)		(1,432	)	$	(1,855	)		(1,432	)

As stated in Note 1, the Company has adopted ASU 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income. For the three and nine months ended September 30, 2013 and 2012, no amounts were reclassified out of accumulated other comprehensive loss.

- Definition

The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=28358780&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e640-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e716-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e709-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e637-108580

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e681-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Reclassification Adjustments
-URI http://asc.fasb.org/extlink&oid=6522872

+ Details

STOCK COMPENSATION

9 Months Ended

Sep. 30, 2013

STOCK COMPENSATION [Abstract]

STOCK COMPENSATION

13. STOCK COMPENSATION

The Company's 2006 Equity Incentive Plan ("Equity Plan") provides long-term incentives to the Company's key employees, including officers, directors, consultants and advisers ("Eligible Participants") and to align stockholder and employee interests. Under the Equity Plan, the Company may grant incentive stock options, restricted stock awards, restricted stock units, and other stock based awards or any combination thereof to Eligible Participants. The Compensation Committee of the Company's Board of Directors establishes the terms and conditions of any awards granted under the plans.

Grants to Eligible Participants of incentive stock options, restricted stock awards, and restricted stock units during the period are indicated in the table below (in thousands):

	Three months ended				Nine months ended
	September 30,				September 30,
	2013		2012		2013		2012
Grants of restricted stock awards and restricted stock units		14		342		852		721
Grants of options to purchase common stock		1,224		31		1,829		414
Total		1,238		373		2,681		1,135

Nonstatutory Stock Option

In October 2011, the Company granted to eligible participants nonstatutory stock options for 2,710,000 shares of common stock and 273,000 restricted shares that vest and become exercisable on the earlier of (i) the first trading day after the Company's common stock shall have traded on the then-applicable national or regional securities exchange or market system constituting the primary market for the stock, as reported in The Wall Street Journal , or such other source as the Company deems reliable, including without limitation if then-applicable, the NASDAQ Stock Market, for more than ten consecutive trading days at or above a per-share closing price of $2.50 or (ii) the day that a binding written agreement is signed for the sale of the Company, as determined by the Company's board of directors in its discretion reasonably exercised.

In July 2013, the Compensation Committee of the Company's Board of Directors modified this award to revise the vesting terms from $2.50 to $0.80. As a result of this modification, the Company's incremental compensation cost is approximately $0.6 million.

In September 2013, the Company's stock price traded for more than ten consecutive trading days above a price per-share closing price of $0.80, which resulted in immediate vesting of these options. The Company recognized the remaining unamortized compensation cost related to immediate vesting of these options of approximately $0.8 million in the third quarter of 2013.

For the three months ended September 30, 2013 and 2012, the Company recorded expense for the fair value of the grant of $0.8 million and less than $0.1 million, respectively and for the nine months ended September 30, 2013 and 2012, the Company recorded expense for the fair value of the grant of $0.9 million and $0.2 million, respectively. The expense recorded for the fair value of the grant is reflected in marketing, general and administrative expenses.

Employee Stock Purchase Plan

The Company's Employee Stock Purchase Plan (the "Plan") provides eligible employees of the Company and its subsidiaries with an opportunity to acquire shares of its common stock at a discount. The Plan permits eligible employees to purchase shares of common stock during two semi-annual offering periods beginning on June 15 and December 15, unless adjusted by the Board or one of its designated committees (the "Offering Periods"). Eligible employees may purchase shares in an amount of up to 15% of their total compensation per pay period, but may purchase no more than the lesser of $25,000 of the fair market value of common stock or 500,000 shares of common stock in any calendar year, as measured as of the first day of each applicable Offering Period. The price an employee pays is 85% of the fair market value of the common stock. Fair market value is equal to the lesser of the closing price of a share of common stock on either the first or last day of the Offering Period.

For the three months ended September 30, 2013 and 2012, the Company recorded expense for the fair value of the grant under the Plan of $0.1 million and less than $0.1 million, respectively, and for the nine months ended September 30, 2013 and 2012, the Company recorded expense for the fair value of the grant of $0.2 million and $0.1 million, respectively. The expense recorded for the fair value of the grant under the Plan is reflected in marketing, general and administrative expenses. Through September 30, 2013, the Company had issued 1,868,401 shares of common stock pursuant to this stock purchase plan.

HEADQUARTERS RELOCATION	9 Months Ended
HEADQUARTERS RELOCATION	Sep. 30, 2013
HEADQUARTERS RELOCATION [Abstract]
HEADQUARTERS RELOCATION	14. HEADQUARTERS RELOCATION During 2010 the Company announced the relocation of its corporate headquarters to Covington, Louisiana. In addition, the Company relocated its product development center, international customer care operations, call center and other global business functions including finance, accounting, sales, marketing and corporate communications. The Company completed the relocation in 2011. In connection with its relocation, the Company entered into a Cooperative Endeavor Agreement with the Louisiana Department of Economic Development ("LED") whereby the Company would be reimbursed for certain qualified relocation costs and lease expenses. In accordance with the terms of the agreement, these reimbursement costs, not to exceed $8.1 million, will be reimbursed to the Company as incurred provided the Company maintains required annual payroll levels in Louisiana through 2019. Since announcing its relocation, the Company has incurred qualifying relocation expenses. Under the terms of the agreement, the Company was reimbursed a total of $4.2 million for qualifying relocation and lease expenses and $1.3 million for facility improvements and replacement equipment in connection with the relocation through September 30, 2013 by LED. LED will continue to reimburse the Company approximately $352,000 per year through 2019 for certain qualifying lease expenses, provided the Company meets the required payroll levels set forth in the agreement. If the Company fails to meet the required payroll in any project year, the Company will reimburse LED for a portion of the shortfall not to exceed the total reimbursement received from LED. Due to a plan to improve its cost structure by reducing headcount, the Company has projected that it would not meet the required payroll levels set forth in the agreement and recorded a liability of $1.3 million at September 30, 2013 for the estimated impact of the payroll shortfall in future years. This liability is included in current and non-current liabilities in the Company's condensed consolidated balance sheet.

GEOGRAPHIC INFORMATION

9 Months Ended

Sep. 30, 2013

GEOGRAPHIC INFORMATION [Abstract]

GEOGRAPHIC INFORMATION

15. GEOGRAPHIC INFORMATION

The Company attributes equipment revenue to various countries based on the location equipment is sold. Service revenue is attributed to the various countries based on where the service is processed. Long-lived assets consist primarily of property and equipment and are attributed to various countries based on the physical location of the asset at a given period-end, except for the satellites which are included in the long-lived assets of the United States. The Company's information by geographic area is as follows (in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2013		2012		2013		2012
Revenues:
Service:
United States	$	11,660	$	11,051	$	33,666	$	29,926
Canada		3,446		2,836		9,123		7,827
Europe		1,185		732		2,736		2,223
Central and South America		625		640		1,918		1,897
Others		140		109		411		273
Total service revenue	$	17,056	$	15,368	$	47,854	$	42,146
Subscriber equipment:
United States		3,688		3,633		8,756		10,724
Canada		1,201		887		2,964		2,555
Europe		327		287		1,228		939
Central and South America		177		220		712		701
Others		100		142		203		191
Total subscriber equipment revenue	$	5,493	$	5,169	$	13,863	$	15,110
Total revenue	$	22,549	$	20,537	$	61,717	$	57,256

	September 30,		December 31,
	2013		2012
Long-lived assets:
United States	$	1,181,700	$	1,209,374
Canada		221		277
Europe		417		474
Central and South America		3,677		3,463
Others		1,273		1,568
Total long-lived assets	$	1,187,288	$	1,215,156

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

+ Details

LOSS PER SHARE	9 Months Ended
LOSS PER SHARE	Sep. 30, 2013
LOSS PER SHARE [Abstract]
LOSS PER SHARE	16. LOSS PER SHARE The Company is required to present basic and diluted earnings per share. Basic earnings per share are computed based on the weighted average number of common shares outstanding during the period. Common stock equivalents are included in the calculation of diluted earnings per share only when the effect of their inclusion would be dilutive. For the three and nine months ended September 30, 2013 and 2012, diluted net loss per share of common stock was the same as basic net loss per share of common stock, because the effects of potentially dilutive securities are anti-dilutive. As of December 31, 2012, 17.3 million Borrowed Shares related to the Company's Share Lending Agreement remained outstanding. The Company does not consider the Borrowed Shares to be outstanding for the purposes of computing and reporting its earnings per share. Effective in July 2013, the Company and the Borrower terminated the Share Lending Agreement resulting in the Borrower returning 10.2 million Borrowed Shares to Globalstar and agreeing to pay a cash settlement for the remaining 7.1 million Borrowed Shares at an average of the volume weighted stock prices over a 20-day trading period ending in August 2013. These shares are no longer included in the calculation to arrive at the Company's September 30, 2013 earnings per share amounts. Pursuant to the terms of the Common Stock Purchase and Option Agreement, approximately 24.0 million shares of nonvoting common stock were issued to Thermo in October 2013. Pursuant to the terms of the Contingent Equity Agreement, approximately 2.1 million nonvoting shares of common stock were issued to Thermo in October 2013. These amounts are not included in the calculation to arrive at the Company's September 30, 2013 earnings per share amounts. See Note 4 for further discussion.

SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION

9 Months Ended

Sep. 30, 2013

SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION [Abstract]

SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION

17. SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION

In connection with the Company's issuance of the 5.0% Notes and 5.0% Warrants, certain of the Company's domestic subsidiaries (the "Guarantor Subsidiaries"), fully, unconditionally, jointly, and severally guaranteed the payment obligations under the 5.0% Notes. The following supplemental financial information sets forth, on a consolidating basis, the balance sheets, statements of operations and statements of cash flows for Globalstar, Inc. (the "Parent Company"), for the Guarantor Subsidiaries and for the Parent Company's other subsidiaries (the "Non-Guarantor Subsidiaries").

The supplemental condensed consolidating financial information has been prepared pursuant to the rules and regulations for condensed financial information and does not include disclosures included in annual financial statements. The principal eliminating entries eliminate investments in subsidiaries, intercompany balances and intercompany revenues and expenses.

Globalstar, Inc.

Supplemental Condensed Consolidating Statement of Operations

Three Months Ended September 30, 2013

(Unaudited)

							Non-
	Parent			Guarantor			Guarantor
	Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	(In thousands)
Revenue:
Service revenues	$	18,726		$	2,478		$	4,940		$	(9,088	)	$	17,056
Subscriber equipment sales		127			4,254			1,070			42			5,493
Total revenue		18,853			6,732			6,010			(9,046	)		22,549
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)		3,125			3,126			1,941			(11	)		8,181
Cost of subscriber equipment sales		90			3,334			1,819			(1,095	)		4,148
Cost of subscriber equipment sales - reduction in the value of inventory		-			-			-			-			-
Marketing, general and administrative		2,008			4,666			3,774			(1,369	)		9,079
Reduction in the value of long-lived assets		-			-			-			-			-
Contract termination charge		-			-			-			-			-
Depreciation, amortization, and accretion		19,645			4,914			6,485			(7,329	)		23,715
Total operating expenses		24,868			16,040			14,019			(9,804	)		45,123
Loss from operations		(6,015	)		(9,308	)		(8,009	)		758			(22,574	)
Other income (expense):
Loss on extinguishment of debt		(63,569	)		-			-			-			(63,569	)
Loss on equity issuance		(2,733	)		-			-			-			(2,733	)
Interest income and expense, net of amounts capitalized		(16,636	)		(3	)		(262	)		-			(16,901	)
Derivative gain (loss)		(97,534	)		-			-			-			(97,534	)
Equity in subsidiary earnings		(17,090	)		(1,729	)		-			18,819			-
Other		(1,343	)		(171	)		(21	)		(5	)		(1,540	)
Total other income (loss)		(198,905	)		(1,903	)		(283	)		18,814			(182,277	)
Loss before income taxes		(204,920	)		(11,211	)		(8,292	)		19,572			(204,851	)
Income tax expense		49			6			63			-			118
Net loss	$	(204,969	)	$	(11,217	)	$	(8,355	)	$	19,572		$	(204,969	)

Comprehensive loss	$	(204,969	)	$	(11,217	)	$	(7,803	)	$	19,572		$	(204,417	)

Globalstar, Inc.

Supplemental Condensed Consolidating Statement of Operations

Three Months Ended September 30, 2012

(Unaudited)

							Non-
	Parent			Guarantor			Guarantor
	Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	(In thousands)
Revenue:
Service revenues	$	14,296		$	10,832		$	4,002		$	(13,762	)	$	15,368
Subscriber equipment sales		255			4,138			2,941			(2,165	)		5,169
Total revenue		14,551			14,970			6,943			(15,927	)		20,537
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)		2,922			4,152			2,133			(1,794	)		7,413
Cost of subscriber equipment sales		134			4,742			3,780			(4,616	)		4,040
Cost of subscriber equipment sales - reduction in the value of inventory		-			658			2			-			660
Marketing, general and administrative		4,098			1,377			3,229			(1,279	)		7,425
Reduction in the value of long-lived assets		-			-			-			-			-
Contract termination charge		-			-			-			-			-
Depreciation, amortization, and accretion		13,313			13,782			4,338			(12,779	)		18,654
Total operating expenses		20,467			24,711			13,482			(20,468	)		38,192
Loss from operations		(5,916	)		(9,741	)		(6,539	)		4,541			(17,655	)
Other income (expense):
Interest income and expense, net of amounts capitalized		(6,172	)		(1	)		(394	)		2			(6,565	)
Derivative loss		(16,473	)		-			-			-			(16,473	)
Equity in subsidiary earnings		(12,120	)		2,205			-			9,915			-
Other		(456	)		(117	)		218			(84	)		(439	)
Total other income (expense)		(35,221	)		2,087			(176	)		9,833			(23,477	)
Loss before income taxes		(41,137	)		(7,654	)		(6,715	)		14,374			(41,132	)
Income tax (benefit) expense		51			(18	)		23			-			56
Net loss	$	(41,188	)	$	(7,636	)	$	(6,738	)	$	14,374		$	(41,188	)

Comprehensive loss	$	(41,188	)	$	(7,636	)	$	(5,619	)	$	14,374		$	(40,069	)

Globalstar, Inc.

Supplemental Condensed Consolidating Statement of Operations

Nine Months Ended September 30, 2013

(Unaudited)

							Non-
	Parent			Guarantor			Guarantor
	Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	(In thousands)
Revenue:
Service revenues	$	50,351		$	8,544		$	13,320		$	(24,361	)	$	47,854
Subscriber equipment sales		287			10,018			13,264			(9,706	)		13,863
Total revenue		50,638			18,562			26,584			(34,067	)		61,717
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)		8,233			7,947			6,791			(58	)		22,913
Cost of subscriber equipment sales		90			8,048			14,323			(11,786	)		10,675
Cost of subscriber equipment sales - reduction in the value of inventory		-			-			-			-			-
Marketing, general and administrative		4,555			11,710			9,895			(3,581	)		22,579
Reduction in the value of long-lived assets		-			-			-			-			-
Contract termination charge		-			-			-			-			-
Depreciation, amortization, and accretion		52,538			15,936			17,167			(19,527	)		66,114
Total operating expenses		65,416			43,641			48,176			(34,952	)		122,281
Loss from operations		(14,778	)		(25,079	)		(21,592	)		885			(60,564	)
Other income (expense):
Loss on extinguishment of debt		(110,809	)		-			-			-			(110,809	)
Loss on equity issuance		(16,701	)		-			-			-			(16,701	)
Interest income and expense, net of amounts capitalized		(38,728	)		(39	)		(1,098	)		(4	)		(39,869	)
Derivative gain (loss)		(126,911	)		-			-			-			(126,911	)
Equity in subsidiary earnings		(47,313	)		(2,794	)		-			50,107			-
Other		(909	)		(170	)		(124	)		78			(1,125	)
Total other income (loss)		(341,371	)		(3,003	)		(1,222	)		50,181			(295,415	)
Loss before income taxes		(356,149	)		(28,082	)		(22,814	)		51,066			(355,979	)
Income tax expense		171			35			135			-			341
Net loss	$	(356,320	)	$	(28,117	)	$	(22,949	)	$	51,066		$	(356,320	)

Comprehensive loss	$	(356,320	)	$	(28,117	)	$	(23,046	)	$	51,066		$	(356,417	)

Globalstar, Inc.

Supplemental Condensed Consolidating Statement of Operations

Nine Months Ended September 30, 2012

(Unaudited)

							Non-
	Parent			Guarantor			Guarantor
	Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	(In thousands)
Revenue:
Service revenues	$	35,609		$	30,528		$	11,609		$	(35,600	)	$	42,146
Subscriber equipment sales		809			12,328			5,676			(3,703	)		15,110
Total revenue		36,418			42,856			17,285			(39,303	)		57,256
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)		8,995			7,936			6,369			(1,082	)		22,218
Cost of subscriber equipment sales		284			9,420			5,377			(4,616	)		10,465
Cost of subscriber equipment sales - reduction in the value of inventory		2			904			51			-			957
Marketing, general and administrative		12,176			3,292			8,945			(3,351	)		21,062
Reduction in the value of long-lived assets		79			7,139			-			-			7,218
Contract termination charge		22,048			-			-			-			22,048
Depreciation, amortization, and accretion		32,789			36,817			12,343			(32,672	)		49,277
Total operating expenses		76,373			65,508			33,085			(41,721	)		133,245
Loss from operations		(39,955	)		(22,652	)		(15,800	)		2,418			(75,989	)
Other income (expense):
Interest income and expense, net of amounts capitalized		(12,126	)		(7	)		(1,261	)		(2	)		(13,396	)
Derivative loss		(2,562	)		-			-			-			(2,562	)
Equity in subsidiary earnings		(37,737	)		6,703			-			31,034			-
Other		(687	)		(12	)		(163	)		(76	)		(938	)
Total other income (expense)		(53,112	)		6,684			(1,424	)		30,956			(16,896	)
Loss before income taxes		(93,067	)		(15,968	)		(17,224	)		33,374			(92,885	)
Income tax expense		179			30			152			-			361
Net loss	$	(93,246	)	$	(15,998	)	$	(17,376	)	$	33,374		$	(93,246	)

Comprehensive loss	$	(93,246	)	$	(15,998	)	$	(15,708	)	$	33,374		$	(91,578	)

Globalstar, Inc.

Supplemental Condensed Consolidating Balance Sheet

As of September 30, 2013

(Unaudited)

	Parent Company			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Elimination			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	4,298		$	359		$	1,986		$	-		$	6,643
Restricted cash		-			-			-			-			-
Accounts receivable		4,430			6,512			5,502			-			16,444
Intercompany receivables		624,466			408,029			17,463			(1,049,958	)		-
Inventory		399			14,941			22,142			-			37,482
Deferred financing costs		-			-			-			-			-
Prepaid expenses and other current assets		4,525			415			2,643			-			7,583
Total current assets		638,118			430,256			49,736			(1,049,958	)		68,152
Property and equipment, net		1,165,336			16,413			7,198			(1,659	)		1,187,288
Restricted cash		37,940			-			-			-			37,940
Intercompany notes receivable		13,629			-			1,800			(15,429	)		-
Investment in subsidiaries		(187,026	)		2,794			-			184,232			-
Deferred financing costs		79,861			-			-			-			79,861
Advances for inventory		9,158			-			-			-			9,158
Intangible and other assets, net		4,104			1,216			2,065			(10	)		7,375
Total assets	$	1,761,120		$	450,679		$	60,799		$	(882,824	)	$	1,389,744

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Current portion of long-term debt	$	-		$	-		$	-		$	-		$	-
Accounts payable		21,331			2,514			2,599			-			26,444
Accrued contract termination charge		23,699			-			-			-			23,699
Accrued expenses		15,613			8,522			8,693			-			32,828
Intercompany payables		421,710			510,497			118,452			(1,050,659	)		-
Payables to affiliates		303			-			-			-			303
Derivative liabilities		41,539			-			-			-			41,539
Deferred revenue		1,743			13,923			2,156			-			17,822
Total current liabilities		525,938			535,456			131,900			(1,050,659	)		142,635
Long-term debt, less current portion		675,690			-			-			-			675,690
Employee benefit obligations		7,117			-			-			-			7,117
Intercompany notes payable		-			-			14,529			(14,529	)		-
Derivative liabilities		254,207			-			-			-			254,207
Deferred revenue		6,760			557			-			-			7,317
Debt restructuring fees		20,795			-			-			-			20,795
Other non-current liabilities		4,011			625			10,775			-			15,411
Total non-current liabilities		968,580			1,182			25,304			(14,529	)		980,537
Stockholders' equity		266,602			(85,959	)		(96,405	)		182,364			266,602
Total liabilities and stockholders' equity	$	1,761,120		$	450,679		$	60,799		$	(882,824	)	$	1,389,744

Globalstar, Inc.

Supplemental Condensed Consolidating Balance Sheet

As of December 31, 2012

(Audited)

	Parent Company			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Elimination			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	10,220		$	251		$	1,321		$	-		$	11,792
Restricted cash		46,777			-			-			-			46,777
Accounts receivable		3,814			4,875			5,255			-			13,944
Intercompany receivables		613,426			411,764			5,534			(1,030,724	)		-
Inventory		262			6,966			34,953			-			42,181
Deferred financing costs		34,622			-			-			-			34,622
Prepaid expenses and other current assets		2,177			388			2,668			-			5,233
Total current assets		711,298			424,244			49,731			(1,030,724	)		154,549
Property and equipment, net		1,095,973			31,382			86,762			1,039			1,215,156
Restricted cash		-			-			-			-			-
Intercompany notes receivable		15,783			-			1,800			(17,583	)		-
Investment in subsidiaries		(144,323	)		(8,232	)		-			152,555			-
Deferred financing costs		16,883			-			-			-			16,883
Advances for inventory		9,158			-			-			-			9,158
Intangible and other assets, net		3,991			1,781			2,273			(16	)		8,029
Total assets	$	1,708,763		$	449,175		$	140,566		$	(894,729	)	$	1,403,775

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Current portion of long-term debt	$	655,874		$	-		$	-		$	-		$	655,874
Accounts payable		12,055			2,410			21,220			-			35,685
Accrued contract termination charge		23,166			-			-			-			23,166
Accrued expenses		6,492			9,798			11,874			-			28,164
Intercompany payables		377,526			494,686			156,166			(1,028,378	)		-
Payables to affiliates		230			-			-			-			230
Deferred revenue		4,576			12,674			791			-			18,041
Total current liabilities		1,079,919			519,568			190,051			(1,028,378	)		761,160
Long-term debt, less current portion		95,155			-			-			-			95,155
Employee benefit obligations		7,221			-			-			-			7,221
Intercompany notes payable		-			-			16,683			(16,683	)		-
Derivative liabilities		25,175			-			-			-			25,175
Deferred revenue		4,306			334			-			-			4,640
Other non-current liabilities		2,443			2,233			11,204			-			15,880
Total non-current liabilities		134,300			2,567			27,887			(16,683	)		148,071
Stockholders' equity		494,544			(72,960	)		(77,372	)		150,332			494,544
Total liabilities and stockholders' equity	$	1,708,763		$	449,175		$	140,566		$	(894,729	)	$	1,403,775

Globalstar, Inc.

Supplemental Condensed Consolidating Statement of Cash Flows

Nine Months Ended September 30, 2013

(Unaudited)

							Non-
	Parent			Guarantor			Guarantor
	Company			Subsidiaries			Subsidiaries			Eliminations		Consolidated
	(In thousands)

Net cash provided by (used in) operating activities	$	426		$	814		$	1,094		$	-	$	2,334

Cash flows from investing activities:
Second-generation satellites, ground and related launch costs		(37,732	)		-			-			-		(37,732	)
Property and equipment additions		-			(706	)		(519	)		-		(1,225	)
Investment in businesses		(496	)		-			-			-		(496	)
Restricted cash		8,838			-			-			-		8,838
Net cash used in investing activities		(29,390	)		(706	)		(519	)		-		(30,615	)

Cash flows from financing activities:
Borrowings from Facility Agreement		672			-			-			-		672
Borrowings from contingent equity account		1,071			-			-			-		1,071
Proceeds from issuance of common stock and stock options		8,979			-			-			-		8,979
Payments to reduce principal amount of exchanged 5.75% Notes		(13,544	)		-			-			-		(13,544	)
Payments to reduce principal amount of 5.75% Notes not exchanged		(6,250	)		-			-			-		(6,250	)
Payments to lenders and other fees associated with exchange		(2,482	)		-			-			-		(2,482	)
Proceeds for equity issuance to related party		51,500			-			-			-		51,500
Payment of deferred financing costs		(16,904	)		-			-			-		(16,904	)
Net cash from by financing activities		23,042			-			-			-		23,042
Effect of exchange rate changes on cash and cash equivalents		-			-			90			-		90
Net increase (decrease) in cash and cash equivalents		(5,922	)		108			665			-		(5,149	)
Cash and cash equivalents at beginning of period		10,220			251			1,321			-		11,792
Cash and cash equivalents at end of period	$	4,298		$	359		$	1,986		$	-	$	6,643

Globalstar, Inc.

Supplemental Condensed Consolidating Statement of Cash Flows

Nine Months Ended September 30, 2012

(Unaudited

							Non-
	Parent			Guarantor			Guarantor
	Company			Subsidiaries			Subsidiaries			Eliminations		Consolidated
	(In thousands)
Net cash provided by (used in) operating activities	$	12,655		$	(165	)	$	(1,612	)	$	-	$	10,878

Cash flows from investing activities:
Second-generation satellites, ground and related launch costs		(43,305	)										(43,305	)
Property and equipment additions		-			(197	)		(185	)		-		(382	)
Investment in businesses		(450	)		-			-			-		(450	)
Restricted cash		(3,650	)		-			-			-		(3,650	)

Net cash used in investing activities		(47,405	)		(197	)		(185	)		-		(47,787	)

Cash flows from financing activities:
Proceeds from issuance of common stock and stock options		100			-			-			-		100
Borrowings from Facility Agreement		5,008			-			-			-		5,008
Proceeds from contingent equity account		23,000			-			-			-		23,000
Payment of deferred financing costs		(250	)		-			-			-		(250	)
Net cash from by financing activities		27,858			-			-			-		27,858
Effect of exchange rate changes on cash and cash equivalents		-			-			319			-		319
Net increase (decrease) in cash and cash equivalents		(6,892	)		(362	)		(1,478	)				(8,732	)
Cash and cash equivalents at beginning of period		7,343			587			2,021			-		9,951
Cash and cash equivalents at end of period	$	451		$	225		$	543		$	-	$	1,219

PROPERTY AND EQUIPMENT (Tables)

9 Months Ended

Sep. 30, 2013

PROPERTY AND EQUIPMENT [Abstract]

Property and Equipment

Property and equipment consists of the following (in thousands):

	September 30,			December 31,
	2013			2012
Globalstar System:
Space component
Second-generation satellites in service	$	1,212,234		$	934,900
Prepaid long-lead items		17,040			17,040
Ground component		48,581			49,089
Construction in progress:
Space component		33,155			299,209
Ground component		109,384			84,423
Other		799			880
Total Globalstar System		1,421,193			1,385,541
Internally developed and purchased software		15,023			14,414
Equipment		12,996			12,800
Land and buildings		3,837			4,003
Leasehold improvements		1,507			1,512
		1,454,556			1,418,270
Accumulated depreciation and amortization		(267,268	)		(203,114	)
	$	1,187,288		$	1,215,156

Capitalized Interest

The following tables summarize capitalized interest for the periods indicated below (in thousands):

	As of
	September 30,		December 31,
	2013		2012
Total interest capitalized	$	231,026	$	216,477

	Three Months Ended						Nine Months Ended
	September 30, 2013			September 30, 2012			September 30, 2013			September 30, 2012
Interest cost eligible to be capitalized	$	13,119		$	13,777		$	38,851		$	43,411
Interest cost recorded in interest expense, net		(10,151	)		(5,543	)		(24,302	)		(10,239	)
Net interest capitalized		2,968			8,234			14,549			33,172

Depreciation Expense

The following table summarizes depreciation expense for the periods indicated below (in thousands):

	Three Months Ended				Nine Months Ended
	September 30, 2013		September 30, 2012		September 30, 2013		September 30, 2012
Depreciation expense	$	23,961	$	17,964	$	65,622	$	47,542

LONG-TERM DEBT (Tables)

9 Months Ended

Sep. 30, 2013

LONG-TERM DEBT [Abstract]

Long-term Debt

Long-term debt consists of the following (in thousands):

	September 30, 2013				December 31, 2012
	Principal		Carrying		Principal		Carrying
	Amount		Value		Amount		Value
Facility Agreement	$	586,342	$	586,342	$	585,670	$	585,670
Thermo Loan Agreement		58,569		20,488		53,499		49,822
5.75% Convertible Senior Unsecured Notes		-		-		71,804		70,204
8.00% Convertible Senior Notes Issued in 2013		47,570		25,547		-		-
5.0% Convertible Senior Unsecured Notes		25,199		11,959		40,920		16,701
8.00% Convertible Senior Unsecured Notes Issued in 2009		49,665		31,354		48,228		28,632
Total Debt		767,345		675,690		800,121		751,029
Less: Current Portion		-		-		657,474		655,874
Long-Term Debt	$	767,345	$	675,690	$	142,647	$	95,155

Schedule of Subordinated Debt

The Company allocated the fair value at issuance as follows (in thousands):

Loan Agreement	$	18,958
Compound embedded derivative liability		101,114
Fair value of Loan Agreement	$	120,072

Schedule of 8.00% Convertible Senior Notes Issued in 2013

The Company allocated the fair value at issuance as follows (in thousands):

Senior notes	$	27,890
Compound embedded derivative liability		56,752
Fair value of 8.00% Notes Issued in 2013	$	84,642

Summary of Warrants Outstanding

	Outstanding Warrants				Strike Price
	September 30, 2013		December 31, 2012		September 30, 2013		December 31, 2012
Contingent Equity Agreement		41,467,980		41,467,980	$	0.01	$	0.01
Thermo Loan Agreement		4,205,608		4,205,608		0.01		0.01
5.0% Notes (1)		9,600,000		15,200,000		0.32		1.25
8.00% Notes Issued in 2009 (2)		51,769,358		61,606,706		0.32		0.32
		107,042,946		122,480,294

	(1)	On April 15, 2013, the exercise price of the 5.0% Warrants was reset to $0.32 due to the reset provision in the indenture.
	(2)	According to the terms of the indenture, additional 8.00% Warrants may be issued to holders if shares of common stock are issued below the then current warrant strike price.

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6584090&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 22
-Article 5

+ Details

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details

DERIVATIVES (Tables)

9 Months Ended

Sep. 30, 2013

DERIVATIVES [Abstract]

Schedule of Fair Values of Derivative Instruments

	September 30, 2013			December 31, 2012
Intangible and other assets:
Interest rate cap	$	170		$	84
Total intangible and other assets	$	170		$	84

Derivative liabilities, current:
Warrants issued with 8.00% Notes Issued in 2009		(41,539	)		-

Derivative liabilities, non-current:
Compound embedded derivative with 8.00% Notes Issued in 2009	$	(41,396	)	$	(4,163	)
Warrants issued with 8.00% Notes Issued in 2009		-			(18,034	)
Contingent put feature embedded in the 5.0% Notes		(845	)		(2,978	)
Compound embedded derivative with 8.00% Notes Issued in 2013		(74,399	)		-
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement		(137,567	)		-
Total derivative liabilities, non-current:		(254,207	)		(25,175	)

Total derivative liabilities, current and non-current	$	(295,746	)	$	(25,175	)

Schedule of Derivative Gains (Losses)

	Three Months Ended
	September 30, 2013			September 30, 2012
Interest rate cap	$	(30	)	$	(39	)
Compound embedded derivative with 8.00% Notes Issued in 2009		(29,986	)		(2,417	)
Warrants issued with 8.00% Notes Issued in 2009		(6,323	)		(13,963	)
Contingent put feature embedded in the 5.0% Notes		848			(54	)
Compound embedded derivative with 8.00% Notes Issued in 2013		(25,590	)		-
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement		(36,453	)		-
Total derivative gain (loss)	$	(97,534	)	$	(16,473	)

	Nine Months Ended
	September 30, 2013			September 30, 2012
Interest rate cap	$	86		$	(161	)
Compound embedded derivative with 8.00% Notes Issued in 2009		(37,233	)		1,287
Warrants issued with 8.00% Notes Issued in 2009		(28,949	)		(4,031	)
Warrants issued in conjunction with contingent equity agreement		-			301
Contingent put feature embedded in the 5.0% Notes		2,133			42
Compound embedded derivative with 8.00% Notes Issued in 2013		(26,495	)		-
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement		(36,453	)		-
Total derivative gain (loss)	$	(126,911	)	$	(2,562	)

FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Sep. 30, 2013

FAIR VALUE MEASUREMENTS [Abstract]

Financial Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table provides a summary of the financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2013 and December 31, 2012 (in thousands):

	Fair Value Measurements at September 30, 2013:
	(Level 1)		(Level 2)		(Level 3)			Total Balance
Assets:
Interest rate cap	$	-	$	170	$	-		$	170
Total assets measured at fair value	$	-	$	170	$	-		$	170

Liabilities:
Derivative Liabilities:
Compound embedded derivative with 8.00% Notes Issued in 2009	$	-	$	-	$	(41,396	)	$	(41,396	)
Warrants issued with 8.00% Notes Issued in 2009		-		-		(41,539	)		(41,539	)
Contingent put feature embedded in 5.0% Notes		-		-		(845	)		(845	)
Compound embedded derivative with 8.00% Notes Issued in 2013		-		-		(74,399	)		(74,399	)
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement		-		-		(137,567	)		(137,567	)
Total Derivative Liabilities		-		-		(295,746	)		(295,746	)

Other Liabilities:
Liability for contingent consideration		-		-		(2,375	)		(2,375	)

Total liabilities measured at fair value	$	-	$	-	$	(298,121	)	$	(298,121	)

	Fair Value Measurements at December 31, 2012:
	(Level 1)		(Level 2)		(Level 3)			Total Balance
Assets:
Interest rate cap	$	-	$	84	$	-		$	84
Total assets measured at fair value	$	-	$	84	$	-		$	84

Liabilities:
Derivative Liabilities:
Compound embedded derivative with 8.00% Notes Issued in 2009	$	-	$	-	$	(4,163	)	$	(4,163	)
Warrants issued with 8.00% Notes Issued in 2009		-		-		(18,034	)		(18,034	)
Contingent put feature embedded in 5.0% Notes		-		-		(2,978	)		(2,978	)
Total Derivative Liabilities		-		-		(25,175	)		(25,175	)

Other Liabilities:
Liability for contingent consideration		-		-		(3,916	)		(3,916	)

Total liabilities measured at fair value	$	-	$	-	$	(29,091	)	$	(29,091	)

Reconciliation of Liabilities Measured at Fair Value on Recurring Basis

Balance at June 30, 2013	$	(113,749	)
Issuance of compound embedded derivative with the Amended and Restated Loan Agreement with Thermo		(101,114	)
Earnout payments made related to liability for contingent consideration		415
Change in fair value of contingent consideration		443
Derivative adjustment related to conversions and exercises		13,386
Unrealized loss, included in derivative gain (loss)		(97,502	)
Balance at September 30, 2013	$	(298,121	)

Balance at December 31, 2012	$	(29,091	)
Issuance of compound embedded derivative with 8.00% Notes Issued in 2013		(56,752	)
Issuance of compound embedded derivative with the Amended and Restated Loan Agreement with Thermo		(101,114	)
Third party issuance costs expensed to derivative gain (loss) in connection with Issuance of 8.00% Notes Issued in 2013		(905	)
Earnout payments made related to liability for contingent consideration		1,351
Change in fair value of contingent consideration		190
Derivative adjustment related to conversions and exercises		13,386
Unrealized loss, included in derivative gain (loss)		(125,186	)
Balance at September 30, 2013	$	(298,121	)

Schedule of Significant Quantitative Level 3 Inputs Utilized

The significant quantitative Level 3 inputs utilized in the valuation models as of September 30, 2013 and December 31, 2012 are shown in the tables below:

	Level 3 Inputs at September 30, 2013:
	Stock Price Volatility			Risk-Free Interest Rate			Note Conversion Price		Warrant Exercise Price		Market Price of Common Stock
Compound embedded derivative with 8.00% Notes Issued in 2009		65 - 100	%		1.3	%	$	1.19	$	N/A	$	1.09
Warrants issued with 8.00% Notes Issued in 2009		100	%		0.1	%	$	N/A	$	0.32	$	1.09
Contingent put feature embedded in 5.0% Notes		33 - 106	%		0.03 - 2.64	%	$	0.50	$	N/A	$	1.09
Compound embedded derivative with 8.00% Notes Issued in 2013		65 - 100	%		1.3	%	$	0.75	$	N/A	$	1.09
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement		65 - 100	%		2.6	%	$	0.75	$	N/A	$	1.09

	Level 3 Inputs at December 31, 2012:
	Stock Price Volatility		Risk-Free Interest Rate		Note Conversion Price		Warrant Exercise Price		Market Price of Common Stock
Compound embedded derivative with 8.00% Notes Issued in 2009	34 -107	%	0.02 - 1.78	%	$	1.59	$	N/A	$	0.31
Warrants issued with 8.00% Notes Issued in 2009	34 -107	%	0.02 - 1.78	%	$	N/A	$	0.32	$	0.31
Contingent put feature embedded in 5.0% Notes	34 -107	%	0.02 - 1.78	%	$	1.25	$	N/A	$	0.31

The significant quantitative Level 3 inputs utilized in the valuation models as of the issuance date of the 8.00% Notes Issued in 2013 are shown in the table below:

	Level 3 Inputs at May 20, 2013:
	Stock Price Volatility			Risk-Free Interest Rate			Note Conversion Price		Discount Rate			Market Price of Common Stock
Compound embedded derivative with 8.00% Notes Issued in 2013		65 - 100	%		0.9	%	$	0.80		27	%	$	0.40

The significant quantitative Level 3 inputs utilized in the valuation models as of the amendment and restatement date of the Loan Agreement are shown in the table below:

	Level 3 Inputs at July 31, 2013:
	Stock Price Volatility			Risk-Free Interest Rate			Note Conversion Price		Discount Rate			Market Price of Common Stock
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement		65 - 100	%		2.6	%	$	0.75		26	%	$	0.60

Schedule of Nonrecurring Fair Value Measurements

	Amount Invested		Issuance Price per Share		Closing Price per Share		Discount Value (5)		Total Fair Value		Shares Issued (6)
May 20, 2013 (1)	$	25,000	$	0.32	$	0.40	$	6,250	$	31,250		78,125,000
May 20, 2013 (1)		5,000		0.32		0.40		1,250		6,250		15,625,000
June 28, 2013 (1)		9,000		0.32		0.55		6,469		15,469		28,125,000
July 29, 2013 (2), (3)		6,000		0.52		0.62		1,154		7,154		11,538,462
August 19, 2013 (2), (3)		6,500		0.52		0.62		1,250		7,750		12,500,000
Total (4)	$	51,500					$	16,373	$	67,873		145,913,462

	(1)	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company's condensed consolidated balance sheet.
	(2)	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement.
	(3)	The terms of the issuance price per share were determined in October 2013; therefore the shares were not issued as of September 30, 2013. The total fair value of the shares of $14.9 million was recorded on the Company's condensed consolidated balance sheet as future equity issuance of common stock to related party.
	(4)	Pursuant to the terms of the Consent Agreement, certain equity transactions which result in cash invested into Globalstar may reduce the amounts committed by Thermo. As of September 30, 2013, the Company had received approximately $8.8 million due to cash received upon the termination of the share lending agreement and subsequent shares purchased by the borrower in that transaction and warrant exercises (see Note 4 for further discussion). These equity transactions reduced the remaining amounts available under the Consent Agreement to $24.7 million as of September 30, 2013.
	(5)	The discount on shares issued is recorded on the Company's condensed consolidated statement of operations in loss on equity issuance. This expense item represents the discount on shares issued to Thermo as well as certain other losses recorded on equity issued during 2013 related to cashless warrant exercises of the Company's 5% Notes.
	(6)	All shares issued to Thermo in connection with these agreements were shares of the Company's nonvoting common stock.

ACCRUED EXPENSES AND NON-CURRENT LIABILITIES (Tables)

9 Months Ended

Sep. 30, 2013

ACCRUED EXPENSES AND NON-CURRENT LIABILITIES [Abstract]

Schedule of Accrued Expenses

Accrued expenses consist of the following (in thousands):

	September 30, 2013		December 31, 2012
Accrued interest	$	10,712	$	5,620
Accrued compensation and benefits		3,737		4,076
Accrued property and other taxes		6,713		6,329
Accrued customer liabilities and deposits		2,666		2,961
Accrued professional and other service provider fees		966		1,006
Accrued liability for contingent consideration		2,021		2,585
Accrued commissions		1,079		685
Accrued telecommunications expenses		621		713
Accrued satellite and ground costs		486		373
Other accrued expenses		3,827		3,816
	$	32,828	$	28,164

Schedule of Other Non-current Liabilities

Non-current liabilities consist of the following (in thousands):

	September 30, 2013		December 31, 2012
Long-term accrued interest	$	1,932	$	457
Asset retirement obligation		1,062		998
Deferred rent		447		579
Liabilities related to the Cooperative Endeavor Agreement with the State of Louisiana		1,536		1,949
Long-term portion of liability for contingent consideration		354		1,332
Uncertain income tax positions		5,399		5,571
Foreign tax contingencies		4,681		4,994
	$	15,411	$	15,880

RELATED PARTY TRANSACTIONS (Tables)

9 Months Ended

Sep. 30, 2013

Related Party Transactions

Thermo incurs certain expenses on behalf of the Company. The table below summarizes the total expense for the periods indicated below (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
General and administrative expense	$	74	$	30	$	229	$	230
Non-cash expenses		137		132		411		396
Loss on sale of equity issuance		2,404		-		16,373		-
Loss on extinguishment of debt related to amendment and restatement of Thermo Loan Agreement		66,088		-		66,088		-
Total	$	68,703	$	162	$	83,101	$	626

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)

9 Months Ended

Sep. 30, 2013

ACCUMULATED OTHER COMPREHENSIVE LOSS [Abstract]

Components of Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss were as follows (in thousands):

	Three months ended						Nine months ended
	September 30,						September 30,
	2013			2012			2013			2012
Accumulated other comprehensive loss, June 30, 2013 and 2012 and December 31, 2012 and 2011, respectively	$	(2,408	)	$	(2,551	)	$	(1,758	)	$	(3,100	)
Other comprehensive income (loss):
Foreign currency translation adjustments		553			1,119			(97	)		1,668
Accumulated other comprehensive loss, September 30, 2013 and 2012, respectively	$	(1,855	)		(1,432	)	$	(1,855	)		(1,432	)

STOCK COMPENSATION (Tables)

9 Months Ended

Sep. 30, 2013

STOCK COMPENSATION [Abstract]

Grants to Eligible Participants of Incentive Stock Options, Restricted Stock Awards, and Restricted Stock Units

Grants to Eligible Participants of incentive stock options, restricted stock awards, and restricted stock units during the period are indicated in the table below (in thousands):

	Three months ended				Nine months ended
	September 30,				September 30,
	2013		2012		2013		2012
Grants of restricted stock awards and restricted stock units		14		342		852		721
Grants of options to purchase common stock		1,224		31		1,829		414
Total		1,238		373		2,681		1,135

GEOGRAPHIC INFORMATION (Tables)

9 Months Ended

Sep. 30, 2013

GEOGRAPHIC INFORMATION [Abstract]

Company's Information on Revenues and Long-lived Assets by Geographic Area

	Three months ended September 30,				Nine months ended September 30,
	2013		2012		2013		2012
Revenues:
Service:
United States	$	11,660	$	11,051	$	33,666	$	29,926
Canada		3,446		2,836		9,123		7,827
Europe		1,185		732		2,736		2,223
Central and South America		625		640		1,918		1,897
Others		140		109		411		273
Total service revenue	$	17,056	$	15,368	$	47,854	$	42,146
Subscriber equipment:
United States		3,688		3,633		8,756		10,724
Canada		1,201		887		2,964		2,555
Europe		327		287		1,228		939
Central and South America		177		220		712		701
Others		100		142		203		191
Total subscriber equipment revenue	$	5,493	$	5,169	$	13,863	$	15,110
Total revenue	$	22,549	$	20,537	$	61,717	$	57,256

	September 30,		December 31,
	2013		2012
Long-lived assets:
United States	$	1,181,700	$	1,209,374
Canada		221		277
Europe		417		474
Central and South America		3,677		3,463
Others		1,273		1,568
Total long-lived assets	$	1,187,288	$	1,215,156

SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION (Tables)

9 Months Ended

Sep. 30, 2013

SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION [Abstract]

Supplemental Condensed Consolidating Statement of Operations

Globalstar, Inc.

Supplemental Condensed Consolidating Statement of Operations

Three Months Ended September 30, 2013

(Unaudited)

							Non-
	Parent			Guarantor			Guarantor
	Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	(In thousands)
Revenue:
Service revenues	$	18,726		$	2,478		$	4,940		$	(9,088	)	$	17,056
Subscriber equipment sales		127			4,254			1,070			42			5,493
Total revenue		18,853			6,732			6,010			(9,046	)		22,549
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)		3,125			3,126			1,941			(11	)		8,181
Cost of subscriber equipment sales		90			3,334			1,819			(1,095	)		4,148
Cost of subscriber equipment sales - reduction in the value of inventory		-			-			-			-			-
Marketing, general and administrative		2,008			4,666			3,774			(1,369	)		9,079
Reduction in the value of long-lived assets		-			-			-			-			-
Contract termination charge		-			-			-			-			-
Depreciation, amortization, and accretion		19,645			4,914			6,485			(7,329	)		23,715
Total operating expenses		24,868			16,040			14,019			(9,804	)		45,123
Loss from operations		(6,015	)		(9,308	)		(8,009	)		758			(22,574	)
Other income (expense):
Loss on extinguishment of debt		(63,569	)		-			-			-			(63,569	)
Loss on equity issuance		(2,733	)		-			-			-			(2,733	)
Interest income and expense, net of amounts capitalized		(16,636	)		(3	)		(262	)		-			(16,901	)
Derivative gain (loss)		(97,534	)		-			-			-			(97,534	)
Equity in subsidiary earnings		(17,090	)		(1,729	)		-			18,819			-
Other		(1,343	)		(171	)		(21	)		(5	)		(1,540	)
Total other income (loss)		(198,905	)		(1,903	)		(283	)		18,814			(182,277	)
Loss before income taxes		(204,920	)		(11,211	)		(8,292	)		19,572			(204,851	)
Income tax expense		49			6			63			-			118
Net loss	$	(204,969	)	$	(11,217	)	$	(8,355	)	$	19,572		$	(204,969	)

Comprehensive loss	$	(204,969	)	$	(11,217	)	$	(7,803	)	$	19,572		$	(204,417	)

Globalstar, Inc.

Supplemental Condensed Consolidating Statement of Operations

Three Months Ended September 30, 2012

(Unaudited)

							Non-
	Parent			Guarantor			Guarantor
	Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	(In thousands)
Revenue:
Service revenues	$	14,296		$	10,832		$	4,002		$	(13,762	)	$	15,368
Subscriber equipment sales		255			4,138			2,941			(2,165	)		5,169
Total revenue		14,551			14,970			6,943			(15,927	)		20,537
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)		2,922			4,152			2,133			(1,794	)		7,413
Cost of subscriber equipment sales		134			4,742			3,780			(4,616	)		4,040
Cost of subscriber equipment sales - reduction in the value of inventory		-			658			2			-			660
Marketing, general and administrative		4,098			1,377			3,229			(1,279	)		7,425
Reduction in the value of long-lived assets		-			-			-			-			-
Contract termination charge		-			-			-			-			-
Depreciation, amortization, and accretion		13,313			13,782			4,338			(12,779	)		18,654
Total operating expenses		20,467			24,711			13,482			(20,468	)		38,192
Loss from operations		(5,916	)		(9,741	)		(6,539	)		4,541			(17,655	)
Other income (expense):
Interest income and expense, net of amounts capitalized		(6,172	)		(1	)		(394	)		2			(6,565	)
Derivative loss		(16,473	)		-			-			-			(16,473	)
Equity in subsidiary earnings		(12,120	)		2,205			-			9,915			-
Other		(456	)		(117	)		218			(84	)		(439	)
Total other income (expense)		(35,221	)		2,087			(176	)		9,833			(23,477	)
Loss before income taxes		(41,137	)		(7,654	)		(6,715	)		14,374			(41,132	)
Income tax (benefit) expense		51			(18	)		23			-			56
Net loss	$	(41,188	)	$	(7,636	)	$	(6,738	)	$	14,374		$	(41,188	)

Comprehensive loss	$	(41,188	)	$	(7,636	)	$	(5,619	)	$	14,374		$	(40,069	)

Globalstar, Inc.

Supplemental Condensed Consolidating Statement of Operations

Nine Months Ended September 30, 2013

(Unaudited)

							Non-
	Parent			Guarantor			Guarantor
	Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	(In thousands)
Revenue:
Service revenues	$	50,351		$	8,544		$	13,320		$	(24,361	)	$	47,854
Subscriber equipment sales		287			10,018			13,264			(9,706	)		13,863
Total revenue		50,638			18,562			26,584			(34,067	)		61,717
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)		8,233			7,947			6,791			(58	)		22,913
Cost of subscriber equipment sales		90			8,048			14,323			(11,786	)		10,675
Cost of subscriber equipment sales - reduction in the value of inventory		-			-			-			-			-
Marketing, general and administrative		4,555			11,710			9,895			(3,581	)		22,579
Reduction in the value of long-lived assets		-			-			-			-			-
Contract termination charge		-			-			-			-			-
Depreciation, amortization, and accretion		52,538			15,936			17,167			(19,527	)		66,114
Total operating expenses		65,416			43,641			48,176			(34,952	)		122,281
Loss from operations		(14,778	)		(25,079	)		(21,592	)		885			(60,564	)
Other income (expense):
Loss on extinguishment of debt		(110,809	)		-			-			-			(110,809	)
Loss on equity issuance		(16,701	)		-			-			-			(16,701	)
Interest income and expense, net of amounts capitalized		(38,728	)		(39	)		(1,098	)		(4	)		(39,869	)
Derivative gain (loss)		(126,911	)		-			-			-			(126,911	)
Equity in subsidiary earnings		(47,313	)		(2,794	)		-			50,107			-
Other		(909	)		(170	)		(124	)		78			(1,125	)
Total other income (loss)		(341,371	)		(3,003	)		(1,222	)		50,181			(295,415	)
Loss before income taxes		(356,149	)		(28,082	)		(22,814	)		51,066			(355,979	)
Income tax expense		171			35			135			-			341
Net loss	$	(356,320	)	$	(28,117	)	$	(22,949	)	$	51,066		$	(356,320	)

Comprehensive loss	$	(356,320	)	$	(28,117	)	$	(23,046	)	$	51,066		$	(356,417	)

Globalstar, Inc.

Supplemental Condensed Consolidating Statement of Operations

Nine Months Ended September 30, 2012

(Unaudited)

							Non-
	Parent			Guarantor			Guarantor
	Company			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	(In thousands)
Revenue:
Service revenues	$	35,609		$	30,528		$	11,609		$	(35,600	)	$	42,146
Subscriber equipment sales		809			12,328			5,676			(3,703	)		15,110
Total revenue		36,418			42,856			17,285			(39,303	)		57,256
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)		8,995			7,936			6,369			(1,082	)		22,218
Cost of subscriber equipment sales		284			9,420			5,377			(4,616	)		10,465
Cost of subscriber equipment sales - reduction in the value of inventory		2			904			51			-			957
Marketing, general and administrative		12,176			3,292			8,945			(3,351	)		21,062
Reduction in the value of long-lived assets		79			7,139			-			-			7,218
Contract termination charge		22,048			-			-			-			22,048
Depreciation, amortization, and accretion		32,789			36,817			12,343			(32,672	)		49,277
Total operating expenses		76,373			65,508			33,085			(41,721	)		133,245
Loss from operations		(39,955	)		(22,652	)		(15,800	)		2,418			(75,989	)
Other income (expense):
Interest income and expense, net of amounts capitalized		(12,126	)		(7	)		(1,261	)		(2	)		(13,396	)
Derivative loss		(2,562	)		-			-			-			(2,562	)
Equity in subsidiary earnings		(37,737	)		6,703			-			31,034			-
Other		(687	)		(12	)		(163	)		(76	)		(938	)
Total other income (expense)		(53,112	)		6,684			(1,424	)		30,956			(16,896	)
Loss before income taxes		(93,067	)		(15,968	)		(17,224	)		33,374			(92,885	)
Income tax expense		179			30			152			-			361
Net loss	$	(93,246	)	$	(15,998	)	$	(17,376	)	$	33,374		$	(93,246	)

Comprehensive loss	$	(93,246	)	$	(15,998	)	$	(15,708	)	$	33,374		$	(91,578	)

Supplemental Condensed Consolidating Balance Sheet

Globalstar, Inc.

Supplemental Condensed Consolidating Balance Sheet

As of September 30, 2013

(Unaudited)

	Parent Company			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Elimination			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	4,298		$	359		$	1,986		$	-		$	6,643
Restricted cash		-			-			-			-			-
Accounts receivable		4,430			6,512			5,502			-			16,444
Intercompany receivables		624,466			408,029			17,463			(1,049,958	)		-
Inventory		399			14,941			22,142			-			37,482
Deferred financing costs		-			-			-			-			-
Prepaid expenses and other current assets		4,525			415			2,643			-			7,583
Total current assets		638,118			430,256			49,736			(1,049,958	)		68,152
Property and equipment, net		1,165,336			16,413			7,198			(1,659	)		1,187,288
Restricted cash		37,940			-			-			-			37,940
Intercompany notes receivable		13,629			-			1,800			(15,429	)		-
Investment in subsidiaries		(187,026	)		2,794			-			184,232			-
Deferred financing costs		79,861			-			-			-			79,861
Advances for inventory		9,158			-			-			-			9,158
Intangible and other assets, net		4,104			1,216			2,065			(10	)		7,375
Total assets	$	1,761,120		$	450,679		$	60,799		$	(882,824	)	$	1,389,744

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Current portion of long-term debt	$	-		$	-		$	-		$	-		$	-
Accounts payable		21,331			2,514			2,599			-			26,444
Accrued contract termination charge		23,699			-			-			-			23,699
Accrued expenses		15,613			8,522			8,693			-			32,828
Intercompany payables		421,710			510,497			118,452			(1,050,659	)		-
Payables to affiliates		303			-			-			-			303
Derivative liabilities		41,539			-			-			-			41,539
Deferred revenue		1,743			13,923			2,156			-			17,822
Total current liabilities		525,938			535,456			131,900			(1,050,659	)		142,635
Long-term debt, less current portion		675,690			-			-			-			675,690
Employee benefit obligations		7,117			-			-			-			7,117
Intercompany notes payable		-			-			14,529			(14,529	)		-
Derivative liabilities		254,207			-			-			-			254,207
Deferred revenue		6,760			557			-			-			7,317
Debt restructuring fees		20,795			-			-			-			20,795
Other non-current liabilities		4,011			625			10,775			-			15,411
Total non-current liabilities		968,580			1,182			25,304			(14,529	)		980,537
Stockholders' equity		266,602			(85,959	)		(96,405	)		182,364			266,602
Total liabilities and stockholders' equity	$	1,761,120		$	450,679		$	60,799		$	(882,824	)	$	1,389,744

Globalstar, Inc.

Supplemental Condensed Consolidating Balance Sheet

As of December 31, 2012

(Audited)

	Parent Company			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Elimination			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	10,220		$	251		$	1,321		$	-		$	11,792
Restricted cash		46,777			-			-			-			46,777
Accounts receivable		3,814			4,875			5,255			-			13,944
Intercompany receivables		613,426			411,764			5,534			(1,030,724	)		-
Inventory		262			6,966			34,953			-			42,181
Deferred financing costs		34,622			-			-			-			34,622
Prepaid expenses and other current assets		2,177			388			2,668			-			5,233
Total current assets		711,298			424,244			49,731			(1,030,724	)		154,549
Property and equipment, net		1,095,973			31,382			86,762			1,039			1,215,156
Restricted cash		-			-			-			-			-
Intercompany notes receivable		15,783			-			1,800			(17,583	)		-
Investment in subsidiaries		(144,323	)		(8,232	)		-			152,555			-
Deferred financing costs		16,883			-			-			-			16,883
Advances for inventory		9,158			-			-			-			9,158
Intangible and other assets, net		3,991			1,781			2,273			(16	)		8,029
Total assets	$	1,708,763		$	449,175		$	140,566		$	(894,729	)	$	1,403,775

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Current portion of long-term debt	$	655,874		$	-		$	-		$	-		$	655,874
Accounts payable		12,055			2,410			21,220			-			35,685
Accrued contract termination charge		23,166			-			-			-			23,166
Accrued expenses		6,492			9,798			11,874			-			28,164
Intercompany payables		377,526			494,686			156,166			(1,028,378	)		-
Payables to affiliates		230			-			-			-			230
Deferred revenue		4,576			12,674			791			-			18,041
Total current liabilities		1,079,919			519,568			190,051			(1,028,378	)		761,160
Long-term debt, less current portion		95,155			-			-			-			95,155
Employee benefit obligations		7,221			-			-			-			7,221
Intercompany notes payable		-			-			16,683			(16,683	)		-
Derivative liabilities		25,175			-			-			-			25,175
Deferred revenue		4,306			334			-			-			4,640
Other non-current liabilities		2,443			2,233			11,204			-			15,880
Total non-current liabilities		134,300			2,567			27,887			(16,683	)		148,071
Stockholders' equity		494,544			(72,960	)		(77,372	)		150,332			494,544
Total liabilities and stockholders' equity	$	1,708,763		$	449,175		$	140,566		$	(894,729	)	$	1,403,775

Supplemental Condensed Consolidating Statement of Cash Flows

Globalstar, Inc.

Supplemental Condensed Consolidating Statement of Cash Flows

Nine Months Ended September 30, 2013

(Unaudited)

							Non-
	Parent			Guarantor			Guarantor
	Company			Subsidiaries			Subsidiaries			Eliminations		Consolidated
	(In thousands)

Net cash provided by (used in) operating activities	$	426		$	814		$	1,094		$	-	$	2,334

Cash flows from investing activities:
Second-generation satellites, ground and related launch costs		(37,732	)		-			-			-		(37,732	)
Property and equipment additions		-			(706	)		(519	)		-		(1,225	)
Investment in businesses		(496	)		-			-			-		(496	)
Restricted cash		8,838			-			-			-		8,838
Net cash used in investing activities		(29,390	)		(706	)		(519	)		-		(30,615	)

Cash flows from financing activities:
Borrowings from Facility Agreement		672			-			-			-		672
Borrowings from contingent equity account		1,071			-			-			-		1,071
Proceeds from issuance of common stock and stock options		8,979			-			-			-		8,979
Payments to reduce principal amount of exchanged 5.75% Notes		(13,544	)		-			-			-		(13,544	)
Payments to reduce principal amount of 5.75% Notes not exchanged		(6,250	)		-			-			-		(6,250	)
Payments to lenders and other fees associated with exchange		(2,482	)		-			-			-		(2,482	)
Proceeds for equity issuance to related party		51,500			-			-			-		51,500
Payment of deferred financing costs		(16,904	)		-			-			-		(16,904	)
Net cash from by financing activities		23,042			-			-			-		23,042
Effect of exchange rate changes on cash and cash equivalents		-			-			90			-		90
Net increase (decrease) in cash and cash equivalents		(5,922	)		108			665			-		(5,149	)
Cash and cash equivalents at beginning of period		10,220			251			1,321			-		11,792
Cash and cash equivalents at end of period	$	4,298		$	359		$	1,986		$	-	$	6,643

Globalstar, Inc.

Supplemental Condensed Consolidating Statement of Cash Flows

Nine Months Ended September 30, 2012

(Unaudited

							Non-
	Parent			Guarantor			Guarantor
	Company			Subsidiaries			Subsidiaries			Eliminations		Consolidated
	(In thousands)
Net cash provided by (used in) operating activities	$	12,655		$	(165	)	$	(1,612	)	$	-	$	10,878

Cash flows from investing activities:
Second-generation satellites, ground and related launch costs		(43,305	)										(43,305	)
Property and equipment additions		-			(197	)		(185	)		-		(382	)
Investment in businesses		(450	)		-			-			-		(450	)
Restricted cash		(3,650	)		-			-			-		(3,650	)

Net cash used in investing activities		(47,405	)		(197	)		(185	)		-		(47,787	)

Cash flows from financing activities:
Proceeds from issuance of common stock and stock options		100			-			-			-		100
Borrowings from Facility Agreement		5,008			-			-			-		5,008
Proceeds from contingent equity account		23,000			-			-			-		23,000
Payment of deferred financing costs		(250	)		-			-			-		(250	)
Net cash from by financing activities		27,858			-			-			-		27,858
Effect of exchange rate changes on cash and cash equivalents		-			-			319			-		319
Net increase (decrease) in cash and cash equivalents		(6,892	)		(362	)		(1,478	)				(8,732	)
Cash and cash equivalents at beginning of period		7,343			587			2,021			-		9,951
Cash and cash equivalents at end of period	$	451		$	225		$	543		$	-	$	1,219

MANAGEMENT'S PLANS REGARDING FUTURE OPERATIONS (Details) - USD ($) $ in Thousands		9 Months Ended
	May 20, 2013	Sep. 30, 2013	Sep. 30, 2012	Apr. 02, 2013	Dec. 31, 2012	Dec. 31, 2008
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Maximum borrowing capacity		$ 60,000
Debt		767,345			$ 800,121
Extinguishment of principal amount of 5.75% Notes		71,804
Credit Facility [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Debt		586,342			585,670
8.00% Convertible Senior Unsecured Notes, Issued in 2013 [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Debt	$ 54,600	47,570
5.75% Convertible Senior Unsecured Notes [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Debt				$ 71,800	$ 71,804	$ 150,000
Extinguishment of principal amount of 5.75% Notes	$ 71,800
Financial Backstop [Member] \| Thermo Capital Partners LLC [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Agreement amount		85,000
Terrapin Opportunity, L.P. [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Maximum borrowing capacity		$ 30,000

PROPERTY AND EQUIPMENT (Schedule of Property and Equipment) (Details) - USD ($) $ in Thousands	Sep. 30, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,454,556	$ 1,418,270
Accumulated depreciation and amortization	(267,268)	(203,114)
Property, Plant and Equipment, Net, Total	1,187,288	1,215,156
Internally Developed and Purchased Software [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	15,023	14,414
Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	12,996	12,800
Land and Buildings [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	3,837	4,003
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,507	1,512
Global Star System [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,421,193	1,385,541
Global Star System [Member] \| Ground Component [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	48,581	49,089
Global Star System [Member] \| Second Generation Satellites [Member] \| Space Component [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,212,234	934,900
Global Star System [Member] \| Prepaid Long-Lead Items [Member] \| Space Component [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	17,040	17,040
Global Star System [Member] \| Construction in Progress [Member] \| Space Component [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	33,155	299,209
Global Star System [Member] \| Construction in Progress [Member] \| Ground Component [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	109,384	84,423
Global Star System [Member] \| Construction in Progress [Member] \| Other [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 799	$ 880

PROPERTY AND EQUIPMENT (Capitalized Interest and Depreciation Expense) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
PROPERTY AND EQUIPMENT [Abstract]
Total interest capitalized	$ 231,026		$ 231,026		$ 216,477
Interest Costs Incurred [Abstract]
Interest cost eligible to be capitalized	13,119	$ 13,777	38,851	$ 43,411
Interest cost recorded in interest expense, net	(10,151)	(5,543)	(24,302)	(10,239)
Net interest capitalized	2,968	8,234	14,549	33,172
Depreciation expense	$ 23,961	$ 17,964	$ 65,622	$ 47,542

LONG-TERM DEBT (Long-term Debt) (Details) - USD ($) $ in Thousands	Sep. 30, 2013	May 20, 2013	Apr. 02, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2008
Principal Amount
Total Debt	$ 767,345			$ 800,121
Less: current portion				657,474
Long term debt	767,345			142,647
Carrying Value
Total Debt	675,690			751,029
Less: current portion				655,874
Long-Term Debt	675,690			95,155
Facility Agreement [Member]
Principal Amount
Total Debt	586,342			585,670
Carrying Value
Total Debt	586,342			585,670
Thermo Loan Agreement [Member]
Principal Amount
Total Debt	58,569			53,499
Carrying Value
Total Debt	20,488			49,822
5.75% Convertible Senior Unsecured Notes [Member]
Principal Amount
Total Debt			$ 71,800	71,804		$ 150,000
Carrying Value
Total Debt				70,204
8.00% Convertible Senior Unsecured Notes, Issued in 2013 [Member]
Principal Amount
Total Debt	47,570	$ 54,600
Carrying Value
Total Debt	25,547	$ 27,890
5.00% Convertible Senior Unsecured Notes [Member]
Principal Amount
Total Debt	25,199			40,920	$ 38,000
Carrying Value
Total Debt	11,959			16,701
8.00% Convertible Senior Unsecured Notes, Issued in 2009 [Member]
Principal Amount
Total Debt	49,665			48,228
Carrying Value
Total Debt	$ 31,354			$ 28,632

LONG-TERM DEBT (Facility Agreement) (Details) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended
	Aug. 31, 2013	Sep. 30, 2013	Sep. 30, 2012	Jul. 31, 2013	Jun. 30, 2013	Dec. 31, 2012
Debt Instrument [Line Items]
Restricted cash						$ 46,777
Debt restructuring fees		20,795
Proceeds from contingent equity agreement	$ 1,100	$ 1,071	$ 23,000
Terrapin Equity Line [Member]
Debt Instrument [Line Items]
Amount available to be drawn	19,500
Facility Agreement [Member]
Debt Instrument [Line Items]
Maturity date		Dec. 31, 2022
Percentage of guarantee provided by French export credit agency to lending syndicate		95.00%
Interest above LIBOR rate		2.75%
Interest rate increase		0.50%
Debt service reserve account	37,900	$ 37,900
Restricted cash		$ 37,900
Restructuring fees	$ 13,900
Restructuring fees, percentage	40.00%
Debt restructuring fees	$ 20,800
Draws on line of credit	700
Proceeds from Debt Service Reserve Account	200
Payments postponed				$ 235,300
Covenant, proceeds	145,000
Minimum liquidity	$ 5,000				$ 4,000
Threshold for change in control	51.00%
Debt restructuring expenses	$ 300
Facility Agreement [Member] \| Scenario, Forecast [Member]
Debt Instrument [Line Items]
Interest above LIBOR rate		5.75%
Interest rate increase		0.50%
Facility Agreement [Member] \| Scenario, Previously Reported [Member]
Debt Instrument [Line Items]
Senior secured facility agreement maturity period		84 months
Interest above LIBOR rate		2.25%
Debt service reserve account		$ 46,800
Change in debt service reserve account		8,900
Facility Agreement [Member] \| Excess Debt Service Reserve Facility [Member]
Debt Instrument [Line Items]
Amount drawn under agreement		$ 8,700
Facility Agreement [Member] \| Thereafter [Member] \| Scenario, Previously Reported [Member]
Debt Instrument [Line Items]
Interest above LIBOR rate		2.40%
Facility Agreement [Member] \| Domestic Subsidiaries [Member]
Debt Instrument [Line Items]
Percentage of equity pledged as collateral		100.00%
Facility Agreement [Member] \| Foreign Subsidiaries [Member]
Debt Instrument [Line Items]
Percentage of equity pledged as collateral		65.00%

LONG-TERM DEBT (Contingent Equity Agreement) (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	9 Months Ended
	Aug. 31, 2013	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Debt Instrument [Line Items]
Discount on shares		20.00%
Proceeds from contingent equity agreement	$ 1,100	$ 1,071	$ 23,000
Contingent Equity Agreement [Member] \| Thermo [Member]
Debt Instrument [Line Items]
Contingent equity account		$ 60,000
Forward-looking period		90 days
Percent to be paid as availability fee		10.00%
Per share value		$ 0.01
Warrant Exercise Period		5 years
Percentage of closing price of common stock		80.00%
Number of trading days		15 days
Amount drawn under agreement				$ 60,000
Shares Issued		160,916,223
Percentage of ownership interest that trigger issuance of voting common stock		70.00%
Common stock, shares not yet issued		2,133,656
Value of future equity issuance		$ 1,300
Interest income		1,100
Deferred financing costs		$ 200

LONG-TERM DEBT (Thermo Loan Agreement) (Details) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Jul. 31, 2013 USD ($)	Sep. 30, 2013 USD ($) $ / warrants shares	Sep. 30, 2012 USD ($)	Sep. 30, 2013 USD ($) $ / warrants shares	Sep. 30, 2012 USD ($)	Dec. 31, 2012 USD ($) $ / warrants	Jun. 30, 2009 USD ($)
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 60,000		$ 60,000
Vendor funded debt service reserve account				8,800
Loss on extinguishment of debt		(63,569)		(110,809)
Loan Agreement		675,690		675,690		$ 751,029
Thermo [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity		37,500		37,500
Loss on extinguishment of debt		$ (66,088)		$ (66,088)
Thermo Loan Agreement [Member]
Debt Instrument [Line Items]
Exercise price of warrants \| $ / warrants		0.01		0.01		0.01
Loss on extinguishment of debt		$ (66,100)
Loan Agreement		20,488		$ 20,488		$ 49,822
Fair value		120,100		120,100
Thermo Loan Agreement [Member] \| Thermo [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 37,500		$ 37,500			$ 25,000
Loan interest rate		12.00%		12.00%
Number of common stock to be purchased with warrant \| shares		4,205,608		4,205,608
Warrants exercise period				5 years
Exercise price of warrants \| $ / warrants		0.01		0.01
Percentage of ownership interest that trigger issuance of voting common stock		70.00%		70.00%
Outstanding interest		$ 21,100		$ 21,100
Loss on extinguishment of debt	$ (66,100)
Loan Agreement		18,958		18,958
Compound embedded derivative liability		101,114		101,114
Fair value		$ 120,072		$ 120,072

LONG-TERM DEBT (5.75% Convertible Senior Notes) (Details) - USD ($) $ in Thousands	Apr. 02, 2013	Sep. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Dec. 31, 2008
Debt Instrument [Line Items]
Debt		$ 767,345		$ 800,121
5.75% Convertible Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Debt	$ 71,800			$ 71,804	$ 150,000
Percentage of debt purchase price	100.00%
Loan interest rate	5.75%				5.75%
Principal amount redeemed	$ 70,700
Outstanding interest			$ 2,100

LONG-TERM DEBT (Exchange Agreement) (Details) - USD ($) $ / shares in Units, $ in Thousands, shares in Millions			3 Months Ended			9 Months Ended
	Jul. 19, 2013	May 20, 2013	Sep. 30, 2013	Jun. 26, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Jun. 30, 2013	Apr. 02, 2013	Dec. 31, 2008
Debt Instrument [Line Items]
Cash paid for: Interest						$ 11,445	$ 18,958
Loss on extinguishment of debt			$ (63,569)			$ (110,809)
5.75% Convertible Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Percentage of principal redeemed in exchange agreement		91.50%
Repayments of convertible debt		$ 13,500
Cash paid for: Interest		$ 500
Conversion of notes into shares of common stock		30.3
Debt conversion amount		$ 12,100
Loan interest rate									5.75%	5.75%
Payments to Trustee		2,100		$ 6,300
Loss on extinguishment of debt		(47,200)
8.00% Convertible Senior Unsecured Notes, Issued in 2013 [Member]
Debt Instrument [Line Items]
Conversion of notes into shares of common stock	14.3
Debt conversion amount		$ 54,600
Loan interest rate		8.00%
Maturity date		Apr. 01, 2028
Conversion price per share of common stock		$ 0.80	$ 0.75			$ 0.75		$ 0.75
Participation rate		50.00%

LONG-TERM DEBT (Consent Agreement) (Details) - 8.00% Convertible Senior Unsecured Notes, Issued in 2013 [Member] - Thermo Capital Partners LLC [Member] $ in Millions	9 Months Ended
	Sep. 30, 2013 USD ($)
Debt Instrument [Line Items]
Compensating balance, amount	$ 4.0
Amount of payment in exchange transaction	25.0
Scenario One [Member]
Debt Instrument [Line Items]
Amount of third party credit enhancements	20.0
Scenario Two [Member]
Debt Instrument [Line Items]
Amount of third party credit enhancements	20.0
Scenario Three [Member]
Debt Instrument [Line Items]
Amount of third party credit enhancements	20.0
Scenario Four [Member]
Debt Instrument [Line Items]
Amount of third party credit enhancements	$ 40.0

LONG-TERM DEBT (Common Stock Purchase Agreement) (Details) - USD ($)
$ / shares in Units, $ in Thousands

3 Months Ended

9 Months Ended

Oct. 03, 2013

Aug. 19, 2013

^[2],[3]

Jul. 29, 2013

^[2],[3]

Jul. 08, 2013

Jun. 28, 2013

^[4]

May 21, 2013

^[4]

May 20, 2013

^[4]

Sep. 30, 2013

Jun. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Class of Stock [Line Items]

Number of shares issued

12,500,000

^[1]

11,538,462

^[1]

28,125,000

^[1]

15,625,000

^[1]

78,125,000

^[1]

24,000,000

121,900,000

145,913,462

^[1],[5]

Proceeds from common stock

$ 6,000

$ 6,500

$ 6,000

$ 9,000

$ 5,000

$ 25,000

$ 12,500

$ 39,000

$ 51,500

^[5]

Shares issued, price per share

$ 0.52

$ 0.32

Loss on sale of equity issuance

2,733

$ 14,000

16,701

Loss on sale of shares

(2,400)

Other capital contributions from Thermo

8,800

Remaining commitment

$ 24,700

Nonvoting Common Stock [Member]

Class of Stock [Line Items]

Increase in number of shares authorized

265,000,000

Common stock, shares authorized

400,000,000

[1]	All shares issued to Thermo in connection with these agreements were shares of the Company's nonvoting common stock.
[2]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement.
[3]	The terms of the issuance price per share were determined in October 2013; therefore the shares were not issued as of September 30, 2013. The total fair value of the shares of $14.9 million was recorded on the Company's condensed consolidated balance sheet as future equity issuance of common stock to related party.
[4]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company's condensed consolidated balance sheet.
[5]	Pursuant to the terms of the Consent Agreement, certain equity transactions which result in cash invested into Globalstar may reduce the amounts committed by Thermo. As of September 30, 2013, the Company had received approximately $8.8 million due to cash received upon the termination of the share lending agreement and subsequent shares purchased by the borrower in that transaction and warrant exercises (see Note 4 for further discussion). These equity transactions reduced the remaining amounts available under the Consent Agreement to $24.7 million as of September 30, 2013.

LONG-TERM DEBT (The Common Stock Purchase and Option Agreement) (Details) - USD ($)
$ / shares in Units, $ in Thousands

3 Months Ended

9 Months Ended

Oct. 14, 2013

Oct. 03, 2013

Aug. 19, 2013

Jul. 29, 2013

^[2],[3]

Jun. 28, 2013

^[4]

May 21, 2013

^[4]

May 20, 2013

^[4]

Dec. 26, 2013

Sep. 30, 2013

Jun. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Class of Stock [Line Items]

Number of shares issued

12,500,000

^[1],[2],[3]

11,538,462

^[1]

28,125,000

^[1]

15,625,000

^[1]

78,125,000

^[1]

24,000,000

121,900,000

145,913,462

^[1],[5]

Proceeds from common stock

$ 6,000

$ 6,500

^[2],[3]

$ 6,000

$ 9,000

$ 5,000

$ 25,000

$ 12,500

$ 39,000

$ 51,500

^[5]

Shares issued, price per share

$ 0.52

^[2],[3]

$ 0.52

$ 0.32

Loss on sale of equity issuance

2,733

$ 14,000

$ 16,701

Loss on sale of shares

$ (2,400)

Thermo Capital Partners LLC [Member]

Class of Stock [Line Items]

Number of shares issued

11,538,461

Shares issued, price per share

$ 0.52

Thermo Capital Partners LLC [Member] | Scenario, Plan [Member]

Class of Stock [Line Items]

Proceeds from common stock

$ 20,000

Shares issued, price per share

$ 0.52

Thermo Capital Partners LLC [Member] | Scenario, Forecast [Member]

Class of Stock [Line Items]

Number of shares issued

38,461,538

Proceeds from common stock

$ 13,500

$ 11,500

Shares issued, price per share

$ 0.52

Percentage of average closing price

85.00%

[1]	All shares issued to Thermo in connection with these agreements were shares of the Company's nonvoting common stock.
[2]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement.
[3]	The terms of the issuance price per share were determined in October 2013; therefore the shares were not issued as of September 30, 2013. The total fair value of the shares of $14.9 million was recorded on the Company's condensed consolidated balance sheet as future equity issuance of common stock to related party.
[4]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company's condensed consolidated balance sheet.
[5]	Pursuant to the terms of the Consent Agreement, certain equity transactions which result in cash invested into Globalstar may reduce the amounts committed by Thermo. As of September 30, 2013, the Company had received approximately $8.8 million due to cash received upon the termination of the share lending agreement and subsequent shares purchased by the borrower in that transaction and warrant exercises (see Note 4 for further discussion). These equity transactions reduced the remaining amounts available under the Consent Agreement to $24.7 million as of September 30, 2013.

LONG-TERM DEBT (Share Lending Agreement) (Details) - USD ($) $ in Millions	1 Months Ended
	Jul. 31, 2013	Sep. 30, 2013	Dec. 31, 2012
Debt Instrument [Line Items]
Share lending agreement, share issued		36,144,570
Borrowed Shares remained outstanding			17,300,000
Shares returned	10,200,000
Proceeds from cash settlement of share lending agreement	$ 4.4
Number of shares settled in cash	7,100,000
Initially Loaned [Member]
Debt Instrument [Line Items]
Share lending agreement, share issued		32,000,000
Additional Shares [Member]
Debt Instrument [Line Items]
Share lending agreement, share issued		4,100,000

LONG-TERM DEBT (8.00% Convertible Senior Notes Issued in 2013) (Details) $ / shares in Units, shares in Millions			9 Months Ended
	Jul. 19, 2013 USD ($) shares	May 20, 2013 USD ($) $ / shares	Sep. 30, 2013 USD ($) $ / shares shares	Sep. 30, 2012 USD ($)	Jun. 30, 2013 $ / shares	Dec. 31, 2012 USD ($)
Debt Instrument [Line Items]
Debt			$ 767,345,000			$ 800,121,000
Principal converted			23,570,000	$ 2,000,000
Senior notes			675,690,000			751,029,000
8.00% Convertible Senior Unsecured Notes, Issued in 2013 [Member]
Debt Instrument [Line Items]
Debt		$ 54,600,000	$ 47,570,000
Conversion price per share of common stock \| $ / shares		$ 0.80	$ 0.75		$ 0.75
Number of shares of common stock convertible into		1,250
Maturity date		Apr. 01, 2028
Loan interest rate		8.00%
Interest rate, payable in cash			5.75%
Interest rate, payable in additional notes			2.25%
Average closing price \| $ / shares			$ 0.20
Percentage of principal, premium			32.00%
Percentage of debt that is convertible			15.00%
Price trigger for convertibility \| $ / shares			$ 0.50
Percentage of principal converted	12.90%
Principal converted	$ 7,000,000
Conversion of notes into shares of common stock \| shares	14.3
Number of days for calculating average price			30 days
Conversion premium percentage			25.00%
Value of stock issuable under covenant			$ 3,590,200
Percentage of principal issuable under covenant			5.00%
Number of shares issuable \| shares			11.2
Amount of default, definition per agreement			$ 10,000,000
Percentage of debt holders required for acceleration of maturity			25.00%
Senior notes		$ 27,890,000	$ 25,547,000
Compound embedded derivative liability		56,752,000
Fair value		$ 84,642,000

LONG-TERM DEBT (5.00% Convertible Senior Notes) (Details)
$ / shares in Units, $ in Thousands

9 Months Ended

12 Months Ended

Sep. 30, 2013

USD ($)

$ / warrants

Dec. 31, 2011

USD ($)

$ / shares

Apr. 15, 2013

$ / shares

$ / warrants

Dec. 31, 2012

USD ($)

$ / warrants

Debt Instrument [Line Items]

Debt

$ 767,345

$ 800,121

5.00% Convertible Senior Unsecured Notes [Member]

Debt Instrument [Line Items]

Debt

$ 25,199

$ 38,000

$ 40,920

Convertible notes stated interest rate

5.00%

Number of common stock to be purchased with warrant | shares

15,200,000

Exercise price of warrants | $ / warrants

0.32

^[1]

0.32

1.25

^[1]

Conversion price per share of common stock | $ / shares

$ 1.25

$ 0.50

Number of shares of common stock convertible into

800

Notes maturity terms

The 5.0% Notes will mature at the earlier to occur of (i) December 14, 2021, or (ii) six months following the maturity date of the Facility Agreement and bear interest at a rate of 5.0% per annum. Interest on the 5.0% Notes is payable in-kind semi-annually in arrears on June 15 and December 15 of each year.

Notes Converted

$ 16,500

Shares issued upon conversions | shares

39,000,000

Number of shares issued upon exercise of warrants | shares

5,100,000

Proceeds from warrant exercise

$ 1,500

[1]	On April 15, 2013, the exercise price of the 5.0% Warrants was reset to $0.32 due to the reset provision in the indenture.

LONG-TERM DEBT (8.00% Convertible Senior Notes) (Details)
$ / shares in Units, shares in Millions, $ in Millions

9 Months Ended

12 Months Ended

Sep. 30, 2013

USD ($)

$ / shares

$ / warrants

Dec. 31, 2009

USD ($)

Dec. 31, 2012

$ / warrants

Debt Instrument [Line Items]

Aggregate principal amount convertible notes maximum borrowing capacity

$ 60.0

8.00% Convertible Senior Unsecured Notes, Issued in 2009 [Member]

Debt Instrument [Line Items]

Aggregate principal amount convertible notes maximum borrowing capacity

$ 55.0

Notes interest payment term

Interest is payable semi-annually in arrears on June 15 and December 15 of each year.

Convertible debt maturity date

Jun. 30, 2019

Convertible notes stated interest rate

8.00%

Exercise price of warrants | $ / warrants

^[1]

0.32

Conversion price per share of common stock | $ / shares

$ 1.19

Notes Converted

$ 17.6

Shares issued upon conversions | shares

16.1

Number of warrants exercised | shares

9.8

Warrants exercised

$ 9.4

Shares issued related to warrant exercised | shares

2.9

[1]	According to the terms of the indenture, additional 8.00% Warrants may be issued to holders if shares of common stock are issued below the then current warrant strike price.

LONG-TERM DEBT (Terrapin Opportunity, L.P. Common Stock Purchase Agreement) (Details) - USD ($)
shares in Millions, $ in Millions

3 Months Ended

9 Months Ended

Oct. 03, 2013

Aug. 19, 2013

^[1],[2]

Jul. 29, 2013

^[1],[2]

Jun. 28, 2013

^[3]

May 21, 2013

^[3]

May 20, 2013

^[3]

Sep. 30, 2013

Jun. 30, 2013

Sep. 30, 2013

^[4]

Dec. 28, 2012

LONG-TERM DEBT [Abstract]

Maximum value of shares required to be purchased per terms of stock purchase agreement

$ 30.0

Stock purchase agreement term

24 months

Minimum discount percentage per each share purchased under the stock purchase agreement

3.50%

Maximum discount percentage per each share purchased under the stock purchase agreement

8.00%

Maximum beneficial ownership percentage allowed per terms of stock purchase agreement

9.90%

Number of shares issued

6.1

Proceeds from common stock

$ 6.0

$ 6.5

$ 6.0

$ 9.0

$ 5.0

$ 25.0

$ 12.5

$ 39.0

$ 51.5

[1]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement.
[2]	The terms of the issuance price per share were determined in October 2013; therefore the shares were not issued as of September 30, 2013. The total fair value of the shares of $14.9 million was recorded on the Company's condensed consolidated balance sheet as future equity issuance of common stock to related party.
[3]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company's condensed consolidated balance sheet.
[4]	Pursuant to the terms of the Consent Agreement, certain equity transactions which result in cash invested into Globalstar may reduce the amounts committed by Thermo. As of September 30, 2013, the Company had received approximately $8.8 million due to cash received upon the termination of the share lending agreement and subsequent shares purchased by the borrower in that transaction and warrant exercises (see Note 4 for further discussion). These equity transactions reduced the remaining amounts available under the Consent Agreement to $24.7 million as of September 30, 2013.

LONG-TERM DEBT (Warrants Outstanding) (Details)

Sep. 30, 2013

$ / warrants

Apr. 15, 2013

$ / warrants

Dec. 31, 2012

$ / warrants

Class of Warrant or Right [Line Items]

Outstanding Warrants

107,042,946

122,480,294

Contingent Equity Agreement [Member]

Class of Warrant or Right [Line Items]

Outstanding Warrants

41,467,980

Strike Price | $ / warrants

0.01

Thermo Loan Agreement [Member]

Class of Warrant or Right [Line Items]

Outstanding Warrants

4,205,608

Strike Price | $ / warrants

0.01

5.00% Convertible Senior Unsecured Notes [Member]

Class of Warrant or Right [Line Items]

Outstanding Warrants

^[1]

9,600,000

15,200,000

Strike Price | $ / warrants

0.32

^[1]

0.32

1.25

^[1]

8.00% Convertible Senior Unsecured Notes, Issued in 2009 [Member]

Class of Warrant or Right [Line Items]

Outstanding Warrants

^[2]

51,769,358

61,606,706

Strike Price | $ / warrants

^[2]

0.32

[1]	On April 15, 2013, the exercise price of the 5.0% Warrants was reset to $0.32 due to the reset provision in the indenture.
[2]	According to the terms of the indenture, additional 8.00% Warrants may be issued to holders if shares of common stock are issued below the then current warrant strike price.

DERIVATIVES (Schedule of Fair Value of Derivative Instruments) (Details) - USD ($) $ in Thousands	Sep. 30, 2013	Dec. 31, 2012
Derivative assets:
Intangible and other assets, net	$ 170	$ 84
Derivative liabilities:
Derivative liabilities, current	(41,539)
Derivative liabilities, non-current	(254,207)	(25,175)
Total derivative liabilities, current and non-current	(295,746)	(25,175)
Interest Rate Cap [Member]
Derivative assets:
Intangible and other assets, net	170	84
Compound Embedded Derivative with 8.00% Notes Issued in 2009 [Member]
Derivative liabilities:
Derivative liabilities, non-current	(41,396)	(4,163)
Warrants Issued with 8.0% Notes Issued in 2009 [Member]
Derivative liabilities:
Derivative liabilities, current	(41,539)
Derivative liabilities, non-current		(18,034)
Contingent Put Feature Embedded in the 5.0% Notes [Member]
Derivative liabilities:
Derivative liabilities, non-current	(845)	(2,978)
Compound Embedded Conversion Option with 8.0% Notes Issued in 2013 [Member]
Derivative liabilities:
Derivative liabilities, non-current	(74,399)
Compound Embedded Derivative with Amended and Restated Thermo Loan Agreement [Member]
Derivative liabilities:
Derivative liabilities, non-current	$ (137,567)

DERIVATIVES (Schedule of Derivative Gain (Loss)) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	$ (97,534)	$ (16,473)	$ (126,911)	$ (2,562)
Interest Rate Cap [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	(30)	(39)	86	(161)
Compound Embedded Derivative with 8.00% Notes Issued in 2009 [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	(29,986)	(2,417)	(37,233)	1,287
Warrants Issued with 8.0% Notes Issued in 2009 [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	(6,323)	(13,963)	(28,949)	(4,031)
Warrants Issued in Conjunction with Contingent Equity Agreement [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)				301
Contingent Put Feature Embedded in the 5.0% Notes [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	848	(54)	2,133	42
Compound Embedded Conversion Option with 8.0% Notes Issued in 2013 [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	(25,590)		(26,495)
Compound Embedded Derivative with Amended and Restated Thermo Loan Agreement [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	$ (36,453)		$ (36,453)

DERIVATIVES (Additional Information) (Details) $ in Millions	9 Months Ended
	Sep. 30, 2013 USD ($) contracts
Interest Rate Cap [Member]
Derivative [Line Items]
Number of Interest rate cap agreements \| contracts	5
Interest rate cap agreements period	10 years
Interest cap rate description	The interest rate cap provides limits on the six-month Libor rate ("Base Rate") used to calculate the coupon interest on outstanding amounts on the Facility Agreement and is capped at 5.50% should the Base Rate not exceed 6.5%.
Interest Rate Cap [Member] \| Minimum [Member]
Derivative [Line Items]
Interest cap rate notional amount	$ 14.8
Interest Rate Cap [Member] \| Maximum [Member]
Derivative [Line Items]
Interest cap rate notional amount	$ 586.3
Interest Rate Cap [Member] \| Six-month LIBOR Rate [Member]
Derivative [Line Items]
Interest on outstanding amounts on the Facility Agreement	6.50%
Base rate to be capped, should the Base Rate not exceed 6.50%	5.50%
Base rate to be lowered from LIBOR, should the base rate exceed 6.50%	(1.00%)
Fee for interest rate cap agreements	$ 12.4
Warrants Issued in Conjunction with Contingent Equity Agreement [Member]
Derivative [Line Items]
Amortization period	1 year

FAIR VALUE MEASUREMENTS (Financial Assets and Liabilities Measured at Fair Value on Recurring Basis) (Details) - USD ($) $ in Thousands	Sep. 30, 2013	Dec. 31, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate cap	$ 170	$ 84
Derivative liabilities	(295,746)	(25,175)
Interest Rate Cap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate cap	170	84
Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	170	84
Derivative liabilities	(295,746)	(25,175)
Liability for contingent consideration	(2,375)	(3,916)
Total liabilities measured at fair value	(298,121)	(29,091)
Fair Value, Measurements, Recurring [Member] \| Interest Rate Cap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate cap	170	84
Fair Value, Measurements, Recurring [Member] \| Compound Embedded Derivative with 8.00% Notes Issued in 2009 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	(41,396)	(4,163)
Fair Value, Measurements, Recurring [Member] \| Warrants Issued with 8.0% Notes Issued in 2009 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	(41,539)	(18,034)
Fair Value, Measurements, Recurring [Member] \| Contingent Put Feature Embedded in the 5.0% Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	(845)	(2,978)
Fair Value, Measurements, Recurring [Member] \| Compound Embedded Conversion Option with 8.0% Notes Issued in 2013 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	(74,399)
Fair Value, Measurements, Recurring [Member] \| Compound Embedded Derivative with Amended and Restated Thermo Loan Agreement [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	(137,567)
Fair Value, Measurements, Recurring [Member] \| Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value
Derivative liabilities
Liability for contingent consideration
Total liabilities measured at fair value
Fair Value, Measurements, Recurring [Member] \| Level 1 [Member] \| Interest Rate Cap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate cap
Fair Value, Measurements, Recurring [Member] \| Level 1 [Member] \| Compound Embedded Derivative with 8.00% Notes Issued in 2009 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Fair Value, Measurements, Recurring [Member] \| Level 1 [Member] \| Warrants Issued with 8.0% Notes Issued in 2009 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Fair Value, Measurements, Recurring [Member] \| Level 1 [Member] \| Contingent Put Feature Embedded in the 5.0% Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Fair Value, Measurements, Recurring [Member] \| Level 1 [Member] \| Compound Embedded Conversion Option with 8.0% Notes Issued in 2013 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Fair Value, Measurements, Recurring [Member] \| Level 1 [Member] \| Compound Embedded Derivative with Amended and Restated Thermo Loan Agreement [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Fair Value, Measurements, Recurring [Member] \| Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	170	84
Derivative liabilities
Liability for contingent consideration
Total liabilities measured at fair value
Fair Value, Measurements, Recurring [Member] \| Level 2 [Member] \| Interest Rate Cap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate cap	170	84
Fair Value, Measurements, Recurring [Member] \| Level 2 [Member] \| Compound Embedded Derivative with 8.00% Notes Issued in 2009 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Fair Value, Measurements, Recurring [Member] \| Level 2 [Member] \| Warrants Issued with 8.0% Notes Issued in 2009 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Fair Value, Measurements, Recurring [Member] \| Level 2 [Member] \| Contingent Put Feature Embedded in the 5.0% Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Fair Value, Measurements, Recurring [Member] \| Level 2 [Member] \| Compound Embedded Conversion Option with 8.0% Notes Issued in 2013 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Fair Value, Measurements, Recurring [Member] \| Level 2 [Member] \| Compound Embedded Derivative with Amended and Restated Thermo Loan Agreement [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities
Fair Value, Measurements, Recurring [Member] \| Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value
Derivative liabilities	(295,746)	(25,175)
Liability for contingent consideration	(2,375)	(3,916)
Total liabilities measured at fair value	(298,121)	(29,091)
Fair Value, Measurements, Recurring [Member] \| Level 3 [Member] \| Interest Rate Cap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate cap
Fair Value, Measurements, Recurring [Member] \| Level 3 [Member] \| Compound Embedded Derivative with 8.00% Notes Issued in 2009 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	(41,396)	(4,163)
Fair Value, Measurements, Recurring [Member] \| Level 3 [Member] \| Warrants Issued with 8.0% Notes Issued in 2009 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	(41,539)	(18,034)
Fair Value, Measurements, Recurring [Member] \| Level 3 [Member] \| Contingent Put Feature Embedded in the 5.0% Notes [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	(845)	$ (2,978)
Fair Value, Measurements, Recurring [Member] \| Level 3 [Member] \| Compound Embedded Conversion Option with 8.0% Notes Issued in 2013 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	(74,399)
Fair Value, Measurements, Recurring [Member] \| Level 3 [Member] \| Compound Embedded Derivative with Amended and Restated Thermo Loan Agreement [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	$ (137,567)

FAIR VALUE MEASUREMENTS (Schedule of Significant Quantitative Level 3 Inputs Utilized) (Details) - $ / shares

1 Months Ended

9 Months Ended

12 Months Ended

May 20, 2013

Jul. 31, 2013

Sep. 30, 2013

Dec. 31, 2012

Aug. 19, 2013

^[2],[3]

Jul. 29, 2013

^[2],[3]

Jun. 28, 2013

^[1]

May 21, 2013

^[1]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Market Price of Common Stock

$ 0.40

^[1]

$ 0.62

$ 0.55

$ 0.40

Compound Embedded Derivative with 8.00% Notes Issued in 2009 [Member]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Risk-Free Interest Rate

1.30%

Note Conversion Price/Warrant Exercise Price

$ 1.19

$ 1.59

Market Price of Common Stock

$ 1.09

$ 0.31

Compound Embedded Derivative with 8.00% Notes Issued in 2009 [Member] | Minimum [Member]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

65.00%

34.00%

Risk-Free Interest Rate

0.02%

Note Conversion Price/Warrant Exercise Price

$ 1.00

Compound Embedded Derivative with 8.00% Notes Issued in 2009 [Member] | Maximum [Member]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

100.00%

107.00%

Risk-Free Interest Rate

1.78%

Warrants Issued with 8.0% Notes Issued in 2009 [Member]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Risk-Free Interest Rate

0.10%

Note Conversion Price/Warrant Exercise Price

$ 0.32

Market Price of Common Stock

1.09

$ 0.31

Warrants Issued with 8.0% Notes Issued in 2009 [Member] | Minimum [Member]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

34.00%

Risk-Free Interest Rate

0.02%

Warrants Issued with 8.0% Notes Issued in 2009 [Member] | Maximum [Member]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

107.00%

Risk-Free Interest Rate

1.78%

Contingent Put Feature Embedded in the 5.0% Notes [Member]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Note Conversion Price/Warrant Exercise Price

0.50

$ 1.25

Market Price of Common Stock

$ 1.09

$ 0.31

Common stock price as a percent of conversion price

200.00%

Contingent Put Feature Embedded in the 5.0% Notes [Member] | Minimum [Member]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

33.00%

34.00%

Risk-Free Interest Rate

0.03%

0.02%

Contingent Put Feature Embedded in the 5.0% Notes [Member] | Maximum [Member]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

106.00%

107.00%

Risk-Free Interest Rate

2.64%

1.78%

Compound Embedded Conversion Option with 8.0% Notes Issued in 2013 [Member]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Risk-Free Interest Rate

0.90%

1.30%

Note Conversion Price/Warrant Exercise Price

$ 0.80

$ 0.75

Discount Rate

27.00%

Market Price of Common Stock

$ 0.40

$ 1.09

Compound Embedded Conversion Option with 8.0% Notes Issued in 2013 [Member] | Minimum [Member]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

65.00%

Compound Embedded Conversion Option with 8.0% Notes Issued in 2013 [Member] | Maximum [Member]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

100.00%

Compound Embedded Derivative with Amended and Restated Thermo Loan Agreement [Member]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Risk-Free Interest Rate

2.60%

Note Conversion Price/Warrant Exercise Price

$ 0.75

Discount Rate

26.00%

Market Price of Common Stock

$ 0.60

$ 1.09

Compound Embedded Derivative with Amended and Restated Thermo Loan Agreement [Member] | Minimum [Member]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

65.00%

Compound Embedded Derivative with Amended and Restated Thermo Loan Agreement [Member] | Maximum [Member]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

100.00%

[1]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company's condensed consolidated balance sheet.
[2]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement.
[3]	The terms of the issuance price per share were determined in October 2013; therefore the shares were not issued as of September 30, 2013. The total fair value of the shares of $14.9 million was recorded on the Company's condensed consolidated balance sheet as future equity issuance of common stock to related party.

FAIR VALUE MEASUREMENTS (Additional Information) (Details) - Axonn [Member] - USD ($) $ in Millions	1 Months Ended	9 Months Ended
	Dec. 31, 2009	Sep. 30, 2013
Fair Value Measurements [Line Items]
Contingent consideration for earnouts	$ 10.8	$ 9.4
Additional earnout payment period	5 years
Company outstanding common stock, percent	10.00%
Common stock, shares outstanding	26,684,807
Earnout payments		$ 6.6
Shares to be issued to exercise cash payment option for earnout payments	13,000,000
Issuance of voting common stock shares for settlement of earnout payments		17,531,459
Fair value of contingent consideration		$ 2.4

FAIR VALUE MEASUREMENTS (Reconciliation of Assets and Liabilities Measured at Fair Value on Recurring Basis) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2013
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	$ (113,749)	$ (29,091)
Third party issuance costs expensed to derivative gain (loss) in connection with Issuance of 8.00% Notes Issued in 2013		(905)
Change in fair value of contingent consideration	443	190
Unrealized loss, included in derivative gain (loss)	(97,502)	(125,186)
Ending balance	(298,121)	(298,121)
Guarantees [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Earnout payments made/Adjustments related to conversions and exercises	415	1,351
Derivative Financial Instruments, Liabilities [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Earnout payments made/Adjustments related to conversions and exercises	13,386	13,386
Compound Embedded Derivative with Amended and Restated Thermo Loan Agreement [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Issuance of compound embedded derivatives	$ (101,114)	(101,114)
Compound Embedded Conversion Option with 8.0% Notes Issued in 2013 [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Issuance of compound embedded derivatives		$ (56,752)

FAIR VALUE MEASUREMENTS (Nonrecurring Fair Value Measurements) (Details) - USD ($)
$ / shares in Units, $ in Thousands

3 Months Ended

9 Months Ended

Oct. 14, 2013

Oct. 03, 2013

Aug. 19, 2013

Jul. 29, 2013

^[2],[3]

Jul. 19, 2013

Jun. 28, 2013

^[4]

May 21, 2013

^[4]

May 20, 2013

Dec. 26, 2013

Sep. 30, 2013

Jun. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2012

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Derivative liability

$ 295,746

$ 25,175

Loss on extinguishment of debt

$ (63,569)

$ (110,809)

Number of shares issued

12,500,000

^[1],[2],[3]

11,538,462

^[1]

28,125,000

^[1]

15,625,000

^[1]

78,125,000

^[1],[4]

24,000,000

121,900,000

145,913,462

^[1],[5]

Proceeds from common stock

$ 6,000

$ 6,500

^[2],[3]

$ 6,000

$ 9,000

$ 5,000

$ 25,000

^[4]

$ 12,500

$ 39,000

$ 51,500

^[5]

Shares issued, price per share

$ 0.52

^[2],[3]

$ 0.52

$ 0.32

^[4]

Fair value of equity

67,300

Additional Paid-in Capital [Member]

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Fair value of equity

53,000

Other Additional Capital [Member]

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Fair value of equity

14,900

Thermo Capital Partners LLC [Member]

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Number of shares issued

11,538,461

Shares issued, price per share

$ 0.52

Thermo Capital Partners LLC [Member] | Scenario, Plan [Member]

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Proceeds from common stock

$ 20,000

Shares issued, price per share

$ 0.52

Thermo Capital Partners LLC [Member] | Scenario, Forecast [Member]

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Number of shares issued

38,461,538

Proceeds from common stock

$ 13,500

$ 11,500

Shares issued, price per share

$ 0.52

Percentage of average closing price

85.00%

5.75% Convertible Senior Unsecured Notes [Member]

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Fair value of notes payable

$ 119,000

Debt conversion, shares issued

30,300,000

Debt conversion, value of shares issued

$ 12,100

Loss on extinguishment of debt

(47,200)

Debt instrument, carrying amount

71,800

8.00% Convertible Senior Unsecured Notes, Issued in 2013 [Member]

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Fair value of notes payable

27,900

Derivative liability

56,700

Debt conversion, shares issued

14,300,000

Debt conversion, value of shares issued

54,600

Fair value of debt

$ 84,642

Thermo Loan Agreement [Member]

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Fair value of notes payable

19,000

Derivative liability

101,100

Loss on extinguishment of debt

(66,100)

Fair value of debt

$ 120,100

[1]	All shares issued to Thermo in connection with these agreements were shares of the Company's nonvoting common stock.
[2]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement.
[3]	The terms of the issuance price per share were determined in October 2013; therefore the shares were not issued as of September 30, 2013. The total fair value of the shares of $14.9 million was recorded on the Company's condensed consolidated balance sheet as future equity issuance of common stock to related party.
[4]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company's condensed consolidated balance sheet.
[5]	Pursuant to the terms of the Consent Agreement, certain equity transactions which result in cash invested into Globalstar may reduce the amounts committed by Thermo. As of September 30, 2013, the Company had received approximately $8.8 million due to cash received upon the termination of the share lending agreement and subsequent shares purchased by the borrower in that transaction and warrant exercises (see Note 4 for further discussion). These equity transactions reduced the remaining amounts available under the Consent Agreement to $24.7 million as of September 30, 2013.

FAIR VALUE MEASUREMENTS (Schedule of Amounts Invested) (Details) - USD ($)
$ / shares in Units, $ in Thousands

3 Months Ended

9 Months Ended

Oct. 03, 2013

Aug. 19, 2013

^[1],[2]

Jul. 29, 2013

^[1],[2]

Jun. 28, 2013

^[3]

May 21, 2013

^[3]

May 20, 2013

^[3]

Sep. 30, 2013

Jun. 30, 2013

Sep. 30, 2013

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Amount Invested

$ 6,000

$ 6,500

$ 6,000

$ 9,000

$ 5,000

$ 25,000

$ 12,500

$ 39,000

$ 51,500

^[4]

Issuance Price per Share

$ 0.52

$ 0.32

Closing Price per Share

$ 0.62

$ 0.55

$ 0.40

Discount Value

^[5]

$ 1,250

$ 1,154

$ 6,469

$ 1,250

$ 6,250

$ 16,373

^[4]

16,373

^[4]

Total Fair Value

$ 7,750

$ 7,154

$ 15,469

$ 6,250

$ 31,250

$ 67,873

^[4]

Shares Issued

12,500,000

^[6]

11,538,462

^[6]

28,125,000

^[6]

15,625,000

^[6]

78,125,000

^[6]

24,000,000

121,900,000

145,913,462

^[4],[6]

Fair value of investment

$ 67,300

Other capital contributions from Thermo

8,800

Remaining amounts available under the Consent Agreement

24,700

Additional Paid-in Capital [Member]

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Fair value of investment

53,000

Other Additional Capital [Member]

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Fair value of investment

$ 14,900

[1]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement.
[2]	The terms of the issuance price per share were determined in October 2013; therefore the shares were not issued as of September 30, 2013. The total fair value of the shares of $14.9 million was recorded on the Company's condensed consolidated balance sheet as future equity issuance of common stock to related party.
[3]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company's condensed consolidated balance sheet.
[4]	Pursuant to the terms of the Consent Agreement, certain equity transactions which result in cash invested into Globalstar may reduce the amounts committed by Thermo. As of September 30, 2013, the Company had received approximately $8.8 million due to cash received upon the termination of the share lending agreement and subsequent shares purchased by the borrower in that transaction and warrant exercises (see Note 4 for further discussion). These equity transactions reduced the remaining amounts available under the Consent Agreement to $24.7 million as of September 30, 2013.
[5]	The discount on shares issued is recorded on the Company's condensed consolidated statement of operations in loss on equity issuance. This expense item represents the discount on shares issued to Thermo as well as certain other losses recorded on equity issued during 2013 related to cashless warrant exercises of the Company's 5% Notes.
[6]	All shares issued to Thermo in connection with these agreements were shares of the Company's nonvoting common stock.

ACCRUED EXPENSES AND NON-CURRENT LIABILITIES (Accrued Expenses) (Details) - USD ($) $ in Thousands	Sep. 30, 2013	Dec. 31, 2012
ACCRUED EXPENSES AND NON-CURRENT LIABILITIES [Abstract]
Accrued interest	$ 10,712	$ 5,620
Accrued compensation and benefits	3,737	4,076
Accrued property and other taxes	6,713	6,329
Accrued customer liabilities and deposits	2,666	2,961
Accrued professional and other service provider fees	966	1,006
Accrued liability for contingent consideration	2,021	2,585
Accrued commissions	1,079	685
Accrued telecommunications expenses	621	713
Accrued satellite and ground costs	486	373
Other accrued expenses	3,827	3,816
Total accrued expenses	$ 32,828	$ 28,164

ACCRUED EXPENSES AND NON-CURRENT LIABILITIES (Non-current Liabilities) (Details) - USD ($) $ in Thousands	Sep. 30, 2013	Dec. 31, 2012
ACCRUED EXPENSES AND NON-CURRENT LIABILITIES [Abstract]
Long-term accrued interest	$ 1,932	$ 457
Asset retirement obligation	1,062	998
Deferred rent	447	579
Liabilities related to the Cooperative Endeavor Agreement with the State of Louisiana	1,536	1,949
Long-term portion of liability for contingent consideration	354	1,332
Uncertain income tax positions	5,399	5,571
Foreign tax contingencies	4,681	4,994
Non-current liabilities	$ 15,411	$ 15,880

COMMITMENTS (Details) - USD ($) $ in Millions	9 Months Ended
COMMITMENTS (Details) - USD ($) $ in Millions	Sep. 30, 2013	Jun. 30, 2013	Dec. 31, 2012
Qualcomm Incorporated [Member]
Commitments [Line Items]
Advances for inventory	$ 9.2		$ 9.2
Hughes Network Systems LLC [Member]
Commitments [Line Items]
Deferred payments interest rate incurred	10.00%
Accounts payable and accrued expenses	$ 10.0	$ 15.8
Costs incurred under capital expenditure contracts	72.6
Outstanding interest	$ 4.9
Discount for payment in stock	7.00%
Hughes Network Systems LLC [Member] \| First Payment [Member]
Commitments [Line Items]
Payment debt	$ 5.8
Hughes Network Systems LLC [Member] \| Second Payment [Member]
Commitments [Line Items]
Payment debt	5.0
Hughes Network Systems LLC [Member] \| Third Payment [Member]
Commitments [Line Items]
Payment debt	5.0
Hughes Network Systems LLC [Member] \| Termination Liability [Member]
Commitments [Line Items]
Payment debt	$ 20.0
Deferred payments interest rate incurred	15.00%
Ericsson Inc. [Member]
Commitments [Line Items]
Payments to vendor	$ 1.6
Deferred payments interest rate incurred	6.50%
Accounts payable and accrued expenses	$ 0.7
Costs incurred under capital expenditure contracts	6.8
Contract termination liability	10.0
Deferred milestone payments	$ 2.3
Discount for payment in stock	5.00%
Ericsson Inc. [Member] \| First Payment [Member]
Commitments [Line Items]
Payment debt	$ 0.1

CONTINGENCIES (Details) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
CONTINGENCIES (Details) $ in Thousands	May 31, 2012 EUR (€)	Sep. 30, 2013 USD ($)	Sep. 30, 2012 USD ($)	Sep. 30, 2013 USD ($)	Sep. 30, 2013 EUR (€)	Sep. 30, 2012 USD ($)
Loss Contingencies [Line Items]
Contract termination charge \| $						$ 22,048
Thales Alenia Space [Member] \| Settlement Agreement [Member]
Loss Contingencies [Line Items]
Contract termination charge					€ 17,500,000
Contract termination, damages paid					€ 17,530,000
Thales Alenia Space [Member] \| Arbitration [Member]
Loss Contingencies [Line Items]
Contract termination, damages sought	€ 51,330,875.00
Contract termination, damages awarded	53,000,000
Thales Alenia Space [Member] \| Discharge of Debt [Member]
Loss Contingencies [Line Items]
Contract termination, damages sought	€ 35,623,770

RELATED PARTY TRANSACTIONS (Additional Information) (Details) - USD ($)
$ in Thousands

1 Months Ended

3 Months Ended

9 Months Ended

Oct. 03, 2013

Aug. 19, 2013

^[1],[2]

Jul. 29, 2013

^[1],[2]

Jun. 28, 2013

^[3]

May 21, 2013

^[3]

May 20, 2013

^[3]

Oct. 31, 2013

Aug. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Jul. 31, 2013

Dec. 31, 2012

Payables to Thermo and other affiliates

$ 300

$ 200

Maximum borrowing capacity

60,000

Proceeds from Common Stock Purchase Agreement

$ 6,000

$ 6,500

$ 6,000

$ 9,000

$ 5,000

$ 25,000

12,500

$ 39,000

51,500

^[4]

Loss on sale of equity issuance

2,733

$ 14,000

16,701

Proceeds from contingent equity agreement

$ 1,100

$ 1,071

23,000

Number of shares issued

6,100,000

Discount on shares

20.00%

Loss on extinguishment of debt

(63,569)

$ (110,809)

Thermo Loan Agreement [Member]

Fair value of debt

$ 120,100

Thermo Capital Partners LLC [Member]

Deposit to contingent equity account

60,000

Short-term loan converted into nonvoting common stock

2,300

Maximum borrowing capacity

37,500

Loss on sale of equity issuance

2,404

16,373

Number of shares issued

2,133,656

Loss on extinguishment of debt

(66,088)

Thermo Capital Partners LLC [Member] | 5.00% Convertible Senior Unsecured Notes [Member]

Notes purchased by related party

20,000

Thermo Capital Partners LLC [Member] | 8.00% Convertible Senior Unsecured Notes, Issued in 2009 [Member]

Notes purchased by related party

$ 11,400

[1]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement.
[2]	The terms of the issuance price per share were determined in October 2013; therefore the shares were not issued as of September 30, 2013. The total fair value of the shares of $14.9 million was recorded on the Company's condensed consolidated balance sheet as future equity issuance of common stock to related party.
[3]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company's condensed consolidated balance sheet.
[4]	Pursuant to the terms of the Consent Agreement, certain equity transactions which result in cash invested into Globalstar may reduce the amounts committed by Thermo. As of September 30, 2013, the Company had received approximately $8.8 million due to cash received upon the termination of the share lending agreement and subsequent shares purchased by the borrower in that transaction and warrant exercises (see Note 4 for further discussion). These equity transactions reduced the remaining amounts available under the Consent Agreement to $24.7 million as of September 30, 2013.

RELATED PARTY TRANSACTIONS (Expense Incurred on Behalf of Company) (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2013	Jun. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Related Party Transaction [Line Items]
Non-cash expenses				$ 16,701
Loss on sale of equity issuance	$ 2,733	$ 14,000		16,701
Loss on extinguishment of debt related to amendment and restatement of Thermo Loan Agreement	63,569			110,809
Thermo Capital Partners LLC [Member]
Related Party Transaction [Line Items]
General and administrative expense	74		30	229	230
Non-cash expenses	137		132	411	396
Loss on sale of equity issuance	2,404			16,373
Loss on extinguishment of debt related to amendment and restatement of Thermo Loan Agreement	66,088			66,088
Total	$ 68,703		$ 162	$ 83,101	$ 626

INCOME TAXES (Details) - USD ($) $ in Millions	Sep. 30, 2013	Dec. 31, 2012
Foreign Tax Authority [Member]
Income Tax Contingency [Line Items]
Tax liability	$ 2.6	$ 2.8

ACCUMULATED OTHER COMPREHENSIVE LOSS (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
ACCUMULATED OTHER COMPREHENSIVE LOSS [Abstract]
Accumulated other comprehensive loss, beginning balance	$ (2,408)	$ (2,551)	$ (1,758)	$ (3,100)
Other comprehensive income (loss):
Foreign currency translation adjustments	553	1,119	(97)	1,668
Accumulated other comprehensive loss, ending balance	$ (1,855)	$ (1,432)	$ (1,855)	$ (1,432)

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References + Details

STOCK COMPENSATION (Additional Information) (Details)		1 Months Ended		3 Months Ended		9 Months Ended
STOCK COMPENSATION (Additional Information) (Details)	Jun. 28, 2013 $ / shares	Jul. 31, 2013 USD ($) $ / shares	Oct. 31, 2011 shares	Sep. 30, 2013 USD ($) shares	Sep. 30, 2012 USD ($) shares	Sep. 30, 2013 USD ($) offerings shares	Sep. 30, 2012 USD ($) shares
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]
Number of common stock offerings annually \| offerings						2
Percentage of share that can be purchased by eligible employees to their total compensation				15.00%		15.00%
Maximum value of shares that can be purchased by eligible employee \| $						$ 25,000
Maximum number of shares that can be purchased by eligible employee						500,000
Percentage of fair market value of common stock payed by employee						85.00%
Company issued shares related to this stock purchase plan						1,868,401
Options granted				1,238,000	373,000	2,681,000	1,135,000
Amortization of stock based compensation \| $		$ 600,000		$ 800,000
Employee Stock Option [Member]
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]
Stock-based compensation expense \| $				800,000	$ 100,000	$ 900,000	$ 200,000
Options granted			2,710,000
Share price triggering vesting \| $ / shares	$ 2.50	$ 0.80
Restricted Stock Units (RSUs) [Member]
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]
Restricted shares granted			273,000
Selling, General and Administrative Expenses [Member]
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]
Stock-based compensation expense \| $				$ 100,000	$ 100,000	$ 200,000	$ 100,000

STOCK COMPENSATION (Grants to Eligible Participants of Incentive Stock Options, Restricted Stock Awards and Restricted Stock Units) (Details) - shares	1 Months Ended	3 Months Ended		9 Months Ended
	Oct. 31, 2011	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total		1,238,000	373,000	2,681,000	1,135,000
Restricted Stock Awards And Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock award (unit) grants		14,000	342,000	852,000	721,000
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option grants		1,224,000	31,000	1,829,000	414,000
Total	2,710,000

HEADQUARTERS RELOCATION (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
HEADQUARTERS RELOCATION (Details) - USD ($) $ in Thousands	Sep. 30, 2013	Dec. 31, 2011
Restructuring Cost and Reserve [Line Items]
Relocation expenses		$ 4,200
Increase in property and equipment facility improvements and replacement equipment in connection with relocation		$ 1,300
Reimbursements for capital expenditures recorded as deferred costs	$ 1,300
Contract Termination [Member]
Restructuring Cost and Reserve [Line Items]
Reimbursement for lease and other expense per year through 2019	352
Cooperative Endeavor Agreement [Member] \| Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Cost of reimbursement expense	$ 8,100

GEOGRAPHIC INFORMATION (Information by Geographic Area Revenues) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Segment Reporting Information [Line Items]
Service revenues	$ 17,056	$ 15,368	$ 47,854	$ 42,146
Subscriber equipment revenues	5,493	5,169	13,863	15,110
Total revenue	22,549	20,537	61,717	57,256
United States [Member]
Segment Reporting Information [Line Items]
Service revenues	11,660	11,051	33,666	29,926
Subscriber equipment revenues	3,688	3,633	8,756	10,724
Canada [Member]
Segment Reporting Information [Line Items]
Service revenues	3,446	2,836	9,123	7,827
Subscriber equipment revenues	1,201	887	2,964	2,555
Europe [Member]
Segment Reporting Information [Line Items]
Service revenues	1,185	732	2,736	2,223
Subscriber equipment revenues	327	287	1,228	939
Central and South America [Member]
Segment Reporting Information [Line Items]
Service revenues	625	640	1,918	1,897
Subscriber equipment revenues	177	220	712	701
Other Countries [Member]
Segment Reporting Information [Line Items]
Service revenues	140	109	411	273
Subscriber equipment revenues	$ 100	$ 142	$ 203	$ 191

GEOGRAPHIC INFORMATION (Information by Geographic Area, Long-Lived Assets) (Details) - USD ($) $ in Thousands	Sep. 30, 2013	Dec. 31, 2012
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	$ 1,187,288	$ 1,215,156
United States [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	181,700	1,209,374
Canada [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	221	277
Europe [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	417	474
Central and South America [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	3,677	3,463
Other Countries [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	$ 1,273	$ 1,568

LOSS PER SHARE (Details) - shares		1 Months Ended		3 Months Ended
LOSS PER SHARE (Details) - shares	Oct. 03, 2013	Oct. 31, 2013	Jul. 31, 2013	Sep. 30, 2013	Dec. 31, 2012
Class of Stock [Line Items]
Number of shares issued	6,100,000
Total shares outstanding under the Company's Share Lending Agreement					17,300,000
Shares returned			10,200,000
Number of shares settled in cash			7,100,000
Thermo Capital Partners LLC [Member]
Class of Stock [Line Items]
Number of shares issued		2,133,656
Nonvoting Common Stock [Member] \| Thermo Capital Partners LLC [Member]
Class of Stock [Line Items]
Number of shares issued		2,100,000		24,000,000

SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION (Supplemental Condensed Consolidating Statement of Operations) (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2013	Jun. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenue:
Service revenues	$ 17,056		$ 15,368	$ 47,854	$ 42,146
Subscriber equipment sales	5,493		5,169	13,863	15,110
Total revenue	22,549		20,537	61,717	57,256
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	8,181		7,413	22,913	22,218
Cost of subscriber equipment sales	4,148		4,040	10,675	10,465
Cost of subscriber equipment sales - reduction in the value of inventory			660		957
Marketing, general, and administrative	9,079		7,425	22,579	21,062
Reduction in the value of long-lived assets					7,218
Contract termination charge					22,048
Depreciation, amortization, and accretion	23,715		18,654	66,114	49,277
Total operating expenses	45,123		38,192	122,281	133,245
Loss from operations	(22,574)		(17,655)	(60,564)	(75,989)
Other income (expense):
Loss on extinguishment of debt	(63,569)			(110,809)
Loss on equity issuance	(2,733)	$ (14,000)		(16,701)
Interest income and expense, net of amounts capitalized	(16,901)		(6,565)	(39,869)	(13,396)
Derivative gain (loss)	(97,534)		(16,473)	(126,911)	(2,562)
Other	(1,540)		(439)	(1,125)	(938)
Total other income (expense)	(182,277)		(23,477)	(295,415)	(16,896)
Loss before income taxes	(204,851)		(41,132)	(355,979)	(92,885)
Income tax expense	118		56	341	361
Net loss	(204,969)		(41,188)	(356,320)	(93,246)
Comprehensive loss	(204,417)		(40,069)	(356,417)	(91,578)
Reportable Legal Entities [Member] \| Parent Company [Member]
Revenue:
Service revenues	18,726		14,296	50,351	35,609
Subscriber equipment sales	127		255	287	809
Total revenue	18,853		14,551	50,638	36,418
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	3,125		2,922	8,233	8,995
Cost of subscriber equipment sales	90		134	90	284
Cost of subscriber equipment sales - reduction in the value of inventory					2
Marketing, general, and administrative	2,008		4,098	4,555	12,176
Reduction in the value of long-lived assets					79
Contract termination charge					22,048
Depreciation, amortization, and accretion	19,645		13,313	52,538	32,789
Total operating expenses	24,868		20,467	65,416	76,373
Loss from operations	(6,015)		(5,916)	(14,778)	(39,955)
Other income (expense):
Loss on extinguishment of debt	(63,569)			(110,809)
Loss on equity issuance	(2,733)			(16,701)
Interest income and expense, net of amounts capitalized	(16,636)		(6,172)	(38,728)	(12,126)
Derivative gain (loss)	(97,534)		(16,473)	(126,911)	(2,562)
Equity in subsidiary earnings	(17,090)		(12,120)	(47,313)	(37,737)
Other	(1,343)		(456)	(909)	(687)
Total other income (expense)	(198,905)		(35,221)	(341,371)	(53,112)
Loss before income taxes	(204,920)		(41,137)	(356,149)	(93,067)
Income tax expense	49		51	171	179
Net loss	(204,969)		(41,188)	(356,320)	(93,246)
Comprehensive loss	(204,969)		(41,188)	(356,320)	(93,246)
Reportable Legal Entities [Member] \| Guarantor Subsidiaries [Member]
Revenue:
Service revenues	2,478		10,832	8,544	30,528
Subscriber equipment sales	4,254		4,138	10,018	12,328
Total revenue	6,732		14,970	18,562	42,856
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	3,126		4,152	7,947	7,936
Cost of subscriber equipment sales	3,334		4,742	8,048	9,420
Cost of subscriber equipment sales - reduction in the value of inventory			658		904
Marketing, general, and administrative	4,666		1,377	11,710	3,292
Reduction in the value of long-lived assets					7,139
Contract termination charge
Depreciation, amortization, and accretion	4,914		13,782	15,936	36,817
Total operating expenses	16,040		24,711	43,641	65,508
Loss from operations	(9,308)		(9,741)	(25,079)	(22,652)
Other income (expense):
Loss on extinguishment of debt
Loss on equity issuance
Interest income and expense, net of amounts capitalized	(3)		(1)	(39)	(7)
Derivative gain (loss)
Equity in subsidiary earnings	(1,729)		2,205	(2,794)	6,703
Other	(171)		(117)	(170)	(12)
Total other income (expense)	(1,903)		2,087	(3,003)	6,684
Loss before income taxes	(11,211)		(7,654)	(28,082)	(15,968)
Income tax expense	6		(18)	35	30
Net loss	(11,217)		(7,636)	(28,117)	(15,998)
Comprehensive loss	(11,217)		(7,636)	(28,117)	(15,998)
Reportable Legal Entities [Member] \| Non-Guarantor Subsidiaries [Member]
Revenue:
Service revenues	4,940		4,002	13,320	11,609
Subscriber equipment sales	1,070		2,941	13,264	5,676
Total revenue	6,010		6,943	26,584	17,285
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	1,941		2,133	6,791	6,369
Cost of subscriber equipment sales	1,819		3,780	14,323	5,377
Cost of subscriber equipment sales - reduction in the value of inventory			2		51
Marketing, general, and administrative	3,774		3,229	9,895	8,945
Reduction in the value of long-lived assets
Contract termination charge
Depreciation, amortization, and accretion	6,485		4,338	17,167	12,343
Total operating expenses	14,019		13,482	48,176	33,085
Loss from operations	(8,009)		(6,539)	(21,592)	(15,800)
Other income (expense):
Loss on extinguishment of debt
Loss on equity issuance
Interest income and expense, net of amounts capitalized	(262)		(394)	(1,098)	(1,261)
Derivative gain (loss)
Equity in subsidiary earnings
Other	(21)		218	(124)	(163)
Total other income (expense)	(283)		(176)	(1,222)	(1,424)
Loss before income taxes	(8,292)		(6,715)	(22,814)	(17,224)
Income tax expense	63		23	135	152
Net loss	(8,355)		(6,738)	(22,949)	(17,376)
Comprehensive loss	(7,803)		(5,619)	(23,046)	(15,708)
Eliminations [Member]
Revenue:
Service revenues	(9,088)		(13,762)	(24,361)	(35,600)
Subscriber equipment sales	42		(2,165)	(9,706)	(3,703)
Total revenue	(9,046)		(15,927)	(34,067)	(39,303)
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	(11)		(1,794)	(58)	(1,082)
Cost of subscriber equipment sales	(1,095)		(4,616)	(11,786)	(4,616)
Cost of subscriber equipment sales - reduction in the value of inventory
Marketing, general, and administrative	(1,369)		(1,279)	(3,581)	(3,351)
Reduction in the value of long-lived assets
Contract termination charge
Depreciation, amortization, and accretion	(7,329)		(12,779)	(19,527)	(32,672)
Total operating expenses	(9,804)		(20,468)	(34,952)	(41,721)
Loss from operations	758		4,541	885	2,418
Other income (expense):
Loss on extinguishment of debt
Loss on equity issuance
Interest income and expense, net of amounts capitalized			2	(4)	(2)
Derivative gain (loss)
Equity in subsidiary earnings	18,819		9,915	50,107	31,034
Other	(5)		(84)	78	(76)
Total other income (expense)	18,814		9,833	50,181	30,956
Loss before income taxes	19,572		14,374	51,066	33,374
Income tax expense
Net loss	19,572		14,374	51,066	33,374
Comprehensive loss	$ 19,572		$ 14,374	$ 51,066	$ 33,374

SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION (Supplemental Condensed Consolidating Balance Sheet) (Details) - USD ($) $ in Thousands	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 6,643	$ 11,792	$ 1,219	$ 9,951
Restricted cash		46,777
Accounts receivable	16,444	13,944
Inventory	37,482	42,181
Deferred financing costs		34,622
Prepaid expenses and other current assets	7,583	5,233
Total current assets	68,152	154,549
Property and equipment, net	1,187,288	1,215,156
Restricted cash	37,940
Deferred financing costs	79,861	16,883
Advances for inventory	9,158	9,158
Intangible and other assets, net	7,375	8,029
Total assets	1,389,774	1,403,775
Current liabilities:
Current portion of long-term debt		655,874
Accounts payable	26,444	35,685
Accrued contract termination charge	23,699	23,166
Accrued expenses	32,828	28,164
Payables to affiliates	303	230
Derivative liabilities	41,539
Deferred revenue	17,822	18,041
Total current liabilities	142,635	761,160
Long-term debt, less current portion	675,690	95,155
Employee benefit obligations	7,117	7,221
Derivative liabilities	254,207	25,175
Deferred revenue	7,317	4,640
Debt restructuring fees	20,795
Other non-current liabilities	15,411	15,880
Total non-current liabilities	980,537	148,071
Stockholders' equity	266,602	494,544
Total liabilities and stockholders' equity	1,389,774	1,403,775
Reportable Legal Entities [Member] \| Parent Company [Member]
Current assets:
Cash and cash equivalents	4,298	10,220	451	7,343
Restricted cash		46,777
Accounts receivable	4,430	3,814
Intercompany receivables	624,466	613,426
Inventory	399	262
Deferred financing costs		34,622
Prepaid expenses and other current assets	4,525	2,177
Total current assets	638,118	711,298
Property and equipment, net	1,165,336	1,095,973
Restricted cash	37,940
Intercompany notes receivable	13,629	15,783
Investment in subsidiaries	(187,026)	(144,323)
Deferred financing costs	79,861	16,883
Advances for inventory	9,158	9,158
Intangible and other assets, net	4,104	3,991
Total assets	1,761,120	1,708,763
Current liabilities:
Current portion of long-term debt		655,874
Accounts payable	21,331	12,055
Accrued contract termination charge	23,699	23,166
Accrued expenses	15,613	6,492
Intercompany payables	421,710	377,526
Payables to affiliates	303	230
Derivative liabilities	41,539
Deferred revenue	1,743	4,576
Total current liabilities	525,938	1,079,919
Long-term debt, less current portion	675,690	95,155
Employee benefit obligations	7,117	7,221
Intercompany notes payable
Derivative liabilities	254,207	25,175
Deferred revenue	6,760	4,306
Debt restructuring fees	20,795
Other non-current liabilities	4,011	2,443
Total non-current liabilities	968,580	134,300
Stockholders' equity	266,602	494,544
Total liabilities and stockholders' equity	1,761,120	1,708,763
Reportable Legal Entities [Member] \| Guarantor Subsidiaries [Member]
Current assets:
Cash and cash equivalents	359	251	225	587
Restricted cash
Accounts receivable	6,512	4,875
Intercompany receivables	408,029	411,764
Inventory	14,941	6,966
Deferred financing costs
Prepaid expenses and other current assets	415	388
Total current assets	430,256	424,244
Property and equipment, net	16,413	31,382
Restricted cash
Intercompany notes receivable
Investment in subsidiaries	2,794	(8,232)
Deferred financing costs
Advances for inventory
Intangible and other assets, net	1,216	1,781
Total assets	450,679	449,175
Current liabilities:
Current portion of long-term debt
Accounts payable	2,514	2,410
Accrued contract termination charge
Accrued expenses	8,522	9,798
Intercompany payables	510,497	494,686
Payables to affiliates
Derivative liabilities
Deferred revenue	13,923	12,674
Total current liabilities	535,456	519,568
Long-term debt, less current portion
Employee benefit obligations
Intercompany notes payable
Derivative liabilities
Deferred revenue	557	334
Debt restructuring fees
Other non-current liabilities	625	2,233
Total non-current liabilities	1,182	2,567
Stockholders' equity	(85,959)	(72,960)
Total liabilities and stockholders' equity	450,679	449,175
Reportable Legal Entities [Member] \| Non-Guarantor Subsidiaries [Member]
Current assets:
Cash and cash equivalents	1,986	1,321	543	2,021
Restricted cash
Accounts receivable	5,502	5,255
Intercompany receivables	17,463	5,534
Inventory	22,142	34,953
Deferred financing costs
Prepaid expenses and other current assets	2,643	2,668
Total current assets	49,736	49,731
Property and equipment, net	7,198	86,762
Restricted cash
Intercompany notes receivable	1,800	1,800
Investment in subsidiaries
Deferred financing costs
Advances for inventory
Intangible and other assets, net	2,065	2,273
Total assets	60,799	140,566
Current liabilities:
Current portion of long-term debt
Accounts payable	2,599	21,220
Accrued contract termination charge
Accrued expenses	8,693	11,874
Intercompany payables	118,452	156,166
Payables to affiliates
Derivative liabilities
Deferred revenue	2,156	791
Total current liabilities	131,900	190,051
Long-term debt, less current portion
Employee benefit obligations
Intercompany notes payable	14,529	16,683
Derivative liabilities
Deferred revenue
Debt restructuring fees
Other non-current liabilities	10,775	11,204
Total non-current liabilities	25,304	27,887
Stockholders' equity	(96,405)	(77,372)
Total liabilities and stockholders' equity	60,799	140,566
Eliminations [Member]
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable
Intercompany receivables	(1,049,958)	(1,030,724)
Inventory
Deferred financing costs
Prepaid expenses and other current assets
Total current assets	(1,049,958)	(1,030,724)
Property and equipment, net	(1,659)	1,039
Restricted cash
Intercompany notes receivable	(15,429)	(17,583)
Investment in subsidiaries	184,232	152,555
Deferred financing costs
Advances for inventory
Intangible and other assets, net	(10)	(16)
Total assets	(882,824)	(894,729)
Current liabilities:
Current portion of long-term debt
Accounts payable
Accrued contract termination charge
Accrued expenses
Intercompany payables	(1,050,659)	(1,028,378)
Payables to affiliates
Derivative liabilities
Deferred revenue
Total current liabilities	(1,050,659)	(1,028,378)
Long-term debt, less current portion
Employee benefit obligations
Intercompany notes payable	(14,529)	(16,683)
Derivative liabilities
Deferred revenue
Debt restructuring fees
Other non-current liabilities
Total non-current liabilities	(14,529)	(16,683)
Stockholders' equity	182,364	150,332
Total liabilities and stockholders' equity	$ (882,824)	$ (894,729)

SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION (Supplemental Condensed Consolidating Statement of Cash Flows) (Details) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended
	Aug. 31, 2013	Sep. 30, 2013	Sep. 30, 2012
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities		$ 2,334	$ 10,878
Cash flows from investing activities:
Second-generation satellites, ground and related launch costs		(37,732)	(43,305)
Property and equipment additions		(1,225)	(382)
Investment in businesses		(496)	(450)
Restricted cash		8,838	(3,650)
Net cash used in investing activities		(30,615)	(47,787)
Cash flows from financing activities:
Proceeds from issuance of common stock and stock options		8,979	100
Borrowings from Facility Agreement		672	5,008
Proceeds from contingent equity account	$ 1,100	1,071	23,000
Payments to reduce principal amount of exchanged 5.75% Notes		(13,544)
Payments to reduce principal amount of 5.75% Notes not exchanged		(6,250)
Payments to lenders and other fees associated with exchange		(2,482)
Proceeds for equity issuance to related party		51,500
Payment of deferred financing costs		(16,904)	(250)
Net cash provided by financing activities		23,042	27,858
Effect of exchange rate changes on cash and cash equivalents		90	319
Net decrease in cash and cash equivalents		(5,149)	(8,732)
Cash and cash equivalents, beginning of period		11,792	9,951
Cash and cash equivalents, end of period		6,643	1,219
Reportable Legal Entities [Member] \| Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities		426	12,655
Cash flows from investing activities:
Second-generation satellites, ground and related launch costs		(37,732)	(43,305)
Property and equipment additions
Investment in businesses		(496)	(450)
Restricted cash		8,838	(3,650)
Net cash used in investing activities		(29,390)	(47,405)
Cash flows from financing activities:
Proceeds from issuance of common stock and stock options		8,979	100
Borrowings from Facility Agreement		672	5,008
Proceeds from contingent equity account		1,071	23,000
Payments to reduce principal amount of exchanged 5.75% Notes		(13,544)
Payments to reduce principal amount of 5.75% Notes not exchanged		(6,250)
Payments to lenders and other fees associated with exchange		(2,482)
Proceeds for equity issuance to related party		51,500
Payment of deferred financing costs		(16,904)	(250)
Net cash provided by financing activities		23,042	27,858
Effect of exchange rate changes on cash and cash equivalents
Net decrease in cash and cash equivalents		(5,922)	(6,892)
Cash and cash equivalents, beginning of period		10,220	7,343
Cash and cash equivalents, end of period		4,298	451
Reportable Legal Entities [Member] \| Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities		814	(165)
Cash flows from investing activities:
Second-generation satellites, ground and related launch costs
Property and equipment additions		(706)	(197)
Investment in businesses
Restricted cash
Net cash used in investing activities		(706)	(197)
Cash flows from financing activities:
Proceeds from issuance of common stock and stock options
Borrowings from Facility Agreement
Proceeds from contingent equity account
Payments to reduce principal amount of exchanged 5.75% Notes
Payments to reduce principal amount of 5.75% Notes not exchanged
Payments to lenders and other fees associated with exchange
Proceeds for equity issuance to related party
Payment of deferred financing costs
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents
Net decrease in cash and cash equivalents		108	(362)
Cash and cash equivalents, beginning of period		251	587
Cash and cash equivalents, end of period		359	225
Reportable Legal Entities [Member] \| Non-Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities		1,094	(1,612)
Cash flows from investing activities:
Second-generation satellites, ground and related launch costs
Property and equipment additions		(519)	(185)
Investment in businesses
Restricted cash
Net cash used in investing activities		(519)	(185)
Cash flows from financing activities:
Proceeds from issuance of common stock and stock options
Borrowings from Facility Agreement
Proceeds from contingent equity account
Payments to reduce principal amount of exchanged 5.75% Notes
Payments to reduce principal amount of 5.75% Notes not exchanged
Payments to lenders and other fees associated with exchange
Proceeds for equity issuance to related party
Payment of deferred financing costs
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents		90	319
Net decrease in cash and cash equivalents		665	(1,478)
Cash and cash equivalents, beginning of period		1,321	2,021
Cash and cash equivalents, end of period		1,986	543
Eliminations [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities
Cash flows from investing activities:
Second-generation satellites, ground and related launch costs
Property and equipment additions
Investment in businesses
Restricted cash
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from issuance of common stock and stock options
Borrowings from Facility Agreement
Proceeds from contingent equity account
Payments to reduce principal amount of exchanged 5.75% Notes
Payments to reduce principal amount of 5.75% Notes not exchanged
Payments to lenders and other fees associated with exchange
Proceeds for equity issuance to related party
Payment of deferred financing costs
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents
Net decrease in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period